[{"text":"RT @edqm_news: See the new design with helpful charts in the latest Certification statistics report http://t.co/ceSI0HyjbG","id":"567324406578679808","created_at":"2015-02-16T14:07:33.000Z","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/ceSI0HyjbG","expanded_url":"http://bit.ly/1EtO2jF","display_url":"bit.ly/1EtO2jF"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567324406578679808","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567320388112486400"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: Unique opportunities for early career researchers to be actively involved in #EFSAExpo2015 conference  https://t.co/QTBE79cvl0","id":"567324329525137408","created_at":"2015-02-16T14:07:15.000Z","entities":{"urls":[{"start":116,"end":139,"url":"https://t.co/QTBE79cvl0","expanded_url":"https://www.youtube.com/watch?v=eYOc189bqUA","display_url":"youtube.com/watch?v=eYOc18…"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":90,"end":103,"tag":"EFSAExpo2015"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567324329525137408","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567318556766113792"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: EMA: Human medicines highlights - January 2015 http://t.co/ydUDX5FiFM http://t.co/Gova5LzFuB","id":"567311448230350848","created_at":"2015-02-16T13:16:04.000Z","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/ydUDX5FiFM","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Newsletter/2015/02/WC500181876.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"},{"start":83,"end":105,"url":"http://t.co/Gova5LzFuB","expanded_url":"https://twitter.com/GCessak/status/567311400453025794/photo/1","display_url":"pic.twitter.com/Gova5LzFuB"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567311448230350848","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567311400453025794"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_567311399404064769"]}},{"text":"We've published the assessment report for #Otezla (#apremilast), for plaque #psoriasis and psoriatic #arthritis: http://t.co/1fn1Sq8n9a","id":"567303169412460544","created_at":"2015-02-16T12:43:10.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/1fn1Sq8n9a","expanded_url":"http://bit.ly/1zi2RmU","display_url":"bit.ly/1zi2RmU"}],"mentions":{},"hashtags":[{"start":42,"end":49,"tag":"Otezla"},{"start":51,"end":62,"tag":"apremilast"},{"start":76,"end":86,"tag":"psoriasis"},{"start":101,"end":111,"tag":"arthritis"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567303169412460544","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AlzheimerEurope: Want to know the objectives of the European Prevention of #Alzheimer's #Dementia (#EPAD) project @IMI_EPAD? http://t.c…","id":"567300995768942592","created_at":"2015-02-16T12:34:31.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":118,"end":127,"username":"IMI_EPAD","id":"2979700941"}],"hashtags":[{"start":79,"end":89,"tag":"Alzheimer"},{"start":92,"end":101,"tag":"Dementia"},{"start":103,"end":108,"tag":"EPAD"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567300995768942592","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567300588543942656"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AlzheimerEurope: Want to know who partners are on @IMI_EPAD project - #research initiative on #Alzheimer’s #dementia prevention? #EPAD …","id":"567300961140740096","created_at":"2015-02-16T12:34:23.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":54,"end":63,"username":"IMI_EPAD","id":"2979700941"}],"hashtags":[{"start":74,"end":83,"tag":"research"},{"start":98,"end":108,"tag":"Alzheimer"},{"start":111,"end":120,"tag":"dementia"},{"start":133,"end":138,"tag":"EPAD"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567300961140740096","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567300555526393859"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: Identify methods to prioritise communicable disease threats for emergency preparedness planning: A literature review http://t.…","id":"567300906820304896","created_at":"2015-02-16T12:34:10.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567300906820304896","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567298675542851585"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: The last monthly activity report for the #Certification of Substances Division is now available! http://t.co/ceSI0HyjbG","id":"567293740654813184","created_at":"2015-02-16T12:05:42.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/ceSI0HyjbG","expanded_url":"http://bit.ly/1EtO2jF","display_url":"bit.ly/1EtO2jF"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":56,"end":70,"tag":"Certification"}],"annotations":[{"start":74,"end":92,"probability":0.3881,"type":"Other","normalized_text":"Substances Division"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567293740654813184","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567290483417051137"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The assessment report for #Ofev (#nibtedanib), a #medicine to treat idiopathic #pulmonary #fibrosis, is available: http://t.co/iuwlQjKzkV","id":"567266477678788608","created_at":"2015-02-16T10:17:22.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/iuwlQjKzkV","expanded_url":"http://bit.ly/1KSYHt8","display_url":"bit.ly/1KSYHt8"}],"mentions":{},"hashtags":[{"start":26,"end":31,"tag":"Ofev"},{"start":33,"end":44,"tag":"nibtedanib"},{"start":49,"end":58,"tag":"medicine"},{"start":79,"end":89,"tag":"pulmonary"},{"start":90,"end":99,"tag":"fibrosis"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"567266477678788608","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Scenesse (#afamelanotide) to treat #erythropoietic #protoporphyria: http://t.co/7gKzmnQXLo","id":"567266327162023937","created_at":"2015-02-16T10:16:46.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/7gKzmnQXLo","expanded_url":"http://bit.ly/1ElF2xW","display_url":"bit.ly/1ElF2xW"}],"mentions":{},"hashtags":[{"start":42,"end":51,"tag":"Scenesse"},{"start":53,"end":67,"tag":"afamelanotide"},{"start":78,"end":93,"tag":"erythropoietic"},{"start":94,"end":109,"tag":"protoporphyria"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567266327162023937","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The highlights of last week's meeting of our #veterinary #medicines committee (CVMP) are available on our website: http://t.co/RJNRKgJnTy","id":"567266146496557056","created_at":"2015-02-16T10:16:03.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/RJNRKgJnTy","expanded_url":"http://bit.ly/1ElP4Pt","display_url":"bit.ly/1ElP4Pt"}],"mentions":{},"hashtags":[{"start":45,"end":56,"tag":"veterinary"},{"start":57,"end":67,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567266146496557056","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our #pharmacovigilance committee has recommended measures to minimise heart risks of #hydroxyzine #medicines: http://t.co/vctSkE2aju","id":"567265875393519616","created_at":"2015-02-16T10:14:58.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/vctSkE2aju","expanded_url":"http://bit.ly/1B5QcZW","display_url":"bit.ly/1B5QcZW"}],"mentions":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":85,"end":97,"tag":"hydroxyzine"},{"start":98,"end":108,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"567265875393519616","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The highlights of last week's #pharmacovigilance committee (PRAC) meeting are available on our website: http://t.co/SahS4bPDLM","id":"567265697987063808","created_at":"2015-02-16T10:14:16.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/SahS4bPDLM","expanded_url":"http://bit.ly/1yvZo2W","display_url":"bit.ly/1yvZo2W"}],"mentions":{},"hashtags":[{"start":30,"end":48,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567265697987063808","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Step-by-step training on the main functionalities of #CombiStats – Places are limited, sign up now! http://t.co/sbx4LtcILU","id":"567264588161630208","created_at":"2015-02-16T10:09:51.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/sbx4LtcILU","expanded_url":"http://bit.ly/1EC9nYY","display_url":"bit.ly/1EC9nYY"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":68,"end":79,"tag":"CombiStats"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567264588161630208","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"567261178360246274"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @LV_MPA: New recommendations for reducing the risk of cardiovascular side effects with hydroxyzine http://t.co/kwImUgRwyJ","id":"567264104730337281","created_at":"2015-02-16T10:07:56.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/kwImUgRwyJ","expanded_url":"http://bit.ly/1vyd7WP","display_url":"bit.ly/1vyd7WP"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"567264104730337281","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@TomMathies This Committee is part of the decision-making process at @EU_Commission. Please contact them for details of the next meeting.","id":"567263719328325632","created_at":"2015-02-16T10:06:24.000Z","entities":{"urls":{},"mentions":[{"start":0,"end":11,"username":"TomMathies","id":"358759878"},{"start":69,"end":83,"username":"EU_Commission","id":"157981564"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"566308262027739137","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"566308262027739137"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"358759878"},{"text":"We've published the EPAR for #Cerdelga (#eliglustat), a #medicine to treat type-1 #Gaucher #disease: http://t.co/5bjDsBo2Zk","id":"566300910587244544","created_at":"2015-02-13T18:20:33.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/5bjDsBo2Zk","expanded_url":"http://bit.ly/1KRXPow","display_url":"bit.ly/1KRXPow"}],"mentions":{},"hashtags":[{"start":29,"end":38,"tag":"Cerdelga"},{"start":40,"end":51,"tag":"eliglustat"},{"start":56,"end":65,"tag":"medicine"},{"start":82,"end":90,"tag":"Gaucher"},{"start":91,"end":99,"tag":"disease"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566300910587244544","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#Consultation on revising #guidance on developing new agents to treat #disease due to #Mycobacterium #tuberculosis: http://t.co/sSkMYKSXan","id":"566300804509102080","created_at":"2015-02-13T18:20:07.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/sSkMYKSXan","expanded_url":"http://bit.ly/1FAYSqj","display_url":"bit.ly/1FAYSqj"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":26,"end":35,"tag":"guidance"},{"start":70,"end":78,"tag":"disease"},{"start":86,"end":100,"tag":"Mycobacterium"},{"start":101,"end":114,"tag":"tuberculosis"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566300804509102080","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#Consultation on data requirements for veterinary medicines to stop vector-borne disease transmission in dogs &amp; cats: http://t.co/zT342ZupGv","id":"566300714545471490","created_at":"2015-02-13T18:19:46.000Z","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/zT342ZupGv","expanded_url":"http://bit.ly/1EkygIL","display_url":"bit.ly/1EkygIL"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566300714545471490","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Ofev (#nibtedanib), a #medicine to treat idiopathic #pulmonary #fibrosis: http://t.co/iuwlQjKzkV","id":"566281925858701312","created_at":"2015-02-13T17:05:06.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/iuwlQjKzkV","expanded_url":"http://bit.ly/1KSYHt8","display_url":"bit.ly/1KSYHt8"}],"mentions":{},"hashtags":[{"start":42,"end":47,"tag":"Ofev"},{"start":49,"end":60,"tag":"nibtedanib"},{"start":65,"end":74,"tag":"medicine"},{"start":95,"end":105,"tag":"pulmonary"},{"start":106,"end":115,"tag":"fibrosis"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566281925858701312","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the highlights of this week's meeting of our #veterinary #medicines committee (CVMP): http://t.co/RJNRKgJnTy","id":"566267990770216960","created_at":"2015-02-13T16:09:44.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/RJNRKgJnTy","expanded_url":"http://bit.ly/1ElP4Pt","display_url":"bit.ly/1ElP4Pt"}],"mentions":{},"hashtags":[{"start":61,"end":72,"tag":"veterinary"},{"start":73,"end":83,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566267990770216960","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Assessment report published for #Scenesse (#afamelanotide), an #implant to treat #erythropoietic #protoporphyria: http://t.co/7gKzmnQXLo","id":"566260066626834432","created_at":"2015-02-13T15:38:15.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/7gKzmnQXLo","expanded_url":"http://bit.ly/1ElF2xW","display_url":"bit.ly/1ElF2xW"}],"mentions":{},"hashtags":[{"start":32,"end":41,"tag":"Scenesse"},{"start":43,"end":57,"tag":"afamelanotide"},{"start":63,"end":71,"tag":"implant"},{"start":81,"end":96,"tag":"erythropoietic"},{"start":97,"end":112,"tag":"protoporphyria"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566260066626834432","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #Vacancy – Call for Head of Scientific Evaluation of Regulated Products Department. Apply by 2 March http://t.co/j7SLxnbBvF","id":"566257469056634880","created_at":"2015-02-13T15:27:55.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/j7SLxnbBvF","expanded_url":"http://bit.ly/1yL9ph5","display_url":"bit.ly/1yL9ph5"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":21,"tag":"Vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566257469056634880","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"566220252229677056"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: More time to #apply and become our new legal #adviser (AD5). Send your application by Monday 23 February http://t.co/fZlbqZsI0s","id":"566257397019443200","created_at":"2015-02-13T15:27:38.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/fZlbqZsI0s","expanded_url":"http://bit.ly/15xbvBD","display_url":"bit.ly/15xbvBD"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"hashtags":[{"start":26,"end":32,"tag":"apply"},{"start":58,"end":66,"tag":"adviser"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566257397019443200","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"566223246694313984"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: February edition of 'Vigilances' bulletin now available: http://t.co/56MS61vBYJ http://t.co/EndEJSgn5v","id":"566256841999798273","created_at":"2015-02-13T15:25:26.000Z","entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/56MS61vBYJ","expanded_url":"http://bit.ly/1F5OSYD","display_url":"bit.ly/1F5OSYD"},{"start":90,"end":112,"url":"http://t.co/EndEJSgn5v","expanded_url":"http://bit.ly/1F5OUQd","display_url":"bit.ly/1F5OUQd"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"hashtags":{},"annotations":[{"start":31,"end":40,"probability":0.2931,"type":"Other","normalized_text":"Vigilances"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566256841999798273","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSA to hold open meeting on its draft #caffeine opinion. Registration closes 20 February. http://t.co/Wx0CMOlURf http://t.co…","id":"566256423450189824","created_at":"2015-02-13T15:23:46.000Z","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/Wx0CMOlURf","expanded_url":"http://bit.ly/1KSJPcg","display_url":"bit.ly/1KSJPcg"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":53,"end":62,"tag":"caffeine"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566256423450189824","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"566231392691159040"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: #Flu season continues at full pace. Get an overview of its impact on the #EU with the weekly @ECDC_EU #infographic http://t.c…","id":"566256395440627712","created_at":"2015-02-13T15:23:39.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":107,"end":115,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":14,"end":18,"tag":"Flu"},{"start":87,"end":90,"tag":"EU"},{"start":116,"end":128,"tag":"infographic"}],"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566256395440627712","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"566233157511700481"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAMedia: FDA approves new drug for differentiated thyroid cancer http://t.co/VtO81WXE2Z","id":"566256160798703616","created_at":"2015-02-13T15:22:43.000Z","entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/VtO81WXE2Z","expanded_url":"http://go.usa.gov/3qFAA","display_url":"go.usa.gov/3qFAA"}],"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"hashtags":{},"annotations":[{"start":14,"end":16,"probability":0.8623,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566256160798703616","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"566248258268573697"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Outbreaks: @ECDC_EU is looking for experienced epidemiologists, fluent in French, to join its #Ebola response teams in Guinea: htt…","id":"566256115017867264","created_at":"2015-02-13T15:22:33.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"ECDC_Outbreaks","id":"2754484003"},{"start":20,"end":28,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":103,"end":109,"tag":"Ebola"}],"annotations":[{"start":128,"end":133,"probability":0.8355,"type":"Place","normalized_text":"Guinea"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566256115017867264","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"566249572599861248"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @escardio: Read the report on Multimodality Imaging (with ESCR), from SCMR/EuroCMR Congress http://t.co/H4DOpzU0GI","id":"566256001599680512","created_at":"2015-02-13T15:22:05.000Z","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/H4DOpzU0GI","expanded_url":"http://bit.ly/1yvTKxH","display_url":"bit.ly/1yvTKxH"}],"mentions":[{"start":3,"end":12,"username":"escardio","id":"21572529"}],"hashtags":{},"annotations":[{"start":33,"end":53,"probability":0.3919,"type":"Organization","normalized_text":"Multimodality Imaging"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566256001599680512","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"566253213930631168"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Did you know that online prices for #EDQM publications are 10% cheaper than catalogue prices? Browse our catalogue! http://t…","id":"566255954980007936","created_at":"2015-02-13T15:21:54.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":51,"end":56,"tag":"EDQM"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566255954980007936","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"566255410207010816"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#Pharmacovigilance committee recommends measures to minimise known heart risks of #hydroxyzine-containing #medicines: http://t.co/vctSkE2aju","id":"566213201604653056","created_at":"2015-02-13T12:32:01.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/vctSkE2aju","expanded_url":"http://bit.ly/1B5QcZW","display_url":"bit.ly/1B5QcZW"}],"mentions":{},"hashtags":[{"start":0,"end":18,"tag":"Pharmacovigilance"},{"start":82,"end":94,"tag":"hydroxyzine"},{"start":106,"end":116,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"566213201604653056","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the highlights of this week's #pharmacovigilance committee (PRAC) meeting: http://t.co/SahS4bPDLM","id":"566212712066473985","created_at":"2015-02-13T12:30:04.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/SahS4bPDLM","expanded_url":"http://bit.ly/1yvZo2W","display_url":"bit.ly/1yvZo2W"}],"mentions":{},"hashtags":[{"start":46,"end":64,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566212712066473985","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Cerdelga (#eliglustat), a #medicine to treat type-1 #Gaucher #disease: http://t.co/5bjDsBo2Zk","id":"566206897985175554","created_at":"2015-02-13T12:06:58.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/5bjDsBo2Zk","expanded_url":"http://bit.ly/1KRXPow","display_url":"bit.ly/1KRXPow"}],"mentions":{},"hashtags":[{"start":42,"end":51,"tag":"Cerdelga"},{"start":53,"end":64,"tag":"eliglustat"},{"start":69,"end":78,"tag":"medicine"},{"start":95,"end":103,"tag":"Gaucher"},{"start":104,"end":112,"tag":"disease"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"566206897985175554","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#Consultation on revising #guidance on developing new agents to treat disease due to #Mycobacterium #tuberculosis: http://t.co/sSkMYKSXan","id":"566205778168926208","created_at":"2015-02-13T12:02:31.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/sSkMYKSXan","expanded_url":"http://bit.ly/1FAYSqj","display_url":"bit.ly/1FAYSqj"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":26,"end":35,"tag":"guidance"},{"start":85,"end":99,"tag":"Mycobacterium"},{"start":100,"end":113,"tag":"tuberculosis"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566205778168926208","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Comment on data requirements for veterinary #medicines to prevent vector-borne disease transmission in dogs and cats: http://t.co/zT342ZupGv","id":"566191871790440448","created_at":"2015-02-13T11:07:16.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/zT342ZupGv","expanded_url":"http://bit.ly/1EkygIL","display_url":"bit.ly/1EkygIL"}],"mentions":{},"hashtags":[{"start":44,"end":54,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566191871790440448","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Exviera (#dasabuvir), a new #medicine for #hepatitisC: http://t.co/vE2rtnwNu7","id":"566190995986214912","created_at":"2015-02-13T11:03:47.000Z","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/vE2rtnwNu7","expanded_url":"http://bit.ly/1yrgpLK","display_url":"bit.ly/1yrgpLK"}],"mentions":{},"hashtags":[{"start":42,"end":50,"tag":"Exviera"},{"start":52,"end":62,"tag":"dasabuvir"},{"start":71,"end":80,"tag":"medicine"},{"start":85,"end":96,"tag":"hepatitisC"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"566190995986214912","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#Consultation open on the draft European Union #herbal monograph on #Hedera helix L., folium (#ivy leaf): http://t.co/Mmy9w2bp9Z","id":"566190956589113344","created_at":"2015-02-13T11:03:38.000Z","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/Mmy9w2bp9Z","expanded_url":"http://bit.ly/1CiC6Cp","display_url":"bit.ly/1CiC6Cp"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":47,"end":54,"tag":"herbal"},{"start":68,"end":75,"tag":"Hedera"},{"start":94,"end":98,"tag":"ivy"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"566190956589113344","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Exviera (#dasabuvir), a new #medicine for #hepatitisC: http://t.co/vE2rtnwNu7","id":"565950383907147778","created_at":"2015-02-12T19:07:41.000Z","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/vE2rtnwNu7","expanded_url":"http://bit.ly/1yrgpLK","display_url":"bit.ly/1yrgpLK"}],"mentions":{},"hashtags":[{"start":42,"end":50,"tag":"Exviera"},{"start":52,"end":62,"tag":"dasabuvir"},{"start":71,"end":80,"tag":"medicine"},{"start":85,"end":96,"tag":"hepatitisC"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"565950383907147778","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAWomen: BLOG: #Measles #Vaccine is safe and effective – and should be used: http://t.co/qo4INTYDLd","id":"565949500460904448","created_at":"2015-02-12T19:04:10.000Z","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/qo4INTYDLd","expanded_url":"http://go.usa.gov/3qfwz","display_url":"go.usa.gov/3qfwz"}],"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"}],"hashtags":[{"start":20,"end":28,"tag":"Measles"},{"start":29,"end":37,"tag":"Vaccine"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565949500460904448","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565931894488199168"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EMCDDA: Just published: our 2015 work programme: http://t.co/WXRSwR6CsE","id":"565948855544725504","created_at":"2015-02-12T19:01:36.000Z","entities":{"urls":[{"start":53,"end":75,"url":"http://t.co/WXRSwR6CsE","expanded_url":"http://www.emcdda.europa.eu/publications/work-programmes/2015","display_url":"emcdda.europa.eu/publications/w…"}],"mentions":[{"start":3,"end":10,"username":"EMCDDA","id":"50638521"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565948855544725504","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565912545224310784"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Two #CEP case study workshops offered as part of the #PhEur Training Session http://t.co/piNNV3dEuu #european #pharmacopoeia","id":"565917912578670592","created_at":"2015-02-12T16:58:39.000Z","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/piNNV3dEuu","expanded_url":"http://bit.ly/1yNjdao","display_url":"bit.ly/1yNjdao"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":19,"end":23,"tag":"CEP"},{"start":68,"end":74,"tag":"PhEur"},{"start":115,"end":124,"tag":"european"},{"start":125,"end":139,"tag":"pharmacopoeia"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565917912578670592","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565908689178353664"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: New avian #influenza A(H7N9) cases reported in China; seasonal pattern beginning to emerge: http://t.co/Uv68yVokQX","id":"565917784618860544","created_at":"2015-02-12T16:58:08.000Z","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/Uv68yVokQX","expanded_url":"http://bit.ly/1KNC6hF","display_url":"bit.ly/1KNC6hF"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"hashtags":[{"start":24,"end":34,"tag":"influenza"}],"annotations":[{"start":61,"end":65,"probability":0.9938,"type":"Place","normalized_text":"China"}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565917784618860544","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565906761761423360"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Eurovaccine: Surveillance of infant #pertussis in #Sweden 1998–2012; severity of disease in relation to national vaccination prog http:…","id":"565917647540604928","created_at":"2015-02-12T16:57:36.000Z","entities":{"urls":{},"mentions":{},"hashtags":[{"start":40,"end":50,"tag":"pertussis"},{"start":54,"end":61,"tag":"Sweden"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565917647540604928","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565904468102094849"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Are you a professional working in a blood establishment? Our Symposium may be of interest to you http://t.co/bfYYDFuzMu","id":"565917199563776000","created_at":"2015-02-12T16:55:49.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/bfYYDFuzMu","expanded_url":"http://bit.ly/1KI2NT0","display_url":"bit.ly/1KI2NT0"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565917199563776000","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565890013666504706"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: Read the ECHA #Newsletter and learn about substituting #SVHCs, #chemicals in textiles and much more. http://t.co/2PklC14uFX","id":"565916873527939072","created_at":"2015-02-12T16:54:31.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/2PklC14uFX","expanded_url":"http://bit.ly/16XGyLG","display_url":"bit.ly/16XGyLG"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"hashtags":[{"start":27,"end":38,"tag":"Newsletter"},{"start":68,"end":74,"tag":"SVHCs"},{"start":76,"end":86,"tag":"chemicals"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565916873527939072","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565887846364762112"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: Have your say on #EFSA - @WHO experts report on threshold of toxicological concern approach http://t.co/zgu9dz3ks7","id":"565916790900154368","created_at":"2015-02-12T16:54:11.000Z","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/zgu9dz3ks7","expanded_url":"http://bit.ly/1EfoXKa","display_url":"bit.ly/1EfoXKa"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":38,"end":42,"username":"WHO","id":"14499829"}],"hashtags":[{"start":30,"end":35,"tag":"EFSA"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565916790900154368","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565887184583274497"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: The Biocidal Products Committee adopts 13 opinions on five active substances in 10 product types http://t.co/BykglIT7Em #Bioci…","id":"565916624482734080","created_at":"2015-02-12T16:53:32.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/BykglIT7Em","expanded_url":"http://bit.ly/1zVIHll","display_url":"bit.ly/1zVIHll"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"hashtags":{},"annotations":[{"start":17,"end":43,"probability":0.6969,"type":"Organization","normalized_text":"Biocidal Products Committee"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565916624482734080","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565885602349199361"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: '€5 Million for #CysticFibrosis patients' http://t.co/LufQtuNIXX #eHealth #H2020 #mHealth @MyCyFAPP","id":"565916443410448385","created_at":"2015-02-12T16:52:48.000Z","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/LufQtuNIXX","expanded_url":"http://europa.eu/!Mx87UK","display_url":"europa.eu/!Mx87UK"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":106,"end":115,"username":"MyCyFAPP","id":"3005409143"}],"hashtags":[{"start":32,"end":47,"tag":"CysticFibrosis"},{"start":81,"end":89,"tag":"eHealth"},{"start":90,"end":96,"tag":"H2020"},{"start":97,"end":105,"tag":"mHealth"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565916443410448385","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565883999193923584"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_MCMi: Feb 24 webinar for pharmacy students: Introduction to FDA’s MedWatch Adverse Reporting Program http://t.co/4mfDWOdZVn","id":"565916360908476419","created_at":"2015-02-12T16:52:29.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/4mfDWOdZVn","expanded_url":"http://ht.ly/IWonm","display_url":"ht.ly/IWonm"}],"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"hashtags":{},"annotations":[{"start":68,"end":70,"probability":0.788,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565916360908476419","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565883684746969089"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: Notice of Public Meetings - Regulation of Combination Drug Medicated Feeds &amp; Conditional Approval of New Animal Drugs …","id":"565910284175675392","created_at":"2015-02-12T16:28:20.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565910284175675392","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565880112269520896"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: 3rd French medicines agency information exchange day with patient associations, Thursday 12 March 2015 http://t.co/wy213XTTYM","id":"565909814900183040","created_at":"2015-02-12T16:26:28.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/wy213XTTYM","expanded_url":"http://bit.ly/1A0oj2A","display_url":"bit.ly/1A0oj2A"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565909814900183040","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#Consultation open on the draft European Union #herbal monograph on #Hedera helix L., folium (#ivy leaf): http://t.co/Mmy9w2bp9Z","id":"565871924170219521","created_at":"2015-02-12T13:55:54.000Z","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/Mmy9w2bp9Z","expanded_url":"http://bit.ly/1CiC6Cp","display_url":"bit.ly/1CiC6Cp"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":47,"end":54,"tag":"herbal"},{"start":68,"end":75,"tag":"Hedera"},{"start":94,"end":98,"tag":"ivy"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565871924170219521","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week left to comment on proposal for application of #transparency rules in European #clinicaltrials Regulation: http://t.co/ISebgNDUlw","id":"565867117506220033","created_at":"2015-02-12T13:36:48.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/ISebgNDUlw","expanded_url":"http://bit.ly/1CuFoVA","display_url":"bit.ly/1CuFoVA"}],"mentions":{},"hashtags":[{"start":56,"end":69,"tag":"transparency"},{"start":88,"end":103,"tag":"clinicaltrials"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"565867117506220033","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IAPOtweets: #Counterfeit medicines pose a growing threat to #patient safety. We are all responsible for dealing with them: http://t.co/…","id":"565866467691094016","created_at":"2015-02-12T13:34:13.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"hashtags":[{"start":16,"end":28,"tag":"Counterfeit"},{"start":64,"end":72,"tag":"patient"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565866467691094016","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565865315893260288"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICEcomms: New quality standard on #psychosis and #schizophrenia in adults now available: http://t.co/QatwPi5SE6","id":"565864361110286336","created_at":"2015-02-12T13:25:51.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/QatwPi5SE6","expanded_url":"http://www.nice.org.uk/guidance/qs80","display_url":"nice.org.uk/guidance/qs80"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"hashtags":[{"start":39,"end":49,"tag":"psychosis"},{"start":54,"end":68,"tag":"schizophrenia"}],"annotations":{}},"public_metrics":{"retweet_count":57,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565864361110286336","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565848445861511169"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICEcomms: Deadline extended until 18th Feb. Join our Highly Specialised Technologies Evaluation Committee: http://t.co/meAal1jBXc","id":"565863771957374976","created_at":"2015-02-12T13:23:31.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/meAal1jBXc","expanded_url":"http://www.nice.org.uk/get-involved/join-a-committee/member-hstec-14-01-2015","display_url":"nice.org.uk/get-involved/j…"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565863771957374976","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565828959406161920"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @URPLWMiPB: Patients and healthcare professionals can both report side effects #safemedicines http://t.co/1viFsQFFjN","id":"565863600502628353","created_at":"2015-02-12T13:22:50.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/1viFsQFFjN","expanded_url":"http://bit.ly/19bS33E","display_url":"bit.ly/19bS33E"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"hashtags":[{"start":82,"end":96,"tag":"safemedicines"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"565863600502628353","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO_Europe: Get vaccinated. Cross protection against A(H3N2) #flu viruses can reduce likelihood of severe outcomes http://t.co/LxPYePDL…","id":"565863102349316096","created_at":"2015-02-12T13:20:51.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":[{"start":65,"end":69,"tag":"flu"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565863102349316096","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565826948794826752"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Programme and other details of workshop on #chronicdiseases and #healthyageing can be found on CHAFEA website - http://t.co/…","id":"565862947298488320","created_at":"2015-02-12T13:20:14.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":58,"end":74,"tag":"chronicdiseases"},{"start":79,"end":93,"tag":"healthyageing"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565862947298488320","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565824199714156544"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: The aim of the #PaedForm is to improve accessibility to suitable and age-appropriate formulations for children: http://t.co/…","id":"565862730373279745","created_at":"2015-02-12T13:19:22.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":30,"end":39,"tag":"PaedForm"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565862730373279745","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565822494561808384"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO_Europe: A(H3N2) #flu virus has undergone an antigenic drift since vaccine recommendations in Feb 2014 http://t.co/LxPYePDLD6","id":"565862681815830528","created_at":"2015-02-12T13:19:11.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/LxPYePDLD6","expanded_url":"http://bit.ly/1CgOenv","display_url":"bit.ly/1CgOenv"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":[{"start":24,"end":28,"tag":"flu"}],"annotations":{}},"public_metrics":{"retweet_count":77,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565862681815830528","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565822375086665728"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO_Europe: “Antigenic drift”: when viruses in vaccine &amp; those circulating in the coming #flu season don’t match http://t.co/LxPYePDLD6","id":"565818958327324672","created_at":"2015-02-12T10:25:26.000Z","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/LxPYePDLD6","expanded_url":"http://bit.ly/1CgOenv","display_url":"bit.ly/1CgOenv"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":[{"start":97,"end":101,"tag":"flu"}],"annotations":{}},"public_metrics":{"retweet_count":54,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565818958327324672","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565806567119802368"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: Type-2 diabetes: The #FDA approves a new medicine combination http://t.co/ha5lvRU4WP","id":"565818913918042112","created_at":"2015-02-12T10:25:16.000Z","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/ha5lvRU4WP","expanded_url":"http://bit.ly/16WHdgc","display_url":"bit.ly/16WHdgc"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":41,"end":45,"tag":"FDA"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"565818913918042112","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: A #genericmedicine name, appearance and packaging differ from the reference medicine’s http://t.co/RwfYZ2GbP1 #EGAgenerics","id":"565818199313514496","created_at":"2015-02-12T10:22:25.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/RwfYZ2GbP1","expanded_url":"http://bit.ly/1xxu4Ea","display_url":"bit.ly/1xxu4Ea"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"hashtags":[{"start":19,"end":35,"tag":"genericmedicine"},{"start":127,"end":139,"tag":"EGAgenerics"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565818199313514496","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565797467044593666"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @kardamyla: @EMA_News Committee for Orphan Medicinal Products (COMP) raises hands for Rare Disease Day @rarediseaseday @eurordis http://…","id":"565567788413370368","created_at":"2015-02-11T17:47:23.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"kardamyla","id":"59722141"},{"start":15,"end":24,"username":"EMA_News","id":"116716199"},{"start":106,"end":121,"username":"rarediseaseday","id":"19982434"},{"start":122,"end":131,"username":"eurordis","id":"26993786"}],"hashtags":{},"annotations":[{"start":39,"end":63,"probability":0.2104,"type":"Organization","normalized_text":"Orphan Medicinal Products"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565567788413370368","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565553371948789760"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One more week to comment on proposal for application of #transparency rules in European #clinicaltrials Regulation: http://t.co/ISebgNDUlw","id":"565551448495501312","created_at":"2015-02-11T16:42:27.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/ISebgNDUlw","expanded_url":"http://bit.ly/1CuFoVA","display_url":"bit.ly/1CuFoVA"}],"mentions":{},"hashtags":[{"start":56,"end":69,"tag":"transparency"},{"start":88,"end":103,"tag":"clinicaltrials"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"565551448495501312","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Study that looks at the impact of lifestyle habits on the efficiency of Europe’s health systems published today  - http://t.…","id":"565483361511411712","created_at":"2015-02-11T12:11:54.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":{},"annotations":[{"start":87,"end":92,"probability":0.9749,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":26,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565483361511411712","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565469476163178498"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Comment on draft #herbal monograph on #Thyme/#Primula root: http://t.co/xMW9wQVvzR #consultation","id":"565483065385160705","created_at":"2015-02-11T12:10:43.000Z","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/xMW9wQVvzR","expanded_url":"http://bit.ly/16MOjUn","display_url":"bit.ly/16MOjUn"}],"mentions":{},"hashtags":[{"start":17,"end":24,"tag":"herbal"},{"start":38,"end":44,"tag":"Thyme"},{"start":45,"end":53,"tag":"Primula"},{"start":83,"end":96,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"565483065385160705","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Rixubis (#nonacog gamma), a #medicine  used in #haemophilia B: http://t.co/DVAHptuh1d","id":"565483018513829888","created_at":"2015-02-11T12:10:32.000Z","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/DVAHptuh1d","expanded_url":"http://bit.ly/1DeNQr3","display_url":"bit.ly/1DeNQr3"}],"mentions":{},"hashtags":[{"start":42,"end":50,"tag":"Rixubis"},{"start":52,"end":60,"tag":"nonacog"},{"start":71,"end":80,"tag":"medicine"},{"start":90,"end":102,"tag":"haemophilia"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565483018513829888","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We have explained our redaction rules in our response to @EUombudsman: http://t.co/xGHdObeEJf","id":"565482981570379777","created_at":"2015-02-11T12:10:23.000Z","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/xGHdObeEJf","expanded_url":"http://bit.ly/1KEnYak","display_url":"bit.ly/1KEnYak"}],"mentions":[{"start":57,"end":69,"username":"EUombudsman","id":"873777758"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565482981570379777","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda of this week's meeting of our #pharmacovigilance committee (PRAC): http://t.co/cJ0pv45gQj","id":"565482947411980291","created_at":"2015-02-11T12:10:15.000Z","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/cJ0pv45gQj","expanded_url":"http://bit.ly/1ASDVrM","display_url":"bit.ly/1ASDVrM"}],"mentions":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":58,"end":76,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565482947411980291","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda of this week's meeting of our committee for #veterinary #medicines (CVMP): http://t.co/CWF4msno0g","id":"565482898053414914","created_at":"2015-02-11T12:10:03.000Z","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/CWF4msno0g","expanded_url":"http://bit.ly/1CQKTOC","display_url":"bit.ly/1CQKTOC"}],"mentions":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":72,"end":83,"tag":"veterinary"},{"start":84,"end":94,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565482898053414914","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EAHPtweet: Head of a hospital pharmacy in an EAHP member country? Don't forget to complete the EAHP practice survey by 28 Feb! http://t…","id":"565208408107016193","created_at":"2015-02-10T17:59:20.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EAHPtweet","id":"203357203"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565208408107016193","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565137757597876224"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Check our #guidance on meetings with applicants on responses to our questions during the centralised procedure: http://t.co/8iyJmGTuoO","id":"565208167853088769","created_at":"2015-02-10T17:58:22.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/8iyJmGTuoO","expanded_url":"http://bit.ly/1vBBB7g","display_url":"bit.ly/1vBBB7g"}],"mentions":{},"hashtags":[{"start":10,"end":19,"tag":"guidance"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"565208167853088769","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: EDQM will participate in 25th Regional Congress of the #ISBT which will be held in London http://t.co/ybxtlmEMm4 [CC @ISBTCO…","id":"565207873014472706","created_at":"2015-02-10T17:57:12.000Z","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/ybxtlmEMm4","expanded_url":"http://bit.ly/1tPVlAV","display_url":"bit.ly/1tPVlAV"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"},{"start":132,"end":139,"username":"ISBTCO","id":"120474253"}],"hashtags":[{"start":70,"end":75,"tag":"ISBT"}],"annotations":[{"start":98,"end":103,"probability":0.983,"type":"Place","normalized_text":"London"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565207873014472706","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565145358637236224"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAWomen: REGISTER: Public conference on drug-induced liver injury March 18-19 http://t.co/6yWLlbDfBX @PhRMA","id":"565207626313891841","created_at":"2015-02-10T17:56:13.000Z","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/6yWLlbDfBX","expanded_url":"http://go.usa.gov/3qqKH","display_url":"go.usa.gov/3qqKH"}],"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"},{"start":106,"end":112,"username":"PhRMA","id":"116748080"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565207626313891841","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565167194812985345"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: #EDQM CombiStats training session – Check out our free online demo http://t.co/DVVK8LMrmP and sign up today! http://t.co/yrW…","id":"565207447636545536","created_at":"2015-02-10T17:55:31.000Z","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/DVVK8LMrmP","expanded_url":"http://bit.ly/1uAewRi","display_url":"bit.ly/1uAewRi"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":15,"end":20,"tag":"EDQM"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565207447636545536","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565178338172731392"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: Due to popular demand we will hold a 2nd webinar on the IMI2 Call 3 neuropsychiatry topic. Join us on 17/2 at 3:30 pm http://t.…","id":"565207386752057344","created_at":"2015-02-10T17:55:16.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565207386752057344","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565181493753180163"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: UPDATED: List of Groups of Experts &amp; Working Parties http://t.co/8nhtxQ4ApD #european #pharmacopoeia","id":"565207254115581952","created_at":"2015-02-10T17:54:45.000Z","entities":{"urls":[{"start":72,"end":94,"url":"http://t.co/8nhtxQ4ApD","expanded_url":"http://bit.ly/1uAr8b9","display_url":"bit.ly/1uAr8b9"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":95,"end":104,"tag":"european"},{"start":105,"end":119,"tag":"pharmacopoeia"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565207254115581952","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565191831399718912"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDACBER: The 18th US - Japan Cellular &amp; Gene Therapy Conference will be Feb. 26, 2015. More details here: http://t.co/CU6xnElAFh","id":"565207051979460608","created_at":"2015-02-10T17:53:56.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/CU6xnElAFh","expanded_url":"http://1.usa.gov/195ywlB","display_url":"1.usa.gov/195ywlB"}],"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"hashtags":{},"annotations":[{"start":22,"end":23,"probability":0.4709,"type":"Place","normalized_text":"US"},{"start":27,"end":66,"probability":0.4695,"type":"Other","normalized_text":"Japan Cellular & Gene Therapy Conference"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565207051979460608","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565193674997260288"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @US_FDA: FDA clears system to reduce stroke risk during stent &amp; angioplasty procedures. http://t.co/5sF5HUrBEa","id":"565206952792580097","created_at":"2015-02-10T17:53:33.000Z","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/5sF5HUrBEa","expanded_url":"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm433482.htm","display_url":"fda.gov/NewsEvents/New…"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":[{"start":12,"end":14,"probability":0.7727,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565206952792580097","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564873827080228865"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda of this week's meeting of our committee for #veterinary #medicines (CVMP): http://t.co/CWF4msno0g","id":"565206783938285569","created_at":"2015-02-10T17:52:52.000Z","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/CWF4msno0g","expanded_url":"http://bit.ly/1CQKTOC","display_url":"bit.ly/1CQKTOC"}],"mentions":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":72,"end":83,"tag":"veterinary"},{"start":84,"end":94,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565206783938285569","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Comment on draft #herbal monograph on #Thyme/#Primula root: http://t.co/xMW9wQVvzR #consultation","id":"565205606047682560","created_at":"2015-02-10T17:48:12.000Z","entities":{"urls":[{"start":60,"end":82,"url":"http://t.co/xMW9wQVvzR","expanded_url":"http://bit.ly/16MOjUn","display_url":"bit.ly/16MOjUn"}],"mentions":{},"hashtags":[{"start":17,"end":24,"tag":"herbal"},{"start":38,"end":44,"tag":"Thyme"},{"start":45,"end":53,"tag":"Primula"},{"start":83,"end":96,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565205606047682560","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Rixubis (#nonacog gamma), a #medicine  used in #haemophilia B: http://t.co/DVAHptuh1d","id":"565165115470016512","created_at":"2015-02-10T15:07:18.000Z","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/DVAHptuh1d","expanded_url":"http://bit.ly/1DeNQr3","display_url":"bit.ly/1DeNQr3"}],"mentions":{},"hashtags":[{"start":42,"end":50,"tag":"Rixubis"},{"start":52,"end":60,"tag":"nonacog"},{"start":71,"end":80,"tag":"medicine"},{"start":90,"end":102,"tag":"haemophilia"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565165115470016512","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We have explained our redaction rules in our response to @EUombudsman: http://t.co/xGHdObeEJf","id":"565164038452441088","created_at":"2015-02-10T15:03:01.000Z","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/xGHdObeEJf","expanded_url":"http://bit.ly/1KEnYak","display_url":"bit.ly/1KEnYak"}],"mentions":[{"start":57,"end":69,"username":"EUombudsman","id":"873777758"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"565164038452441088","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda of this week's meeting of our #pharmacovigilance committee (PRAC): http://t.co/cJ0pv45gQj","id":"565120200602034176","created_at":"2015-02-10T12:08:49.000Z","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/cJ0pv45gQj","expanded_url":"http://bit.ly/1ASDVrM","display_url":"bit.ly/1ASDVrM"}],"mentions":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":58,"end":76,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565120200602034176","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published #guidance on meetings with applicants on responses to our questions during the centralised procedure: http://t.co/8iyJmGTuoO","id":"565087684159619072","created_at":"2015-02-10T09:59:37.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/8iyJmGTuoO","expanded_url":"http://bit.ly/1vBBB7g","display_url":"bit.ly/1vBBB7g"}],"mentions":{},"hashtags":[{"start":16,"end":25,"tag":"guidance"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565087684159619072","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Call for scientific data for the systematic review of the #herbal monograph on #Hypericum perforatum: http://t.co/BKuRP2IpIw #consultation","id":"565087043496472576","created_at":"2015-02-10T09:57:04.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/BKuRP2IpIw","expanded_url":"http://bit.ly/16GDTpu","display_url":"bit.ly/16GDTpu"}],"mentions":{},"hashtags":[{"start":58,"end":65,"tag":"herbal"},{"start":79,"end":89,"tag":"Hypericum"},{"start":125,"end":138,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565087043496472576","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#Consultation open on our draft EU #herbal monograph on #Vaccinium myrtillus, fructus siccus (dried #bilberry fruit) http://t.co/JOuOyOKKnf","id":"565086856866717696","created_at":"2015-02-10T09:56:20.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/JOuOyOKKnf","expanded_url":"http://bit.ly/1CLYxmc","display_url":"bit.ly/1CLYxmc"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":35,"end":42,"tag":"herbal"},{"start":56,"end":66,"tag":"Vaccinium"},{"start":100,"end":109,"tag":"bilberry"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565086856866717696","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#Consultation open on the draft EU #herbal monograph on #Vaccinium myrtillus, fructus recens (fresh #bilberry fruit) http://t.co/RLEhblRtSV","id":"565086803498373120","created_at":"2015-02-10T09:56:07.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/RLEhblRtSV","expanded_url":"http://bit.ly/1vAowLg","display_url":"bit.ly/1vAowLg"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":35,"end":42,"tag":"herbal"},{"start":56,"end":66,"tag":"Vaccinium"},{"start":100,"end":109,"tag":"bilberry"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565086803498373120","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Call for data for the review of the #herbal monograph on #Harpagophytum procumbens &amp; H. zeyheri: http://t.co/mT0lEyahcM #consultation","id":"565086735970091008","created_at":"2015-02-10T09:55:51.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/mT0lEyahcM","expanded_url":"http://bit.ly/1vdTHGo","display_url":"bit.ly/1vdTHGo"}],"mentions":{},"hashtags":[{"start":36,"end":43,"tag":"herbal"},{"start":57,"end":71,"tag":"Harpagophytum"},{"start":124,"end":137,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565086735970091008","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: PhEur #ReferenceStandards – EDQM policies and processes. Download the PhEur Training Session programme http://t.co/piNNV3dEuu","id":"565076253729112066","created_at":"2015-02-10T09:14:12.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/piNNV3dEuu","expanded_url":"http://bit.ly/1yNjdao","display_url":"bit.ly/1yNjdao"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":21,"end":40,"tag":"ReferenceStandards"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"565076253729112066","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"565075930335694848"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDACBER: Read CBER Director’s testimony on Preventing Influenza &amp; Protecting the American Public Through Vaccination. http://t.co/q6tnI…","id":"564904337403420672","created_at":"2015-02-09T21:51:04.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564904337403420672","source":"Twitter for iPhone","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564846281898479616"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@byzondereekster And you can follow the meetings of our human medicine committee here: http://t.co/dwC0S8CPbW","id":"564841819536891904","created_at":"2015-02-09T17:42:38.000Z","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/dwC0S8CPbW","expanded_url":"http://bit.ly/1eSRmZC","display_url":"bit.ly/1eSRmZC"}],"mentions":[{"start":0,"end":16,"username":"byzondereekster","id":"284748226"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"564838913210990592","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"564840979673276416"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"text":"Call for scientific data for the systematic review of the #herbal monograph on #Hypericum perforatum: http://t.co/BKuRP2IpIw #consultation","id":"564841341914722304","created_at":"2015-02-09T17:40:44.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/BKuRP2IpIw","expanded_url":"http://bit.ly/16GDTpu","display_url":"bit.ly/16GDTpu"}],"mentions":{},"hashtags":[{"start":58,"end":65,"tag":"herbal"},{"start":79,"end":89,"tag":"Hypericum"},{"start":125,"end":138,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564841341914722304","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@byzondereekster You can view the list of human medicines currently under evaluation here: http://t.co/tVfbCmDrbq","id":"564840979673276416","created_at":"2015-02-09T17:39:18.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/tVfbCmDrbq","expanded_url":"http://bit.ly/1zPkNYA","display_url":"bit.ly/1zPkNYA"}],"mentions":[{"start":0,"end":16,"username":"byzondereekster","id":"284748226"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"564838913210990592","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"564838913210990592"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"284748226"},{"text":"Call for data for the review of the #herbal monograph on #Harpagophytum procumbens &amp; H. zeyheri: http://t.co/mT0lEyahcM #consultation","id":"564838399014871040","created_at":"2015-02-09T17:29:03.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/mT0lEyahcM","expanded_url":"http://bit.ly/1vdTHGo","display_url":"bit.ly/1vdTHGo"}],"mentions":{},"hashtags":[{"start":36,"end":43,"tag":"herbal"},{"start":57,"end":71,"tag":"Harpagophytum"},{"start":124,"end":137,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564838399014871040","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#Consultation open on the draft EU #herbal monograph on #Vaccinium myrtillus, fructus recens (fresh #bilberry fruit) http://t.co/RLEhblRtSV","id":"564837386145005568","created_at":"2015-02-09T17:25:01.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/RLEhblRtSV","expanded_url":"http://bit.ly/1vAowLg","display_url":"bit.ly/1vAowLg"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":35,"end":42,"tag":"herbal"},{"start":56,"end":66,"tag":"Vaccinium"},{"start":100,"end":109,"tag":"bilberry"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564837386145005568","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#Consultation open on our draft EU #herbal monograph on #Vaccinium myrtillus, fructus siccus (dried #bilberry fruit) http://t.co/JOuOyOKKnf","id":"564836755103580162","created_at":"2015-02-09T17:22:31.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/JOuOyOKKnf","expanded_url":"http://bit.ly/1CLYxmc","display_url":"bit.ly/1CLYxmc"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":35,"end":42,"tag":"herbal"},{"start":56,"end":66,"tag":"Vaccinium"},{"start":100,"end":109,"tag":"bilberry"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"564836755103580162","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @kardamyla: @EMA_News - Patients and carers updated webpages http://t.co/VhfOoiflGl ...more updates to come.... watch this space!!","id":"564826691915497472","created_at":"2015-02-09T16:42:31.000Z","entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/VhfOoiflGl","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/audience/alp_audiencetype_000001.jsp&mid","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":3,"end":13,"username":"kardamyla","id":"59722141"},{"start":15,"end":24,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564826691915497472","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564805791560241152"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EUTenders: Last year we published almost 6000 #Publicprocurement notices from the EU Institutions: TED is the official source of contra…","id":"564826502483959809","created_at":"2015-02-09T16:41:46.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EUTenders","id":"294046348"}],"hashtags":[{"start":50,"end":68,"tag":"Publicprocurement"}],"annotations":[{"start":86,"end":100,"probability":0.6735,"type":"Organization","normalized_text":"EU Institutions"},{"start":103,"end":105,"probability":0.5848,"type":"Person","normalized_text":"TED"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564826502483959809","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564801442859737088"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: Tomorrow the new @URPLWMiPB campaign on reporting adverse drug reactions starts. Here's the last one http://t.co/pPv1PaR5u3","id":"564826039810269184","created_at":"2015-02-09T16:39:56.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/pPv1PaR5u3","expanded_url":"http://bit.ly/1A5RxQB","display_url":"bit.ly/1A5RxQB"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"},{"start":30,"end":40,"username":"URPLWMiPB","id":"556679074"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"564826039810269184","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Watch #EU #Health &amp; #Food #Safety Cssr. @V_Andriukaitis: #first100days in office #video http://t.co/cnrHZqb0Pt #priorities","id":"564825470844534784","created_at":"2015-02-09T16:37:40.000Z","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/cnrHZqb0Pt","expanded_url":"http://europa.eu/!gM66dr","display_url":"europa.eu/!gM66dr"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":59,"end":74,"username":"V_Andriukaitis","id":"575269517"}],"hashtags":[{"start":21,"end":24,"tag":"EU"},{"start":25,"end":32,"tag":"Health"},{"start":39,"end":44,"tag":"Food"},{"start":45,"end":52,"tag":"Safety"},{"start":76,"end":89,"tag":"first100days"},{"start":100,"end":106,"tag":"video"},{"start":130,"end":141,"tag":"priorities"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564825470844534784","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564799752546828289"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Food_EU: Watch #EU #Health &amp; #Food #Safety Cssr. @V_Andriukaitis: #first100days in office #video http://t.co/YxD2q15HmE #priorities","id":"564825455946366976","created_at":"2015-02-09T16:37:37.000Z","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/YxD2q15HmE","expanded_url":"http://europa.eu/!gM66dr","display_url":"europa.eu/!gM66dr"}],"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"},{"start":57,"end":72,"username":"V_Andriukaitis","id":"575269517"}],"hashtags":[{"start":19,"end":22,"tag":"EU"},{"start":23,"end":30,"tag":"Health"},{"start":37,"end":42,"tag":"Food"},{"start":43,"end":50,"tag":"Safety"},{"start":74,"end":87,"tag":"first100days"},{"start":98,"end":104,"tag":"video"},{"start":128,"end":139,"tag":"priorities"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564825455946366976","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564799558409277440"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EUExpo2015: Enhancing scientific cooperation. EFSA outsources scientific activities through grants and procurements. http://t.co/xoF8GL…","id":"564824001835728896","created_at":"2015-02-09T16:31:50.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EUExpo2015","id":"2202869202"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564824001835728896","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564785804565024769"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: #Hepatitis C could become rare disease in #USA by 2036 thanks to new effective treatments &amp; screening of newborns http://…","id":"564823159430737921","created_at":"2015-02-09T16:28:29.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":[{"start":18,"end":28,"tag":"Hepatitis"},{"start":60,"end":64,"tag":"USA"}],"annotations":{}},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564823159430737921","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564779009045561344"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: It is a common misperception that #measles is a harmless disease. #prevention #vaccines http://t.co/WSFElPLipn HT @Eurovacci…","id":"564809315945820160","created_at":"2015-02-09T15:33:29.000Z","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/WSFElPLipn","expanded_url":"http://bit.ly/1ES8BuG","display_url":"bit.ly/1ES8BuG"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":49,"end":57,"tag":"measles"},{"start":81,"end":92,"tag":"prevention"},{"start":93,"end":102,"tag":"vaccines"}],"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564809315945820160","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564766013057933312"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EuropaBio: #competition open! Calling all #innovative #biotech #SMEs in Europe: apply 2 win €10k &amp; free membership - closes 6 A…https:/…","id":"564809208156409856","created_at":"2015-02-09T15:33:03.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"}],"hashtags":[{"start":15,"end":27,"tag":"competition"},{"start":46,"end":57,"tag":"innovative"},{"start":58,"end":66,"tag":"biotech"},{"start":67,"end":72,"tag":"SMEs"}],"annotations":[{"start":76,"end":81,"probability":0.9851,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564809208156409856","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564764670028820480"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Eurovaccine: It is a common misperception that #measles is a harmless disease. Address misconceptions on measles vaccination http://t.c…","id":"564809100874485760","created_at":"2015-02-09T15:32:37.000Z","entities":{"urls":{},"mentions":{},"hashtags":[{"start":51,"end":59,"tag":"measles"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564809100874485760","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564762252688252928"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EuropaBio: @EuropaBio is looking for the most #innovative #biotech #SME in #Europe! enter the #competition &amp; apply by 6 April http://t.…","id":"564808841934958592","created_at":"2015-02-09T15:31:36.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"},{"start":15,"end":25,"username":"EuropaBio","id":"19642657"}],"hashtags":[{"start":50,"end":61,"tag":"innovative"},{"start":62,"end":70,"tag":"biotech"},{"start":71,"end":75,"tag":"SME"},{"start":79,"end":86,"tag":"Europe"},{"start":98,"end":110,"tag":"competition"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564808841934958592","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564758485074997248"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ScienceHub: R U a scientist interested in supporting #EU policies w/ yr research?This is your chance http://t.co/u5ZVjYnLJ8 http://t…","id":"564808215733751808","created_at":"2015-02-09T15:29:06.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/u5ZVjYnLJ8","expanded_url":"http://europa.eu/!vH97cN","display_url":"europa.eu/!vH97cN"}],"mentions":[{"start":3,"end":17,"username":"EU_ScienceHub","id":"2754681001"}],"hashtags":[{"start":60,"end":63,"tag":"EU"}],"annotations":{}},"public_metrics":{"retweet_count":15,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564808215733751808","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564755603286155264"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myCORDIS: The EU is recruiting researchers - JRC Science Hub http://t.co/o7yX1dcKkP via @EU_Commission","id":"564808113820553216","created_at":"2015-02-09T15:28:42.000Z","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/o7yX1dcKkP","expanded_url":"http://europa.eu/!VQ39bD","display_url":"europa.eu/!VQ39bD"}],"mentions":[{"start":3,"end":12,"username":"myCORDIS","id":"818505470608572416"},{"start":92,"end":106,"username":"EU_Commission","id":"157981564"}],"hashtags":{},"annotations":[{"start":18,"end":19,"probability":0.7178,"type":"Organization","normalized_text":"EU"},{"start":49,"end":63,"probability":0.7445,"type":"Organization","normalized_text":"JRC Science Hub"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564808113820553216","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564754508237258753"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: A #genericmedicine is developed to work the same way as a reference medicine already on the market  http://t.co/RwfYZ2GbP1…","id":"564807661276119041","created_at":"2015-02-09T15:26:54.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/RwfYZ2GbP1","expanded_url":"http://bit.ly/1xxu4Ea","display_url":"bit.ly/1xxu4Ea"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"hashtags":[{"start":19,"end":35,"tag":"genericmedicine"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564807661276119041","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564740501392220160"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @igznl: IGZ Patient Safety Congress: June 18, De Doelen Rotterdam. Theme this year: transfer of information. http://t.co/oMDy9UzENk","id":"564806315051327489","created_at":"2015-02-09T15:21:33.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/oMDy9UzENk","expanded_url":"http://bit.ly/1DTZeXF","display_url":"bit.ly/1DTZeXF"}],"mentions":[{"start":3,"end":9,"username":"Igznl","id":"1601603352"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564806315051327489","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @URPLWMiPB: New campaign on the safety of medicines starts tomorrow. Today, once again, our previous one http://t.co/q12MFgbmiZ","id":"564805988407328770","created_at":"2015-02-09T15:20:15.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/q12MFgbmiZ","expanded_url":"http://bit.ly/1M68LAD","display_url":"bit.ly/1M68LAD"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564805988407328770","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @luca__pani: Medicinal preparations for cutaneous use containing ketoprofen. Beware of the sun. http://t.co/RQSMBqZomY","id":"564805555446112256","created_at":"2015-02-09T15:18:32.000Z","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/RQSMBqZomY","expanded_url":"http://bit.ly/1DTYP7z","display_url":"bit.ly/1DTYP7z"}],"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564805555446112256","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @luca__pani:The Italian medicines agency has published an important update on medicines containing valproate | http://t.co/8zeJhOB0PO","id":"564804591058178048","created_at":"2015-02-09T15:14:42.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/8zeJhOB0PO","expanded_url":"http://bit.ly/1DTYiCL","display_url":"bit.ly/1DTYiCL"}],"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"564804591058178048","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: Can DNA Nanobots successfully treat #cancer #patients? First human trial soon http://t.co/ugUNTolrPk #science","id":"564710506100183040","created_at":"2015-02-09T09:00:51.000Z","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/ugUNTolrPk","expanded_url":"http://bit.ly/1D8YPQp","display_url":"bit.ly/1D8YPQp"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"hashtags":[{"start":53,"end":60,"tag":"cancer"},{"start":61,"end":70,"tag":"patients"},{"start":118,"end":126,"tag":"science"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564710506100183040","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564710297420570624"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: If your organisation would like to participate in a #physicobio Proficiency Testing Scheme study, register today! http://t.c…","id":"564710269994409984","created_at":"2015-02-09T08:59:54.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":67,"end":78,"tag":"physicobio"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564710269994409984","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564710144446312448"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Eurovaccine: Looking for data on #measles for #EU Member States? See surveillance data of the past 12 months http://t.co/km3Mgcpsgq","id":"564710257977733120","created_at":"2015-02-09T08:59:51.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/km3Mgcpsgq","expanded_url":"http://bit.ly/1FoPCFw","display_url":"bit.ly/1FoPCFw"}],"mentions":{},"hashtags":[{"start":37,"end":45,"tag":"measles"},{"start":50,"end":53,"tag":"EU"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"564710257977733120","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"564710002435170304"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our committee for #pharmacovigilance (#PRAC) meets next week. Highlights out next Friday: http://t.co/uuov9Ch5Z9","id":"563737980935090177","created_at":"2015-02-06T16:36:23.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/uuov9Ch5Z9","expanded_url":"http://bit.ly/16yBr4D","display_url":"bit.ly/16yBr4D"}],"mentions":{},"hashtags":[{"start":18,"end":36,"tag":"pharmacovigilance"},{"start":38,"end":43,"tag":"PRAC"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563737980935090177","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our committee for #veterinary #medicines (#CVMP) meets next week. Highlights out next Friday: http://t.co/aZlBKalWZU","id":"563737876442402816","created_at":"2015-02-06T16:35:58.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/aZlBKalWZU","expanded_url":"http://bit.ly/1LTPoL4","display_url":"bit.ly/1LTPoL4"}],"mentions":{},"hashtags":[{"start":18,"end":29,"tag":"veterinary"},{"start":30,"end":40,"tag":"medicines"},{"start":42,"end":47,"tag":"CVMP"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"563737876442402816","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Comment on guidelines on data requirements for #veterinary #medicines for minor use minor species: http://t.co/mS1SW2OSZR #consultation","id":"563737720322019328","created_at":"2015-02-06T16:35:20.000Z","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/mS1SW2OSZR","expanded_url":"http://bit.ly/1CGopON","display_url":"bit.ly/1CGopON"}],"mentions":{},"hashtags":[{"start":47,"end":58,"tag":"veterinary"},{"start":59,"end":69,"tag":"medicines"},{"start":122,"end":135,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"563737720322019328","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: Impact of #flu #vaccine mismatch is being seen: http://t.co/ZAp6Rr0M48 Read the @ECDC_EU seasonal risk assessment: http://t.c…","id":"563698718755799040","created_at":"2015-02-06T14:00:22.000Z","entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/ZAp6Rr0M48","expanded_url":"http://bit.ly/1DlKrXJ","display_url":"bit.ly/1DlKrXJ"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":94,"end":102,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":24,"end":28,"tag":"flu"},{"start":29,"end":37,"tag":"vaccine"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563698718755799040","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563665056991563776"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @fet_eu: The #future of #brain #cancer treatment: video pioneering #tech helping to treat it http://t.co/Zj2HY8QZcM via @ICTscienceEU cc…","id":"563698685729832961","created_at":"2015-02-06T14:00:14.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/Zj2HY8QZcM","expanded_url":"http://www.bbc.co.uk/news/health-31018247","display_url":"bbc.co.uk/news/health-31…"}],"mentions":[{"start":3,"end":10,"username":"fet_eu","id":"122458732"},{"start":123,"end":136,"username":"ICTscienceEU","id":"930380481966886912"}],"hashtags":[{"start":16,"end":23,"tag":"future"},{"start":27,"end":33,"tag":"brain"},{"start":34,"end":41,"tag":"cancer"},{"start":70,"end":75,"tag":"tech"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563698685729832961","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563665974403272706"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: Interested in working with @ECDC_EU as a Seconded National Expert? A new call goes out today: http://t.co/kO2l05C6Tf Deadline …","id":"563698573947461632","created_at":"2015-02-06T13:59:47.000Z","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/kO2l05C6Tf","expanded_url":"http://bit.ly/16yBgGy","display_url":"bit.ly/16yBgGy"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":40,"end":48,"username":"ECDC_EU","id":"204752573"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563698573947461632","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563669706918592512"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EuropeanLung: Research links a healthy diet to a lower #COPD risk http://t.co/gj2yiOTI6s","id":"563698547091329024","created_at":"2015-02-06T13:59:41.000Z","entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/gj2yiOTI6s","expanded_url":"http://bit.ly/1v4p6uZ","display_url":"bit.ly/1v4p6uZ"}],"mentions":[{"start":3,"end":16,"username":"EuropeanLung","id":"121759520"}],"hashtags":[{"start":59,"end":64,"tag":"COPD"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563698547091329024","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563672277896921088"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Need practical advice on using and interpreting #European #Pharmacopoeia General Chapters and #Monographs? Join us! http://t…","id":"563698395672739840","created_at":"2015-02-06T13:59:05.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":63,"end":72,"tag":"European"},{"start":73,"end":87,"tag":"Pharmacopoeia"},{"start":109,"end":120,"tag":"Monographs"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563698395672739840","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563691883013373952"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our #pharmacovigilance committee (#PRAC) meets next week. Highlights out next Friday: http://t.co/uuov9Ch5Z9","id":"563667593425584128","created_at":"2015-02-06T11:56:41.000Z","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/uuov9Ch5Z9","expanded_url":"http://bit.ly/16yBr4D","display_url":"bit.ly/16yBr4D"}],"mentions":{},"hashtags":[{"start":4,"end":22,"tag":"pharmacovigilance"},{"start":34,"end":39,"tag":"PRAC"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"563667593425584128","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our #veterinary #medicines committee (#CVMP) meets next week. Highlights out next Friday: http://t.co/aZlBKalWZU","id":"563667276789202944","created_at":"2015-02-06T11:55:25.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/aZlBKalWZU","expanded_url":"http://bit.ly/1LTPoL4","display_url":"bit.ly/1LTPoL4"}],"mentions":{},"hashtags":[{"start":4,"end":15,"tag":"veterinary"},{"start":16,"end":26,"tag":"medicines"},{"start":38,"end":43,"tag":"CVMP"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"563667276789202944","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"A week to comment on revising guidelines on data requirements for #veterinary #medicines for minor use minor species: http://t.co/mS1SW2OSZR","id":"563666857501392896","created_at":"2015-02-06T11:53:45.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/mS1SW2OSZR","expanded_url":"http://bit.ly/1CGopON","display_url":"bit.ly/1CGopON"}],"mentions":{},"hashtags":[{"start":66,"end":77,"tag":"veterinary"},{"start":78,"end":88,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"563666857501392896","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#Consultation now open on our concept paper on #guidelines on good #manufacturing practice for sterile #medicines: http://t.co/NjwOqdZCiS","id":"563627916349964288","created_at":"2015-02-06T09:19:01.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/NjwOqdZCiS","expanded_url":"http://bit.ly/1zTSTxI","display_url":"bit.ly/1zTSTxI"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"},{"start":47,"end":58,"tag":"guidelines"},{"start":67,"end":81,"tag":"manufacturing"},{"start":103,"end":113,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"563627916349964288","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: Are you a veterinarian? Check out the resources #FDA has for you - http://t.co/g124b22qrN","id":"563398302948163584","created_at":"2015-02-05T18:06:37.000Z","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/g124b22qrN","expanded_url":"http://bit.ly/egEMlp","display_url":"bit.ly/egEMlp"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"hashtags":[{"start":69,"end":73,"tag":"FDA"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563398302948163584","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563330076142755840"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_HIVAIDS: Mobile apps &amp; MSM: how to reach out to young people to help create healthy online communities? #HIV #STI http://t.co/Fr3H…","id":"563398142021079041","created_at":"2015-02-05T18:05:59.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"ECDC_HIVAIDS","id":"2182569746"}],"hashtags":[{"start":117,"end":121,"tag":"HIV"},{"start":122,"end":126,"tag":"STI"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563398142021079041","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563345338967535617"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: Summary of the #CMDh meeting in January 2015: http://t.co/5CJ5cP4dYp","id":"563398066888519681","created_at":"2015-02-05T18:05:41.000Z","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/5CJ5cP4dYp","expanded_url":"http://bit.ly/18RyUnt","display_url":"bit.ly/18RyUnt"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"hashtags":[{"start":25,"end":30,"tag":"CMDh"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563398066888519681","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: B.Url: #OpenEFSA will make us more accountable &amp; trusted,more comprehensible &amp; meaningful to the lives of Europeans http://t.c…","id":"563397354892828672","created_at":"2015-02-05T18:02:51.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":20,"end":29,"tag":"OpenEFSA"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563397354892828672","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563353486197555200"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDACBER: Stay informed on #Ebola response updates from FDA. http://t.co/r3svrO0WsE","id":"563394119360585729","created_at":"2015-02-05T17:50:00.000Z","entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/r3svrO0WsE","expanded_url":"http://go.usa.gov/h4rT","display_url":"go.usa.gov/h4rT"}],"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"hashtags":[{"start":30,"end":36,"tag":"Ebola"}],"annotations":[{"start":59,"end":61,"probability":0.8182,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563394119360585729","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563351520851144704"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Summaries of #EU scientific opinions - New factsheet on 'Safety of metal-on-metal hip implants' published today - http://t.c…","id":"563393921741758464","created_at":"2015-02-05T17:49:12.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":28,"end":31,"tag":"EU"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563393921741758464","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563360817547313152"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IAPOtweets: Patient-centred healthcare is only possible with #ethical and #transparent clinical trials and research: http://t.co/y4PECu…","id":"563393851134836737","created_at":"2015-02-05T17:48:56.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"hashtags":[{"start":65,"end":73,"tag":"ethical"},{"start":78,"end":90,"tag":"transparent"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563393851134836737","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563366510560018432"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Need practical advice on using and interpreting the #European #Pharmacopoeia General Chapters and #Monographs? http://t.co/p…","id":"563393431436001280","created_at":"2015-02-05T17:47:16.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":67,"end":76,"tag":"European"},{"start":77,"end":91,"tag":"Pharmacopoeia"},{"start":113,"end":124,"tag":"Monographs"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563393431436001280","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563382638472601601"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Did you know that online prices for #EDQM publications are 10% cheaper than catalogue prices? Browse our catalogue! http://t…","id":"563392875799797761","created_at":"2015-02-05T17:45:03.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":51,"end":56,"tag":"EDQM"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563392875799797761","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563355831065145345"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"#Consultation is now open on our concept paper on guidelines on good manufacturing practice for sterile medicines: http://t.co/NjwOqdZCiS","id":"563349895244177408","created_at":"2015-02-05T14:54:16.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/NjwOqdZCiS","expanded_url":"http://bit.ly/1zTSTxI","display_url":"bit.ly/1zTSTxI"}],"mentions":{},"hashtags":[{"start":0,"end":13,"tag":"Consultation"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"563349895244177408","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've changed the registration procedures for #SMEs to reduce administrative burden: http://t.co/8shWgP2Mg0","id":"563281693738815488","created_at":"2015-02-05T10:23:15.000Z","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/8shWgP2Mg0","expanded_url":"http://bit.ly/1zfpZ9d","display_url":"bit.ly/1zfpZ9d"}],"mentions":{},"hashtags":[{"start":46,"end":51,"tag":"SMEs"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"563281693738815488","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"This year's #SME report shows increased success rates for SME applications for 2011-4 compared to previous 4 years: http://t.co/mKRJ1nzbtr","id":"563281616362278912","created_at":"2015-02-05T10:22:57.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/mKRJ1nzbtr","expanded_url":"http://bit.ly/1EG9PsN","display_url":"bit.ly/1EG9PsN"}],"mentions":{},"hashtags":[{"start":12,"end":16,"tag":"SME"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563281616362278912","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_Drug_Info: FDA approves new drug for postmenopausal women with advanced #breastcancer: http://t.co/2w5e4K08yU.","id":"563011380878774272","created_at":"2015-02-04T16:29:08.000Z","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/2w5e4K08yU","expanded_url":"http://go.usa.gov/hPdR","display_url":"go.usa.gov/hPdR"}],"mentions":[{"start":3,"end":17,"username":"FDA_Drug_Info","id":"53039176"}],"hashtags":[{"start":80,"end":93,"tag":"breastcancer"}],"annotations":[{"start":19,"end":21,"probability":0.9605,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":37,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563011380878774272","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563008266939412480"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Did you know? The #Pharmacopoeia promotes #publichealth by providing common standards for the quality of medicines http://t.…","id":"563011233889415169","created_at":"2015-02-04T16:28:33.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":33,"end":47,"tag":"Pharmacopoeia"},{"start":57,"end":70,"tag":"publichealth"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563011233889415169","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563006716380737537"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Eur. #Pharmacopoeia: discover the 5 trigger factors behind the creation or revision of a text http://t.co/1IBwhEbQU9 http://…","id":"563011209516310528","created_at":"2015-02-04T16:28:27.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/1IBwhEbQU9","expanded_url":"http://bit.ly/1yHHifn","display_url":"bit.ly/1yHHifn"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":20,"end":34,"tag":"Pharmacopoeia"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"563011209516310528","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"563006419960864770"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've changed the registration procedures for #SMEs to reduce administrative burden: http://t.co/8shWgP2Mg0","id":"562992053777616897","created_at":"2015-02-04T15:12:20.000Z","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/8shWgP2Mg0","expanded_url":"http://bit.ly/1zfpZ9d","display_url":"bit.ly/1zfpZ9d"}],"mentions":{},"hashtags":[{"start":46,"end":51,"tag":"SMEs"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"562992053777616897","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"This year's #SME report shows increased success rates for SME applications for 2011-4 compared to previous 4 years: http://t.co/mKRJ1nzbtr","id":"562991449172893697","created_at":"2015-02-04T15:09:56.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/mKRJ1nzbtr","expanded_url":"http://bit.ly/1EG9PsN","display_url":"bit.ly/1EG9PsN"}],"mentions":{},"hashtags":[{"start":12,"end":16,"tag":"SME"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":5,"quote_count":0},"conversation_id":"562991449172893697","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @HealthCanada: Supporting childhood #brain #cancer research thanks to #GoC @BrainCanada @cancersociety partnership http://t.co/4tmYxrbgg3","id":"562989811993440256","created_at":"2015-02-04T15:03:25.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/4tmYxrbgg3","expanded_url":"http://ow.ly/ItPw4","display_url":"ow.ly/ItPw4"}],"mentions":[{"start":3,"end":16,"username":"HealthCanada","id":"928334374256472064"},{"start":78,"end":90,"username":"BrainCanada","id":"1377360972"},{"start":91,"end":105,"username":"cancersociety","id":"15411998"}],"hashtags":[{"start":39,"end":45,"tag":"brain"},{"start":46,"end":53,"tag":"cancer"},{"start":73,"end":77,"tag":"GoC"}],"annotations":{}},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562989811993440256","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562989476830777348"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on the #transparency provisions of the European #ClinicalTrial Regulation: http://t.co/ISebgNDUlw  #consultation","id":"562989611660873729","created_at":"2015-02-04T15:02:37.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/ISebgNDUlw","expanded_url":"http://bit.ly/1CuFoVA","display_url":"bit.ly/1CuFoVA"}],"mentions":{},"hashtags":[{"start":33,"end":46,"tag":"transparency"},{"start":74,"end":88,"tag":"ClinicalTrial"},{"start":125,"end":138,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"562989611660873729","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #minutes from the December meeting of our human #medicines committee (CHMP) are available on our website: http://t.co/tAIIOLRdM2","id":"562989465669763073","created_at":"2015-02-04T15:02:03.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/tAIIOLRdM2","expanded_url":"http://bit.ly/1vsdJmu","display_url":"bit.ly/1vsdJmu"}],"mentions":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":52,"end":62,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562989465669763073","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @US_FDA: More about FDA’s current expanded access policies, requirements for enrolling &amp; steps you can take to get more info. http://t.c…","id":"562988501554438144","created_at":"2015-02-04T14:58:13.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":[{"start":23,"end":25,"probability":0.9274,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562988501554438144","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562976077514293248"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_H2020: #EU #research is targeting the drivers of difficult-to-treat breast cancers http://t.co/tImuDMUURf #WorldCancerDay #WCD2015 @…","id":"562988304732532736","created_at":"2015-02-04T14:57:26.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/tImuDMUURf","expanded_url":"http://ec.europa.eu/programmes/horizon2020/en/news/targeting-drivers-difficult-treat-breast-cancers","display_url":"ec.europa.eu/programmes/hor…"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"hashtags":[{"start":14,"end":17,"tag":"EU"},{"start":18,"end":27,"tag":"research"},{"start":113,"end":128,"tag":"WorldCancerDay"},{"start":129,"end":137,"tag":"WCD2015"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562988304732532736","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562974681347919872"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @innovationunion: #EU #research is targeting the drivers of difficult-to-treat breast cancers http://t.co/Zh2npy5wuc #WorldCancerDay #WC…","id":"562988293722488834","created_at":"2015-02-04T14:57:23.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/Zh2npy5wuc","expanded_url":"http://ec.europa.eu/programmes/horizon2020/en/news/targeting-drivers-difficult-treat-breast-cancers","display_url":"ec.europa.eu/programmes/hor…"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":21,"end":24,"tag":"EU"},{"start":25,"end":34,"tag":"research"},{"start":120,"end":135,"tag":"WorldCancerDay"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562988293722488834","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562974681289224193"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Eurovaccine: #Varicella vaccination guidance for EU launched http://t.co/uTogdBbCLp","id":"562987870965993472","created_at":"2015-02-04T14:55:42.000Z","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/uTogdBbCLp","expanded_url":"http://bit.ly/1xg6yb5","display_url":"bit.ly/1xg6yb5"}],"mentions":{},"hashtags":[{"start":17,"end":27,"tag":"Varicella"}],"annotations":[{"start":53,"end":54,"probability":0.6923,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562987870965993472","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562973460876759040"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @US_FDA: FDA Voice blog: Expanded access means helping patients most in need by streamlining access to investigational drugs. http://t.c…","id":"562987753739395073","created_at":"2015-02-04T14:55:14.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":[{"start":12,"end":14,"probability":0.7383,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":33,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562987753739395073","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562972812504489986"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: Report on therapeutic positioning of pomalidomide (Imnovid®) in the treatment of multiple myeloma http://t.co/MS1s7lsXTv","id":"562987216449052673","created_at":"2015-02-04T14:53:06.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/MS1s7lsXTv","expanded_url":"http://bit.ly/16h3iWD","display_url":"bit.ly/16h3iWD"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"562987216449052673","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: #WorldCancerDay New common procedure 2 improve #EU #cancer #data collection @EC_JRC_IHCPnews http://t.co/p5Sg9URzBI http://t…","id":"562986640428507136","created_at":"2015-02-04T14:50:49.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":15,"end":30,"tag":"WorldCancerDay"},{"start":62,"end":65,"tag":"EU"},{"start":66,"end":73,"tag":"cancer"},{"start":74,"end":79,"tag":"data"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562986640428507136","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562965751280467972"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #minutes from the December meeting of our committee on human #medicines (CHMP): http://t.co/tAIIOLRdM2","id":"562942142776369154","created_at":"2015-02-04T11:54:00.000Z","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/tAIIOLRdM2","expanded_url":"http://bit.ly/1vsdJmu","display_url":"bit.ly/1vsdJmu"}],"mentions":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":81,"end":91,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562942142776369154","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: Possible that #influenza A(H7N9) will be imported to Europe, but unlikely to spread. Updated risk assessment: http://t.co/Qh0…","id":"562938863484932096","created_at":"2015-02-04T11:40:58.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"hashtags":[{"start":28,"end":38,"tag":"influenza"}],"annotations":[{"start":67,"end":72,"probability":0.9953,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562938863484932096","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562938496462389248"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: Register for #EU_ECHA 10th Stakeholders' Day by 1 May #Sday10 http://t.co/LMGPcyqVyI http://t.co/dTp7BwBuCB","id":"562938026528350209","created_at":"2015-02-04T11:37:39.000Z","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/LMGPcyqVyI","expanded_url":"http://bit.ly/1BV39U0","display_url":"bit.ly/1BV39U0"},{"start":98,"end":120,"url":"http://t.co/dTp7BwBuCB","expanded_url":"https://twitter.com/EU_ECHA/status/562937347319549953/photo/1","display_url":"pic.twitter.com/dTp7BwBuCB"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"hashtags":[{"start":26,"end":34,"tag":"EU_ECHA"},{"start":67,"end":74,"tag":"Sday10"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562938026528350209","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562937347319549953"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_562937346161930240"]}},{"text":"RT @innovationunion: See the #EU projects analysing #tumour cells in real time to stay 1 step ahead of mutations #WorldCancerDay #WCD2015 h…","id":"562931603123736579","created_at":"2015-02-04T11:12:07.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":29,"end":32,"tag":"EU"},{"start":52,"end":59,"tag":"tumour"},{"start":113,"end":128,"tag":"WorldCancerDay"},{"start":129,"end":137,"tag":"WCD2015"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562931603123736579","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562929552381730816"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_H2020: See the #EU projects analysing #tumour cells in real time to stay 1 step ahead of mutations #WorldCancerDay #WCD2015 http://t…","id":"562931588070375425","created_at":"2015-02-04T11:12:04.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"hashtags":[{"start":22,"end":25,"tag":"EU"},{"start":45,"end":52,"tag":"tumour"},{"start":106,"end":121,"tag":"WorldCancerDay"},{"start":122,"end":130,"tag":"WCD2015"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562931588070375425","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562929552369135616"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Need practical advice on using and interpreting #European #Pharmacopoeia General Chapters and #Monographs? Join us! http://t…","id":"562930673972162561","created_at":"2015-02-04T11:08:26.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":63,"end":72,"tag":"European"},{"start":73,"end":87,"tag":"Pharmacopoeia"},{"start":109,"end":120,"tag":"Monographs"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562930673972162561","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562919161547194368"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on the #transparency provisions of the European #ClinicalTrial Regulation: http://t.co/ISebgNDUlw #consultation","id":"562904384372477952","created_at":"2015-02-04T09:23:58.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/ISebgNDUlw","expanded_url":"http://bit.ly/1CuFoVA","display_url":"bit.ly/1CuFoVA"}],"mentions":{},"hashtags":[{"start":33,"end":46,"tag":"transparency"},{"start":74,"end":88,"tag":"ClinicalTrial"},{"start":124,"end":137,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"562904384372477952","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EMA H-G. Eichler explains the relevance of #EFSAExpo2015 conference and the importance of scientific cooperation https://t.co…","id":"562901967656480768","created_at":"2015-02-04T09:14:21.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":17,"tag":"EMA"},{"start":57,"end":70,"tag":"EFSAExpo2015"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562901967656480768","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562895297215733760"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IAPOtweets: Changing laws, new resources: our February news is out now! Check your inboxes or here: http://t.co/Q1bYSukvwR http://t.co/…","id":"562663651296161793","created_at":"2015-02-03T17:27:22.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/Q1bYSukvwR","expanded_url":"http://bit.ly/1BSolaR","display_url":"bit.ly/1BSolaR"}],"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562663651296161793","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562653075693768704"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Updated #H2020 F.A.Q. on topics related to #ehealth http://t.co/66w0L2HTbj @EU_H2020 HT @EU_eHealth http://t.co/Pk7zWkvqmq","id":"562663557154996226","created_at":"2015-02-03T17:27:00.000Z","entities":{"urls":[{"start":67,"end":89,"url":"http://t.co/66w0L2HTbj","expanded_url":"http://europa.eu/!TP43MN","display_url":"europa.eu/!TP43MN"},{"start":115,"end":137,"url":"http://t.co/Pk7zWkvqmq","expanded_url":"https://twitter.com/EU_Health/status/562657517831225344/photo/1","display_url":"pic.twitter.com/Pk7zWkvqmq"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":90,"end":99,"username":"EU_H2020","id":"920249612329504768"},{"start":103,"end":114,"username":"EU_eHealth","id":"931560712484343810"}],"hashtags":[{"start":23,"end":29,"tag":"H2020"},{"start":58,"end":66,"tag":"ehealth"}],"annotations":{}},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562663557154996226","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562657517831225344"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_562657517051052034"]}},{"text":"RT @edqm_news: The #EDQM has been engaged in efforts to strengthen consumer #healthprotection in Europe, with a focus on cosmetics http://t…","id":"562608376275030017","created_at":"2015-02-03T13:47:44.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":19,"end":24,"tag":"EDQM"},{"start":76,"end":93,"tag":"healthprotection"}],"annotations":[{"start":97,"end":102,"probability":0.9908,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562608376275030017","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562564124539092993"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: Don't have a @rarediseaseday event to attend locally? Participate in our #RareEU2015 event online Feb 24 http://t.co/8Ees2Ubc…","id":"562608269030862848","created_at":"2015-02-03T13:47:18.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":27,"end":42,"username":"rarediseaseday","id":"19982434"}],"hashtags":[{"start":87,"end":98,"tag":"RareEU2015"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562608269030862848","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562570012826042368"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #caffeine - #EFSA discusses its draft opinion with stakeholders in Brussels on 5 March – register now http://t.co/iVYougo1fN","id":"562608218686636032","created_at":"2015-02-03T13:47:06.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/iVYougo1fN","expanded_url":"http://bit.ly/1uTtrAV","display_url":"bit.ly/1uTtrAV"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":22,"tag":"caffeine"},{"start":25,"end":30,"tag":"EFSA"}],"annotations":[{"start":80,"end":87,"probability":0.9737,"type":"Place","normalized_text":"Brussels"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562608218686636032","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562573434421805056"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @PrimaryCare4um: NIDIAG #EU @FP7_Projects Improve quality #PrimaryCare to reduce burden of Neglected Infectious Diseases @ITMantwerp htt…","id":"562605952491597824","created_at":"2015-02-03T13:38:06.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":31,"end":44,"username":"FP7_Projects","id":"102663017"},{"start":124,"end":135,"username":"ITMantwerp","id":"397151941"}],"hashtags":[{"start":27,"end":30,"tag":"EU"},{"start":61,"end":73,"tag":"PrimaryCare"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562605952491597824","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562589981206921216"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Did you know? The protection of animal rights has long been a subject of interest for the #EDQM Council of Europe http://t.c…","id":"562605109495234560","created_at":"2015-02-03T13:34:45.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":105,"end":110,"tag":"EDQM"}],"annotations":[{"start":122,"end":127,"probability":0.6924,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562605109495234560","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562602247394459648"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda of next week's orphan medicine committee (COMP) meeting: http://t.co/Mj9DdAL0ma","id":"562541936712884225","created_at":"2015-02-03T09:23:43.000Z","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/Mj9DdAL0ma","expanded_url":"http://bit.ly/1LElGcK","display_url":"bit.ly/1LElGcK"}],"mentions":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"562541936712884225","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: Publication of the 5th edition of the Spanish Pharmacopeia &amp; the 2nd edition of the National Formulary http://t.co/OVa2einurS","id":"562298032868589570","created_at":"2015-02-02T17:14:32.000Z","entities":{"urls":[{"start":121,"end":143,"url":"http://t.co/OVa2einurS","expanded_url":"http://bit.ly/1wY3FeG","display_url":"bit.ly/1wY3FeG"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"562298032868589570","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @INFARMED_IP: Public consultation: \"Draft proposal... Functional specifications for the EU portal and EU... http://t.co/fFHGz7L4Qj","id":"562297817881133056","created_at":"2015-02-02T17:13:41.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/fFHGz7L4Qj","expanded_url":"http://bit.ly/1HM1zdl","display_url":"bit.ly/1HM1zdl"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"562297817881133056","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda of February's orphan medicine committee (COMP) meeting: http://t.co/Mj9DdAL0ma","id":"562289309773221888","created_at":"2015-02-02T16:39:52.000Z","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/Mj9DdAL0ma","expanded_url":"http://bit.ly/1LElGcK","display_url":"bit.ly/1LElGcK"}],"mentions":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"562289309773221888","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: #EDQM Training session on 8th edition #European #Pharmacopoeia is now open for registration! Download the programme: http://…","id":"562284057997082624","created_at":"2015-02-02T16:19:00.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":15,"end":20,"tag":"EDQM"},{"start":53,"end":62,"tag":"European"},{"start":63,"end":77,"tag":"Pharmacopoeia"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562284057997082624","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562283024017264642"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @agesnews: @ECDC_EU / @EFSA_EU / @EMA_News EU report on antibiotics in animal breeding and resistance in humans http://t.co/aJ5Wvqvrip","id":"562279071200313344","created_at":"2015-02-02T15:59:11.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/aJ5Wvqvrip","expanded_url":"http://bit.ly/1CSpiDW","display_url":"bit.ly/1CSpiDW"}],"mentions":[{"start":3,"end":12,"username":"agesnews","id":"223456379"},{"start":14,"end":22,"username":"ECDC_EU","id":"204752573"},{"start":25,"end":33,"username":"EFSA_EU","id":"84582815"},{"start":36,"end":45,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"562279071200313344","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: The #PhEur Commission will hold its 151st Session on 17-18 March 2015. See all the upcoming dates: http://t.co/ufFK2a64Rn","id":"562274352952246273","created_at":"2015-02-02T15:40:26.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/ufFK2a64Rn","expanded_url":"http://bit.ly/1vfhnzS","display_url":"bit.ly/1vfhnzS"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":19,"end":25,"tag":"PhEur"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562274352952246273","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562273266606551040"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: Read about IMI projects @PRECISESADS &amp; AETIONOMY in @NatRevDrugDisc ‘Towards the taxonomy of human disease’ http://t.co/IfZ5zbJ…","id":"562274245674549248","created_at":"2015-02-02T15:40:01.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":36,"end":48,"username":"PRECISESADS","id":"2574450325"},{"start":68,"end":83,"username":"NatRevDrugDisc","id":"36066745"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562274245674549248","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562271292875747328"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IFAHEurope: IFAH-Europe welcomes joint agencies' report on antibiotic resistance in humans &amp; animals http://t.co/exDz5vqhEu @EMA_News @…","id":"562274158118469633","created_at":"2015-02-02T15:39:40.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/exDz5vqhEu","expanded_url":"http://bit.ly/1wXgOVk","display_url":"bit.ly/1wXgOVk"}],"mentions":[{"start":132,"end":141,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":21,"end":26,"probability":0.928,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562274158118469633","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562270028482220033"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Do you know about the #EDQM 3Rs achievements? \n#animaltesting http://t.co/LOzYekwuIE","id":"562267280781086720","created_at":"2015-02-02T15:12:20.000Z","entities":{"urls":[{"start":77,"end":99,"url":"http://t.co/LOzYekwuIE","expanded_url":"http://bit.ly/1JUEFhl","display_url":"bit.ly/1JUEFhl"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":37,"end":42,"tag":"EDQM"},{"start":62,"end":76,"tag":"animaltesting"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562267280781086720","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562264693373673472"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EURLex: #eurlextip You can read all about the new numbering of #EU legal acts here (PDF): http://t.co/Dc8ZAoBree  #EULaw http://t.co/LZ…","id":"562267215387705344","created_at":"2015-02-02T15:12:05.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/Dc8ZAoBree","expanded_url":"http://ow.ly/Ilgyz","display_url":"ow.ly/Ilgyz"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"}],"hashtags":[{"start":12,"end":22,"tag":"eurlextip"},{"start":67,"end":70,"tag":"EU"},{"start":118,"end":124,"tag":"EULaw"}],"annotations":{}},"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562267215387705344","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562262431796559872"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Looking for a CEP? Search our #Certification \nDatabase for info on Certificates of #Suitability granted by the #EDQM: http:/…","id":"562267082885455872","created_at":"2015-02-02T15:11:33.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":45,"end":59,"tag":"Certification"},{"start":98,"end":110,"tag":"Suitability"},{"start":126,"end":131,"tag":"EDQM"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562267082885455872","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562260999093637120"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ZVALatvija: We invite you to the press conference on February 5th at 2p.m.(Meeting of the Heads of Medicines Agencies of Europe):https:…","id":"562266772234317824","created_at":"2015-02-02T15:10:19.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"ZVALatvija","id":"1576993495"}],"hashtags":{},"annotations":[{"start":94,"end":130,"probability":0.446,"type":"Organization","normalized_text":"Heads of Medicines Agencies of Europe"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562266772234317824","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562256590917877760"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ZVALatvija: Call to the press conference on 5 February at 14:00 after the Heads of Medicines Agencies meeting: http://t.co/s8x5zyeEBj","id":"562266696153853952","created_at":"2015-02-02T15:10:01.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/s8x5zyeEBj","expanded_url":"http://bit.ly/1CSgaz5","display_url":"bit.ly/1CSgaz5"}],"mentions":[{"start":3,"end":14,"username":"ZVALatvija","id":"1576993495"}],"hashtags":{},"annotations":[{"start":78,"end":104,"probability":0.4559,"type":"Organization","normalized_text":"Heads of Medicines Agencies"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562266696153853952","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: How does IMI research measure up? Pretty well, according to this analysis by @thomsonreuters http://t.co/p9lQQInZmi http://t.co…","id":"562265510445068288","created_at":"2015-02-02T15:05:18.000Z","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/p9lQQInZmi","expanded_url":"http://bit.ly/1voQv0g","display_url":"bit.ly/1voQv0g"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":89,"end":104,"username":"thomsonreuters","id":"14412844"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562265510445068288","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562248982483587072"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @LV_MPA: Monthly report from the CHMP (January 2015) http://t.co/jMkmmacj3V","id":"562265225551171584","created_at":"2015-02-02T15:04:10.000Z","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/jMkmmacj3V","expanded_url":"http://bit.ly/1CSf3Q9","display_url":"bit.ly/1CSf3Q9"}],"mentions":[{"start":3,"end":10,"username":"LV_MPA","id":"77047226"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562265225551171584","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: The 1st IMI newsletter of 2015 is online: New projects on #Ebola &amp; #Alzheimer’s, plus news from our ongoing projects http://t.c…","id":"562239696383008768","created_at":"2015-02-02T13:22:44.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":[{"start":70,"end":76,"tag":"Ebola"},{"start":83,"end":93,"tag":"Alzheimer"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562239696383008768","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562238243987816448"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@sbird331 Our website is up and running again now. Sorry for the inconvenience.","id":"562232560529735680","created_at":"2015-02-02T12:54:22.000Z","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"sbird331","id":"3011861393"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561227773461925888","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"562180105313988608"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"116716199"},{"text":"Public #consultation open on our #guideline on procedure for suspected contamination of a #vaccine with bovine virus: http://t.co/YWoLTxV79A","id":"562232075521368065","created_at":"2015-02-02T12:52:27.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/YWoLTxV79A","expanded_url":"http://bit.ly/1KelkWH","display_url":"bit.ly/1KelkWH"}],"mentions":{},"hashtags":[{"start":7,"end":20,"tag":"consultation"},{"start":33,"end":43,"tag":"guideline"},{"start":90,"end":98,"tag":"vaccine"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"562232075521368065","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Report from EU agencies includes first integrated analysis of human &amp; animal data on antimicrobial resistance: http://t.co/qGghG9dQiJ #AMR","id":"562231856675164160","created_at":"2015-02-02T12:51:35.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/qGghG9dQiJ","expanded_url":"http://bit.ly/1DmYSZo","display_url":"bit.ly/1DmYSZo"}],"mentions":{},"hashtags":[{"start":138,"end":142,"tag":"AMR"}],"annotations":[{"start":12,"end":13,"probability":0.8614,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"562231856675164160","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The EPAR for #Ketoconazole HRA, a #medicine to treat #Cushing’s syndrome, is available on our website: http://t.co/LPTXVDUxZv","id":"562230958980890624","created_at":"2015-02-02T12:48:01.000Z","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/LPTXVDUxZv","expanded_url":"http://bit.ly/1yeHUsP","display_url":"bit.ly/1yeHUsP"}],"mentions":{},"hashtags":[{"start":13,"end":26,"tag":"Ketoconazole"},{"start":34,"end":43,"tag":"medicine"},{"start":53,"end":61,"tag":"Cushing"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562230958980890624","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The EPAR for #Duavive (#oestrogens conjugated / #bazedoxifene) to treat #oestrogen deficiency symptoms is available: http://t.co/7N6KGDp1cz","id":"562230906036174848","created_at":"2015-02-02T12:47:48.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/7N6KGDp1cz","expanded_url":"http://bit.ly/1DePS8l","display_url":"bit.ly/1DePS8l"}],"mentions":{},"hashtags":[{"start":13,"end":21,"tag":"Duavive"},{"start":23,"end":34,"tag":"oestrogens"},{"start":48,"end":61,"tag":"bazedoxifene"},{"start":72,"end":82,"tag":"oestrogen"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"562230906036174848","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Food_EU: .@EU_Commission published the replies to endocrine disruptors #publicconsultation; summary report to follow http://t.co/ecQOJs…","id":"562230349162614785","created_at":"2015-02-02T12:45:35.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"},{"start":14,"end":28,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":75,"end":94,"tag":"publicconsultation"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562230349162614785","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562227291582115840"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: .@EU_Commission published the replies to endocrine disruptors #publicconsultation; summary report to follow http://t.co/vmTY…","id":"562230314177933314","created_at":"2015-02-02T12:45:27.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":30,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":77,"end":96,"tag":"publicconsultation"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562230314177933314","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562227080092725248"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSA to hold a stakeholders meeting on #feed additives applications in Barcelona next 5 May – Register now http://t.co/LIQUIs…","id":"562220786732527616","created_at":"2015-02-02T12:07:35.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":53,"end":58,"tag":"feed"}],"annotations":[{"start":85,"end":93,"probability":0.9735,"type":"Place","normalized_text":"Barcelona"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562220786732527616","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562218901820698624"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_H2020: Fighting #antimicrobial resistance: \nhttp://t.co/6DAgHgzCiP &gt;  #HorizonPrize of €1m http://t.co/By21nohY5W… #H2020","id":"562220239065473025","created_at":"2015-02-02T12:05:25.000Z","entities":{"urls":[{"start":51,"end":73,"url":"http://t.co/6DAgHgzCiP","expanded_url":"http://bit.ly/1ETylnt","display_url":"bit.ly/1ETylnt"},{"start":101,"end":123,"url":"http://t.co/By21nohY5W","expanded_url":"http://ec.europa.eu/research/horiz","display_url":"ec.europa.eu/research/horiz"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"hashtags":[{"start":23,"end":37,"tag":"antimicrobial"},{"start":80,"end":93,"tag":"HorizonPrize"},{"start":125,"end":131,"tag":"H2020"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562220239065473025","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562211599457337344"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @innovationunion: Fighting #antimicrobial resistance: \nhttp://t.co/oq2PagHvKV &gt;  #HorizonPrize of €1m http://t.co/wvjrnCjtss… #H2020","id":"562220224209223680","created_at":"2015-02-02T12:05:21.000Z","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/oq2PagHvKV","expanded_url":"http://bit.ly/1ETylnt","display_url":"bit.ly/1ETylnt"},{"start":108,"end":130,"url":"http://t.co/wvjrnCjtss","expanded_url":"http://ec.europa.eu/research/horiz","display_url":"ec.europa.eu/research/horiz"}],"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":30,"end":44,"tag":"antimicrobial"},{"start":87,"end":100,"tag":"HorizonPrize"},{"start":132,"end":138,"tag":"H2020"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562220224209223680","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562211390350311424"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: EU agencies publish first integrated analysis of data from humans and animals http://t.co/p3yhu3iBaj","id":"562219692614758400","created_at":"2015-02-02T12:03:14.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/p3yhu3iBaj","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/01/news_detail_002260.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"annotations":[{"start":13,"end":14,"probability":0.8147,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562219692614758400","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562207281853771778"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_H2020: @ECDC_EU @EFSA_EU @EMA_News #HorizonPrize is offering €1m to address the unnecessary use of antibiotics http://t.co/XVjbZARHu…","id":"562202628894228480","created_at":"2015-02-02T10:55:26.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"},{"start":14,"end":22,"username":"ECDC_EU","id":"204752573"},{"start":23,"end":31,"username":"EFSA_EU","id":"84582815"},{"start":32,"end":41,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":42,"end":55,"tag":"HorizonPrize"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562202628894228480","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562202348840579074"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @innovationunion: @ECDC_EU @EFSA_EU @EMA_News #HorizonPrize is offering €1m to address the unnecessary use of antibiotics http://t.co/Ht…","id":"562202555556835328","created_at":"2015-02-02T10:55:09.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"},{"start":21,"end":29,"username":"ECDC_EU","id":"204752573"},{"start":30,"end":38,"username":"EFSA_EU","id":"84582815"},{"start":39,"end":48,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":49,"end":62,"tag":"HorizonPrize"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562202555556835328","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562202348836372480"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myESMO: FDA expands approved use of ibrutinib to #Waldenström’s #Macroglobulinaemia @_rarecancer http://t.co/R61zAsCev9","id":"562201362243788800","created_at":"2015-02-02T10:50:24.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/R61zAsCev9","expanded_url":"http://ow.ly/Ikk4V","display_url":"ow.ly/Ikk4V"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"},{"start":88,"end":100,"username":"_rarecancer","id":"2301430153"}],"hashtags":[{"start":53,"end":65,"tag":"Waldenström"},{"start":68,"end":87,"tag":"Macroglobulinaemia"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562201362243788800","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562196492312920064"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Interested in attending the #PhEur Training session in July? Special Online Registration Rates are available:  http://t.co/Q…","id":"562195858457116672","created_at":"2015-02-02T10:28:32.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":43,"end":49,"tag":"PhEur"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562195858457116672","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562195444428980224"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egabiosimilars: #DidYouKnow that you can read the @EU_Commission Consensus Information Document on #biosimilars in Portuguese? http://t…","id":"562181055571320832","created_at":"2015-02-02T09:29:43.000Z","entities":{"urls":{},"mentions":[{"start":54,"end":68,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":20,"end":31,"tag":"DidYouKnow"},{"start":103,"end":115,"tag":"biosimilars"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562181055571320832","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562173581430255616"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: The 136th session of WHO Executive Board:\nWatch LIVE http://t.co/wrz43iuJyw   \nUse hashtag #EB136\nTwitter list: http://t.co/wrz43i…","id":"562180685663047680","created_at":"2015-02-02T09:28:14.000Z","entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/wrz43iuJyw","expanded_url":"http://goo.gl/e1vYqX","display_url":"goo.gl/e1vYqX"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":100,"end":106,"tag":"EB136"}],"annotations":{}},"public_metrics":{"retweet_count":34,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"562180685663047680","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"562166570328551424"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@sbird331 Apologies for the outage - we're working on it.","id":"562180105313988608","created_at":"2015-02-02T09:25:56.000Z","entities":{"urls":{},"mentions":[{"start":0,"end":9,"username":"sbird331","id":"3011861393"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"561227773461925888","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"562166888000942080"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"3011861393"},{"text":"One week left to apply to our tender for effectiveness and #pharmacoepidemiology studies: http://t.co/cFDK7GRFAk #procurement","id":"561227773461925888","created_at":"2015-01-30T18:21:42.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"mentions":{},"hashtags":[{"start":59,"end":80,"tag":"pharmacoepidemiology"},{"start":113,"end":125,"tag":"procurement"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"561227773461925888","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Still time to comment on paper on revising #guidelines on data for #veterinary medicines for minor use minor species: http://t.co/UGyhmV0RLA","id":"561227724145328128","created_at":"2015-01-30T18:21:31.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/UGyhmV0RLA","expanded_url":"http://bit.ly/1CGopON","display_url":"bit.ly/1CGopON"}],"mentions":{},"hashtags":[{"start":43,"end":54,"tag":"guidelines"},{"start":67,"end":78,"tag":"veterinary"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561227724145328128","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: Find out what #FDA Guidances are under development for 2015 http://t.co/5feE25Yyha","id":"561224375962439680","created_at":"2015-01-30T18:08:12.000Z","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/5feE25Yyha","expanded_url":"http://1.usa.gov/WxXRvO","display_url":"1.usa.gov/WxXRvO"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"hashtags":[{"start":35,"end":39,"tag":"FDA"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561224375962439680","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561224007178256385"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Comment on a #guideline on procedure for suspected contamination of a #vaccine with bovine viral diarrhoea virus: http://t.co/YWoLTxV79A","id":"561203711733944320","created_at":"2015-01-30T16:46:06.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/YWoLTxV79A","expanded_url":"http://bit.ly/1KelkWH","display_url":"bit.ly/1KelkWH"}],"mentions":{},"hashtags":[{"start":13,"end":23,"tag":"guideline"},{"start":70,"end":78,"tag":"vaccine"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"561203711733944320","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Training course on the 8th Edition #European #Pharmacopoeia to be held next July in #Strasbourg. Sign up today! http://t.co/…","id":"561197281454858241","created_at":"2015-01-30T16:20:33.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":50,"end":59,"tag":"European"},{"start":60,"end":74,"tag":"Pharmacopoeia"},{"start":99,"end":110,"tag":"Strasbourg"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561197281454858241","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561186762421440513"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: Questions about #FDA's Role in Animal Health - Find out what #FDA does and does not regulate http://t.co/PdmABJ4xd5","id":"561197176127504385","created_at":"2015-01-30T16:20:07.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/PdmABJ4xd5","expanded_url":"http://1.usa.gov/1vflrjy","display_url":"1.usa.gov/1vflrjy"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"hashtags":[{"start":37,"end":41,"tag":"FDA"},{"start":82,"end":86,"tag":"FDA"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561197176127504385","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561194934280400896"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the EPAR for #Duavive (#oestrogens conjugated/#bazedoxifene) to treat #oestrogen deficiency symptoms: http://t.co/7N6KGDp1cz","id":"561196600073400320","created_at":"2015-01-30T16:17:50.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/7N6KGDp1cz","expanded_url":"http://bit.ly/1DePS8l","display_url":"bit.ly/1DePS8l"}],"mentions":{},"hashtags":[{"start":29,"end":37,"tag":"Duavive"},{"start":39,"end":50,"tag":"oestrogens"},{"start":62,"end":75,"tag":"bazedoxifene"},{"start":86,"end":96,"tag":"oestrogen"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"561196600073400320","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Ketoconazole HRA, a #medicine to treat #Cushing’s syndrome:  http://t.co/LPTXVDUxZv","id":"561195262413385729","created_at":"2015-01-30T16:12:31.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/LPTXVDUxZv","expanded_url":"http://bit.ly/1yeHUsP","display_url":"bit.ly/1yeHUsP"}],"mentions":{},"hashtags":[{"start":42,"end":55,"tag":"Ketoconazole"},{"start":63,"end":72,"tag":"medicine"},{"start":82,"end":90,"tag":"Cushing"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561195262413385729","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"EU report provides basis for effective fight against development of resistant #bacteria: http://t.co/qGghG9dQiJ #AMR http://t.co/hF3bscniju","id":"561139619220422656","created_at":"2015-01-30T12:31:25.000Z","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/qGghG9dQiJ","expanded_url":"http://bit.ly/1DmYSZo","display_url":"bit.ly/1DmYSZo"},{"start":117,"end":139,"url":"http://t.co/hF3bscniju","expanded_url":"https://twitter.com/EMA_News/status/561139619220422656/photo/1","display_url":"pic.twitter.com/hF3bscniju"}],"mentions":{},"hashtags":[{"start":78,"end":87,"tag":"bacteria"},{"start":112,"end":116,"tag":"AMR"}],"annotations":[{"start":0,"end":1,"probability":0.7578,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":23,"reply_count":0,"like_count":7,"quote_count":0},"conversation_id":"561139619220422656","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_561139618348007425"]}},{"text":"RT @ECDC_Flu: #flu season in Europe, early #vaccine effectiveness estimates from Canada &amp; more on #influenza @Eurosurveillanc: http://t.co/…","id":"561127866210222081","created_at":"2015-01-30T11:44:43.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":113,"end":129,"username":"Eurosurveillanc","id":"455839750"}],"hashtags":[{"start":14,"end":18,"tag":"flu"},{"start":43,"end":51,"tag":"vaccine"},{"start":102,"end":112,"tag":"influenza"}],"annotations":[{"start":29,"end":34,"probability":0.9976,"type":"Place","normalized_text":"Europe"},{"start":81,"end":86,"probability":0.9917,"type":"Place","normalized_text":"Canada"}]},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561127866210222081","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561086801042239488"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: Prevent bacteria spreading by using different utensils for raw &amp; cooked foods #animaldiseases http://t.co/xzEE21hC2I http://t.…","id":"561127793959129088","created_at":"2015-01-30T11:44:25.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/xzEE21hC2I","expanded_url":"http://bit.ly/1HbmypJ","display_url":"bit.ly/1HbmypJ"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":95,"end":110,"tag":"animaldiseases"}],"annotations":{}},"public_metrics":{"retweet_count":18,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561127793959129088","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561090208561889280"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AlzheimerEurope: Our January 2015 #dementia e-#newsletter will be out on Monday. Sign up here to receive it: http://t.co/GiPYqkSkYQ htt…","id":"561127742360784896","created_at":"2015-01-30T11:44:13.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/GiPYqkSkYQ","expanded_url":"http://goo.gl/BwSaBD","display_url":"goo.gl/BwSaBD"}],"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"hashtags":[{"start":38,"end":47,"tag":"dementia"},{"start":50,"end":61,"tag":"newsletter"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561127742360784896","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561095588230742016"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myESMO: First major analysis of Human Protein Atlas includes detailed picture of proteins linked to #cancer http://t.co/WCaM6gvJi7","id":"561127688921186304","created_at":"2015-01-30T11:44:00.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/WCaM6gvJi7","expanded_url":"http://ow.ly/Icq78","display_url":"ow.ly/Icq78"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"hashtags":[{"start":104,"end":111,"tag":"cancer"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561127688921186304","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561098912346693632"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICESciAdvice: 2014 FDA drug approvals - analysis of the 41 new therapeutics, predicted sales, therapeutic area and more http://t.co/JX…","id":"561127659863031808","created_at":"2015-01-30T11:43:54.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"NICESciAdvice","id":"2834291205"}],"hashtags":{},"annotations":[{"start":24,"end":26,"probability":0.6378,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561127659863031808","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561101702234112001"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: 13th International Conference on #Duchenne &amp; #Becker #MuscularDystrophy 21-22 Feb Rome http://t.co/lIl4OHvk2n @Parent_Project…","id":"561127610533834752","created_at":"2015-01-30T11:43:42.000Z","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/lIl4OHvk2n","expanded_url":"http://ow.ly/I196m","display_url":"ow.ly/I196m"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":128,"end":143,"username":"Parent_Project","id":"2328607112"}],"hashtags":[{"start":47,"end":56,"tag":"Duchenne"},{"start":63,"end":70,"tag":"Becker"},{"start":71,"end":89,"tag":"MuscularDystrophy"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561127610533834752","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561101813379006465"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eumsplatform: Our January newsletter is out! http://t.co/ZlsvslK9LX Find news about our #employment project #MultipleSclerosis #MSatWor…","id":"561127578468360193","created_at":"2015-01-30T11:43:34.000Z","entities":{"urls":[{"start":49,"end":71,"url":"http://t.co/ZlsvslK9LX","expanded_url":"http://bit.ly/1LpqvGV","display_url":"bit.ly/1LpqvGV"}],"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"}],"hashtags":[{"start":92,"end":103,"tag":"employment"},{"start":112,"end":130,"tag":"MultipleSclerosis"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561127578468360193","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561103169435222016"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Need practical advice on using and interpreting the #European #Pharmacopoeia General Chapters and #Monographs? http://t.co/Q…","id":"561127534595932160","created_at":"2015-01-30T11:43:24.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":67,"end":76,"tag":"European"},{"start":77,"end":91,"tag":"Pharmacopoeia"},{"start":113,"end":124,"tag":"Monographs"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561127534595932160","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561107024407461888"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @PrimaryCare4um: International #PrimaryCare Research Leadership programme @UniofOxford \nhttp://t.co/5mXgdiBuWJ","id":"561127454509920256","created_at":"2015-01-30T11:43:05.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/5mXgdiBuWJ","expanded_url":"http://www.oxfordleadershipprogramme.co.uk/about","display_url":"oxfordleadershipprogramme.co.uk/about"}],"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":77,"end":89,"username":"UniofOxford","id":"48289662"}],"hashtags":[{"start":34,"end":46,"tag":"PrimaryCare"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561127454509920256","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561113137630707712"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: #FP7 project #REMPARK developed a personal health device to detect&amp;manage #Parkinson. Watch the video: http://t.co/mLvapblf…","id":"561127434138177536","created_at":"2015-01-30T11:43:00.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"hashtags":[{"start":16,"end":20,"tag":"FP7"},{"start":29,"end":37,"tag":"REMPARK"},{"start":94,"end":104,"tag":"Parkinson"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561127434138177536","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561113422503620608"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: #influenza intensity is increasing across Europe. Majority of #EU &amp; EEA countries report medium or high intensity. http://t.c…","id":"561127402622181376","created_at":"2015-01-30T11:42:52.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"hashtags":[{"start":14,"end":24,"tag":"influenza"},{"start":76,"end":79,"tag":"EU"}],"annotations":[{"start":56,"end":61,"probability":0.9854,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561127402622181376","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561114830112034816"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"50 years of #pharmaceutical #legislation: @EU_Health just launched a new website! http://t.co/krfhE0Pocu #EUpharma50 http://t.co/X9D2bwNi5V","id":"561127182756741120","created_at":"2015-01-30T11:42:00.000Z","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/krfhE0Pocu","expanded_url":"http://bit.ly/1tDJfMW","display_url":"bit.ly/1tDJfMW"},{"start":117,"end":139,"url":"http://t.co/X9D2bwNi5V","expanded_url":"http://bit.ly/1zdl48U","display_url":"bit.ly/1zdl48U"}],"mentions":[{"start":42,"end":52,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":12,"end":27,"tag":"pharmaceutical"},{"start":28,"end":40,"tag":"legislation"},{"start":105,"end":116,"tag":"EUpharma50"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"561127182756741120","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: What happened in 50 years of #EU pharmaceutical legislation? Check our timeline! http://t.co/fGyw5aCYy8 #EUpharma50 http://t…","id":"561125861966245888","created_at":"2015-01-30T11:36:45.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/fGyw5aCYy8","expanded_url":"http://europa.eu/!PK36tf","display_url":"europa.eu/!PK36tf"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":44,"end":47,"tag":"EU"},{"start":119,"end":130,"tag":"EUpharma50"}],"annotations":{}},"public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561125861966245888","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561118909563424769"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: Updated #H2020 F.A.Q. on topics related to #ehealth http://t.co/Krb810GYhm","id":"561122580040806400","created_at":"2015-01-30T11:23:42.000Z","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/Krb810GYhm","expanded_url":"http://ec.europa.eu/digital-agenda/en/news/faqs-horizon-2020-topics-related-ehealth","display_url":"ec.europa.eu/digital-agenda…"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"hashtags":[{"start":24,"end":30,"tag":"H2020"},{"start":59,"end":67,"tag":"ehealth"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561122580040806400","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561118663181627392"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @MHRAgovuk: #MHRAvariations seminar on CCC submissions: spaces avail for the AM session on 5 Feb - book your last minute space http://t.…","id":"561122380043780096","created_at":"2015-01-30T11:22:55.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"hashtags":[{"start":15,"end":30,"tag":"MHRAvariations"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"561122380043780096","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"561121154954719232"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@margav7339 @Groote It was shown to @Europarl_EN: http://t.co/oYyywjoLNd. Clinical trial information on our website: http://t.co/48iI7cJkUr","id":"561119270210633728","created_at":"2015-01-30T11:10:33.000Z","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/oYyywjoLNd","expanded_url":"http://bit.ly/1yTeNPt","display_url":"bit.ly/1yTeNPt"},{"start":117,"end":139,"url":"http://t.co/48iI7cJkUr","expanded_url":"http://bit.ly/1614nBu","display_url":"bit.ly/1614nBu"}],"mentions":[{"start":0,"end":11,"username":"margav7339","id":"90486281"},{"start":12,"end":19,"username":"Groote","id":"16297777"},{"start":36,"end":48,"username":"Europarl_EN","id":"36329597"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"560846394953850881","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"561089281801060352"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"90486281"},{"text":"One more week to apply to our tender for effectiveness and #pharmacoepidemiology studies: http://t.co/cFDK7GRFAk #procurement","id":"561114806833664000","created_at":"2015-01-30T10:52:49.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"mentions":{},"hashtags":[{"start":59,"end":80,"tag":"pharmacoepidemiology"},{"start":113,"end":125,"tag":"procurement"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"561114806833664000","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks to comment on paper on revising #guidelines on data for #veterinary medicines for minor use minor species: http://t.co/UGyhmV0RLA","id":"561113754075942912","created_at":"2015-01-30T10:48:38.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/UGyhmV0RLA","expanded_url":"http://bit.ly/1CGopON","display_url":"bit.ly/1CGopON"}],"mentions":{},"hashtags":[{"start":42,"end":53,"tag":"guidelines"},{"start":66,"end":77,"tag":"veterinary"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"561113754075942912","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @luca__pani: EMA workshop on #Alzheimer is now online here http://t.co/ygGFdSOfAc @EMA_News @US_FDA @Aifa_ufficiale @PopSci @sciam @WebM…","id":"560849893472751617","created_at":"2015-01-29T17:20:09.000Z","entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/ygGFdSOfAc","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2014/04/event_detail_000932.jsp&mid=WC0b01ac058004d5c3","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"},{"start":85,"end":94,"username":"EMA_News","id":"116716199"},{"start":95,"end":102,"username":"US_FDA","id":"208120290"},{"start":103,"end":118,"username":"Aifa_ufficiale","id":"441940097"},{"start":119,"end":126,"username":"PopSci","id":"19722699"},{"start":127,"end":133,"username":"sciam","id":"14647570"}],"hashtags":[{"start":32,"end":42,"tag":"Alzheimer"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560849893472751617","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560849675751010304"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Groote: Excellent presentation by EMA Clinical Trials in Third Countries by Fergus Sweeney in the Committee for Public Health. @EMA_News","id":"560846558971719680","created_at":"2015-01-29T17:06:54.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"Groote","id":"16297777"},{"start":131,"end":140,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":38,"end":56,"probability":0.2902,"type":"Organization","normalized_text":"EMA Clinical Trials"},{"start":80,"end":93,"probability":0.8616,"type":"Person","normalized_text":"Fergus Sweeney"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560846558971719680","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560846394953850881"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @rarediseaseday: Discover the Rare Disease Day #MobileExperience today &amp; share it with your mobile contacts! http://t.co/7OSxcYqGWj http…","id":"560846195661082625","created_at":"2015-01-29T17:05:27.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/7OSxcYqGWj","expanded_url":"http://ow.ly/Ia5qi","display_url":"ow.ly/Ia5qi"}],"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"hashtags":[{"start":50,"end":67,"tag":"MobileExperience"}],"annotations":[{"start":33,"end":48,"probability":0.3688,"type":"Other","normalized_text":"Rare Disease Day"}]},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560846195661082625","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560844928310607874"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @laurentlouette: Exchange of views in @EP_Environment with @EMA_News on recent suspension of medicines from GVK in India. http://t.co/r2…","id":"560839223821869056","created_at":"2015-01-29T16:37:45.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"laurentlouette","id":"207525510"},{"start":41,"end":56,"username":"EP_Environment","id":"951333319"},{"start":62,"end":71,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":118,"end":122,"probability":0.9979,"type":"Place","normalized_text":"India"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560839223821869056","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560830257155297280"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICEcomms: We’ve published an interactive online learning tool to help put our lipid modification guidelines into practice http://t.co/…","id":"560838973891694592","created_at":"2015-01-29T16:36:45.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560838973891694592","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560829561836167168"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAMedia: FDA expands drug use for treatment of rare form of non-Hodgkin lymphoma: http://t.co/Z7G3AB0Mpd","id":"560838821982392321","created_at":"2015-01-29T16:36:09.000Z","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/Z7G3AB0Mpd","expanded_url":"http://go.usa.gov/Sfgx","display_url":"go.usa.gov/Sfgx"}],"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"hashtags":{},"annotations":[{"start":14,"end":16,"probability":0.9191,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560838821982392321","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560829223661998080"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Our calendar tells you when the texts from the #PhEur 8th Edition - new and revised in 2014 - will be legally binding http:/…","id":"560838740117946370","created_at":"2015-01-29T16:35:50.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":62,"end":68,"tag":"PhEur"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560838740117946370","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560829123082616834"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: More severe #flu season: @ECDC_EU risk assessment on seasonal #influenza http://t.co/lTzLXR9Jv9 cc. @ECDC_Flu http://t.co/fy…","id":"560825591436296192","created_at":"2015-01-29T15:43:35.000Z","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/lTzLXR9Jv9","expanded_url":"http://europa.eu/!rU88YU","display_url":"europa.eu/!rU88YU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":40,"end":48,"username":"ECDC_EU","id":"204752573"},{"start":115,"end":124,"username":"ECDC_Flu","id":"1371668696"}],"hashtags":[{"start":27,"end":31,"tag":"flu"},{"start":77,"end":87,"tag":"influenza"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560825591436296192","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560823328181858304"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: EMA recommended 20 new medicines for animals in 2014 - three of which are for minor species and rare diseases: http://t.co/UeH…","id":"560825560683655168","created_at":"2015-01-29T15:43:27.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560825560683655168","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560823139920510976"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: Public consultation on application of transparency rules of EU Clinical Trial Regulation http://t.co/3JJIVYu5TC","id":"560825542249676803","created_at":"2015-01-29T15:43:23.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/3JJIVYu5TC","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/01/news_detail_002253.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"annotations":[{"start":73,"end":100,"probability":0.3376,"type":"Other","normalized_text":"EU Clinical Trial Regulation"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560825542249676803","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560822931815940096"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: #PublicConsultation How to apply transparency rules w. #EU #clinicaltrials regs. - reply to @EMA_News by 18.02 http://t.co/2…","id":"560821101794574336","created_at":"2015-01-29T15:25:44.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":107,"end":116,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":15,"end":34,"tag":"PublicConsultation"},{"start":70,"end":73,"tag":"EU"},{"start":74,"end":89,"tag":"clinicaltrials"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560821101794574336","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560819954833166336"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAWomen: COMING SOON: Updates to labels for #pregnant and #breastfeeding women http://t.co/UwNnXSj7na via @medscape","id":"560820827629694976","created_at":"2015-01-29T15:24:39.000Z","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/UwNnXSj7na","expanded_url":"http://ow.ly/I78fb","display_url":"ow.ly/I78fb"}],"mentions":[{"start":3,"end":12,"username":"FDAWomen","id":"65416742"},{"start":111,"end":120,"username":"Medscape","id":"16892009"}],"hashtags":[{"start":49,"end":58,"tag":"pregnant"},{"start":63,"end":77,"tag":"breastfeeding"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560820827629694976","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560804643018919936"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: #Genericmedicine producers must research and develop their own formulae http://t.co/Icpze22k5X #EGAgenerics","id":"560820724781166592","created_at":"2015-01-29T15:24:14.000Z","entities":{"urls":[{"start":89,"end":111,"url":"http://t.co/Icpze22k5X","expanded_url":"http://bit.ly/1yM6AcQ","display_url":"bit.ly/1yM6AcQ"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"hashtags":[{"start":17,"end":33,"tag":"Genericmedicine"},{"start":112,"end":124,"tag":"EGAgenerics"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560820724781166592","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560814736644636672"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @INFARMED_IP: Voluntary recall of 20 generic medicines - EMA recommendation on studies at GVK Biosciences company http://t.co/jmL1XBKYq6","id":"560820522666057728","created_at":"2015-01-29T15:23:26.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/jmL1XBKYq6","expanded_url":"http://bit.ly/1CCNUjU","display_url":"bit.ly/1CCNUjU"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":{},"annotations":[{"start":93,"end":107,"probability":0.9163,"type":"Organization","normalized_text":"GVK Biosciences"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560820522666057728","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @rarediseaseday: See what's happening around the world for Rare Disease Day! http://t.co/1HO71DYalF Post your event here: http://t.co/Iy…","id":"560819672019263489","created_at":"2015-01-29T15:20:03.000Z","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/1HO71DYalF","expanded_url":"http://ow.ly/I94WM","display_url":"ow.ly/I94WM"}],"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"hashtags":{},"annotations":[{"start":62,"end":77,"probability":0.9122,"type":"Other","normalized_text":"Rare Disease Day"}]},"public_metrics":{"retweet_count":22,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560819672019263489","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560799730612318208"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: FDA Ghana and #EDQM are currently discussing Certification procedure and CEPs for #ActivePharmaceuticalIngredients http://t.…","id":"560819460240453632","created_at":"2015-01-29T15:19:13.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":29,"end":34,"tag":"EDQM"},{"start":97,"end":129,"tag":"ActivePharmaceuticalIngredients"}],"annotations":[{"start":15,"end":23,"probability":0.7611,"type":"Organization","normalized_text":"FDA Ghana"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560819460240453632","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560796249738465280"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: Report Release: Conclusions of the @EFPIA &amp; @HCWHeurope joint debate on Pharmaceuticals In the Environment: http://t.co/vwVXpP0u…","id":"560819428183396352","created_at":"2015-01-29T15:19:05.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":46,"end":52,"username":"EFPIA","id":"52084584"},{"start":59,"end":70,"username":"HCWHeurope","id":"282063958"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560819428183396352","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560795750339444736"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Legemiddelinfo: The EU is making a web portal on clinical trials. You are invited to make suggestions: http://t.co/hneWjKfY4c","id":"560818791802609664","created_at":"2015-01-29T15:16:34.000Z","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/hneWjKfY4c","expanded_url":"http://bit.ly/1CCMhmm","display_url":"bit.ly/1CCMhmm"}],"mentions":[{"start":3,"end":18,"username":"Legemiddelinfo","id":"89806212"}],"hashtags":{},"annotations":[{"start":24,"end":25,"probability":0.3811,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"560818791802609664","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AlzheimerEurope: Study into #hibernation claims to have found new #Alzheimer's disease drug target http://t.co/8A3WGtYnQF #dementia htt…","id":"560779907412668417","created_at":"2015-01-29T12:42:03.000Z","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/8A3WGtYnQF","expanded_url":"http://goo.gl/sNCQtD","display_url":"goo.gl/sNCQtD"}],"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"hashtags":[{"start":32,"end":44,"tag":"hibernation"},{"start":70,"end":80,"tag":"Alzheimer"},{"start":126,"end":135,"tag":"dementia"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560779907412668417","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560779531917983744"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AlzheimerEurope: Applications are now open for second @eupatients Expert Patient Training Course http://t.co/23hc9zCDPa","id":"560779078429446147","created_at":"2015-01-29T12:38:45.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/23hc9zCDPa","expanded_url":"http://goo.gl/gBJP5V","display_url":"goo.gl/gBJP5V"}],"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":58,"end":69,"username":"eupatients","id":"465674067"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560779078429446147","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560778500932907008"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AlzheimerEurope: Our friends @alzheimerssoc have launched the first issue of their \"Care and cure\" research magazine http://t.co/n9mak2…","id":"560778900599345153","created_at":"2015-01-29T12:38:03.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"},{"start":33,"end":47,"username":"alzheimerssoc","id":"34267043"}],"hashtags":{},"annotations":[{"start":88,"end":100,"probability":0.5502,"type":"Other","normalized_text":"Care and cure"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560778900599345153","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560778116688515072"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AlzheimerEurope: Decade-old cancer drug to be tested as potential #Alzheimer's disease treatment http://t.co/ySGtqWHft9 #dementia","id":"560778784979161088","created_at":"2015-01-29T12:37:35.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/ySGtqWHft9","expanded_url":"http://goo.gl/u4bAVg","display_url":"goo.gl/u4bAVg"}],"mentions":[{"start":3,"end":19,"username":"AlzheimerEurope","id":"1536274003"}],"hashtags":[{"start":70,"end":80,"tag":"Alzheimer"},{"start":124,"end":133,"tag":"dementia"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560778784979161088","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560777755915481088"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: #antivirals important this #flu season due to dominance of drifted #influenza A(H3N2) virus. Full risk assessment: http://t.c…","id":"560763794960302080","created_at":"2015-01-29T11:38:01.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"hashtags":[{"start":14,"end":25,"tag":"antivirals"},{"start":41,"end":45,"tag":"flu"},{"start":81,"end":91,"tag":"influenza"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560763794960302080","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560760533557997568"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #minutes from the December meeting of our Committee for #AdvancedTherapies (CAT) is available on our website: http://t.co/gb1mZF7n0p","id":"560738510811193344","created_at":"2015-01-29T09:57:33.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/gb1mZF7n0p","expanded_url":"http://bit.ly/1wAUdOm","display_url":"bit.ly/1wAUdOm"}],"mentions":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":60,"end":78,"tag":"AdvancedTherapies"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560738510811193344","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #agenda of this week's #herbal medicine committee (HMPC) meeting is available on our website: http://t.co/mjUBezkMNp","id":"560738374668283904","created_at":"2015-01-29T09:57:01.000Z","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/mjUBezkMNp","expanded_url":"http://bit.ly/1BxzPCQ","display_url":"bit.ly/1BxzPCQ"}],"mentions":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":27,"end":34,"tag":"herbal"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"560738374668283904","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: The French medicines agency publishes an update on the January #CHMP #EMA http://t.co/fNwbd2V4Up","id":"560736635319382019","created_at":"2015-01-29T09:50:06.000Z","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/fNwbd2V4Up","expanded_url":"http://bit.ly/1BznGxh","display_url":"bit.ly/1BznGxh"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"hashtags":[{"start":73,"end":78,"tag":"CHMP"},{"start":79,"end":83,"tag":"EMA"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560736635319382019","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egabiosimilars: Follow the  exchange today on biosimilars in the French National Assembly  http://t.co/ox63MKIj7X","id":"560736213619859456","created_at":"2015-01-29T09:48:25.000Z","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/ox63MKIj7X","expanded_url":"http://videos.assemblee-nationale.fr/index.php","display_url":"videos.assemblee-nationale.fr/index.php"}],"mentions":{},"hashtags":{},"annotations":[{"start":69,"end":92,"probability":0.4933,"type":"Other","normalized_text":"French National Assembly"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560736213619859456","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560731795671764992"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @luca__pani: The European Medicines Agency turns 20. Happy Birthday to EMA! @EMA_News  @US_FDA @Aifa_ufficiale http://t.co/X8It8plz9D","id":"560736104265945088","created_at":"2015-01-29T09:47:59.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/X8It8plz9D","expanded_url":"http://bit.ly/1BznwG6","display_url":"bit.ly/1BznwG6"}],"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"},{"start":79,"end":88,"username":"EMA_News","id":"116716199"},{"start":90,"end":97,"username":"US_FDA","id":"208120290"},{"start":98,"end":113,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":[{"start":20,"end":44,"probability":0.4567,"type":"Organization","normalized_text":"European Medicines Agency"},{"start":74,"end":76,"probability":0.4615,"type":"Person","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"560736104265945088","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: 2014 was a special year for the #EDQM. Read about the highlights: http://t.co/2R474jsfvG  #50thanniversary","id":"560735956815183873","created_at":"2015-01-29T09:47:24.000Z","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/2R474jsfvG","expanded_url":"http://bit.ly/1Dp1RUe","display_url":"bit.ly/1Dp1RUe"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":47,"end":52,"tag":"EDQM"},{"start":105,"end":121,"tag":"50thanniversary"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560735956815183873","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560730760127475713"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: FDA Ghana and #EDQM engaged in fruitful exchanges on the Certification scheme including assessments and inspections http://t…","id":"560735875156307969","created_at":"2015-01-29T09:47:05.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":29,"end":34,"tag":"EDQM"}],"annotations":[{"start":15,"end":23,"probability":0.7417,"type":"Organization","normalized_text":"FDA Ghana"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560735875156307969","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560730260275478529"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ICH_news: ICH E2B(R3) Q&amp;As document clarifying several aspects of the E2B(R3) ICSR IG available on the ICH ESTRI site. See more http://…","id":"560735363866443777","created_at":"2015-01-29T09:45:03.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"ICH_news","id":"305434870"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560735363866443777","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560722479296299008"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: The European Medicines Agency (EMA) turns 20 years old http://t.co/Ix7qzNsSpa","id":"560731383157366785","created_at":"2015-01-29T09:29:14.000Z","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/Ix7qzNsSpa","expanded_url":"http://bit.ly/1BzlFRK","display_url":"bit.ly/1BzlFRK"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":{},"annotations":[{"start":24,"end":48,"probability":0.2451,"type":"Organization","normalized_text":"European Medicines Agency"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560731383157366785","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: Attend our #RareEU2015 @rarediseaseday event 24 Feb in #Brussels to hear @V_Andriukaitis speak. @EU_Health Register: http://t…","id":"560496909304205312","created_at":"2015-01-28T17:57:31.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":37,"end":52,"username":"rarediseaseday","id":"19982434"},{"start":87,"end":102,"username":"V_Andriukaitis","id":"575269517"},{"start":110,"end":120,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":25,"end":36,"tag":"RareEU2015"},{"start":69,"end":78,"tag":"Brussels"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560496909304205312","source":"Twitter for iPhone","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560496353286291458"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @MHRAgovuk: MHRA website is now on GOV.UK: http://t.co/dNEwAhNGSb #mhraongovuk let us know what you think http://t.co/Htb9YHH383","id":"560490576655970304","created_at":"2015-01-28T17:32:21.000Z","entities":{"urls":[{"start":46,"end":68,"url":"http://t.co/dNEwAhNGSb","expanded_url":"http://ow.ly/I6i9W","display_url":"ow.ly/I6i9W"},{"start":109,"end":131,"url":"http://t.co/Htb9YHH383","expanded_url":"http://ow.ly/I6i9X","display_url":"ow.ly/I6i9X"}],"mentions":[{"start":3,"end":13,"username":"MHRAgovuk","id":"330993102"}],"hashtags":[{"start":69,"end":81,"tag":"mhraongovuk"}],"annotations":{}},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560490576655970304","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560490249584128002"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: A more severe #flu season can be expected in Europe. Our annual risk assessment on seasonal #influenza is out: http://t.co/vN4…","id":"560489376858537985","created_at":"2015-01-28T17:27:35.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":27,"end":31,"tag":"flu"},{"start":105,"end":115,"tag":"influenza"}],"annotations":[{"start":58,"end":63,"probability":0.996,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560489376858537985","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560487981786877952"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: #FDA is hiring 2 staff fellows. Apply now! http://t.co/GmzDgEThxX","id":"560471794961108992","created_at":"2015-01-28T16:17:43.000Z","entities":{"urls":[{"start":64,"end":86,"url":"http://t.co/GmzDgEThxX","expanded_url":"http://1.usa.gov/HT5gRs","display_url":"1.usa.gov/HT5gRs"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"hashtags":[{"start":21,"end":25,"tag":"FDA"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560471794961108992","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560468255908065280"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: #Controlofmedicines New Human #OCABR guideline to come into from 1st February 2015 http://t.co/l64YByG6MN","id":"560465476032413696","created_at":"2015-01-28T15:52:37.000Z","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/l64YByG6MN","expanded_url":"http://bit.ly/1DMENjv","display_url":"bit.ly/1DMENjv"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":15,"end":34,"tag":"Controlofmedicines"},{"start":45,"end":51,"tag":"OCABR"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560465476032413696","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560464177685598208"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda of this week's #herbal medicine committee (HMPC) meeting: http://t.co/mjUBezkMNp","id":"560462411233505280","created_at":"2015-01-28T15:40:26.000Z","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/mjUBezkMNp","expanded_url":"http://bit.ly/1BxzPCQ","display_url":"bit.ly/1BxzPCQ"}],"mentions":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":43,"end":50,"tag":"herbal"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"560462411233505280","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #minutes from the December meeting of our Committee for #AdvancedTherapies (CAT): http://t.co/gb1mZF7n0p","id":"560462023449149441","created_at":"2015-01-28T15:38:53.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/gb1mZF7n0p","expanded_url":"http://bit.ly/1wAUdOm","display_url":"bit.ly/1wAUdOm"}],"mentions":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":76,"end":94,"tag":"AdvancedTherapies"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560462023449149441","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @URPLWMiPB: Twenty years of the European Medicines Agency (EMA)\n\nhttp://t.co/Oa7ulpNuQN","id":"560456934252609536","created_at":"2015-01-28T15:18:40.000Z","entities":{"urls":[{"start":68,"end":90,"url":"http://t.co/Oa7ulpNuQN","expanded_url":"http://bit.ly/1v4czxh","display_url":"bit.ly/1v4czxh"}],"mentions":[{"start":3,"end":13,"username":"URPLWMiPB","id":"556679074"}],"hashtags":{},"annotations":[{"start":35,"end":59,"probability":0.401,"type":"Other","normalized_text":"European Medicines Agency"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560456934252609536","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: Twenty years of the European Medicines Agency (EMA) http://t.co/fwzyxybya1","id":"560456844892966912","created_at":"2015-01-28T15:18:19.000Z","entities":{"urls":[{"start":65,"end":87,"url":"http://t.co/fwzyxybya1","expanded_url":"http://bit.ly/1wASf0c","display_url":"bit.ly/1wASf0c"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"annotations":[{"start":33,"end":57,"probability":0.3883,"type":"Organization","normalized_text":"European Medicines Agency"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"560456844892966912","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Training course on the 8th Edition #European #Pharmacopoeia to be held next July in #Strasbourg. Sign up today! http://t.co/…","id":"560452239320686592","created_at":"2015-01-28T15:00:01.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":50,"end":59,"tag":"European"},{"start":60,"end":74,"tag":"Pharmacopoeia"},{"start":99,"end":110,"tag":"Strasbourg"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560452239320686592","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560451807340933120"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDACBER: #DrugFacts Week: Trivalent vaccines protect against 3 strains of flu viruses &amp; quadrivalent protect against 4. http://t.co/Tw6…","id":"560447949462065152","created_at":"2015-01-28T14:42:58.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"hashtags":[{"start":13,"end":23,"tag":"DrugFacts"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560447949462065152","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560444732103335937"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @euparkinsons: #GVK Biosciences: European Medicines Agency (#EMA) recommends suspending medicines over flawed studies - http://t.co/yAZg…","id":"560447587665600512","created_at":"2015-01-28T14:41:32.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"euparkinsons","id":"190227425"}],"hashtags":[{"start":18,"end":22,"tag":"GVK"},{"start":63,"end":67,"tag":"EMA"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560447587665600512","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560441067569692672"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: This week’s eNews: Apply for @eupatients Course to become an effective #PatientAdvocate involved in medicines #RandD http://t…","id":"560422424882479105","created_at":"2015-01-28T13:01:32.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":43,"end":54,"username":"eupatients","id":"465674067"}],"hashtags":[{"start":85,"end":101,"tag":"PatientAdvocate"},{"start":124,"end":130,"tag":"RandD"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560422424882479105","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560422167935213569"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICEcomms: NICE News for January is out now, bringing you the latest news,features and guidance from NICE this month: http://t.co/UVBhU…","id":"560416030569529344","created_at":"2015-01-28T12:36:08.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560416030569529344","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560406034490339328"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @PrimaryCare4um: @EMA_News - GVK Biosciences: European Medicines Agency recommends suspending medicines over flawed studies http://t.co/…","id":"560402052254547968","created_at":"2015-01-28T11:40:35.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":18,"username":"PrimaryCare4um","id":"164835748"},{"start":20,"end":29,"username":"EMA_News","id":"116716199"}],"hashtags":{},"annotations":[{"start":49,"end":73,"probability":0.5014,"type":"Organization","normalized_text":"European Medicines Agency"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560402052254547968","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560401479480377344"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: What are the key treatment areas for #genericmedicines? http://t.co/Icpze22k5X #EGAgenerics","id":"560393894274535424","created_at":"2015-01-28T11:08:10.000Z","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/Icpze22k5X","expanded_url":"http://bit.ly/1yM6AcQ","display_url":"bit.ly/1yM6AcQ"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"hashtags":[{"start":54,"end":71,"tag":"genericmedicines"},{"start":96,"end":108,"tag":"EGAgenerics"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560393894274535424","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560391842915557376"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICEcomms: Here's a full list of our guidance, including our 1st highly specialised technology guidance, published this month: http://t…","id":"560388957276762112","created_at":"2015-01-28T10:48:33.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":20,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560388957276762112","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560385343145652224"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Last year #Pheur #ReferenceMaterials were distributed in 112 countries. See the #EDQM catalogue: http://t.co/jfo0LUHRGR","id":"560374661704585216","created_at":"2015-01-28T09:51:45.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/jfo0LUHRGR","expanded_url":"http://bit.ly/1DTArpR","display_url":"bit.ly/1DTArpR"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":25,"end":31,"tag":"Pheur"},{"start":32,"end":51,"tag":"ReferenceMaterials"},{"start":95,"end":100,"tag":"EDQM"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560374661704585216","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560374401196359680"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"In 2014 we recommended 20 new #veterinary #medicines including three for minor species and rare diseases: http://t.co/tvkYzcIVtI","id":"560374226587496448","created_at":"2015-01-28T09:50:01.000Z","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/tvkYzcIVtI","expanded_url":"http://bit.ly/1wz29j7","display_url":"bit.ly/1wz29j7"}],"mentions":{},"hashtags":[{"start":30,"end":41,"tag":"veterinary"},{"start":42,"end":52,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560374226587496448","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: Information on public consultation document 'draft proposal for an addendum, on transparency, to the... http://t.co/X70jScJEX4","id":"560369922346590209","created_at":"2015-01-28T09:32:55.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/X70jScJEX4","expanded_url":"http://bit.ly/15NGbT2","display_url":"bit.ly/15NGbT2"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"560369922346590209","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"In our 20 years we've recommended authorising 975 human and 188 veterinary #medicines: http://t.co/ezDRLrf946 #EMA20 http://t.co/me0iQwstSI","id":"560116164362526720","created_at":"2015-01-27T16:44:34.000Z","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/ezDRLrf946","expanded_url":"http://bit.ly/1zoJn5u","display_url":"bit.ly/1zoJn5u"},{"start":117,"end":139,"url":"http://t.co/me0iQwstSI","expanded_url":"https://twitter.com/EMA_News/status/560116164362526720/photo/1","display_url":"pic.twitter.com/me0iQwstSI"}],"mentions":{},"hashtags":[{"start":75,"end":85,"tag":"medicines"},{"start":110,"end":116,"tag":"EMA20"}],"annotations":{}},"public_metrics":{"retweet_count":21,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"560116164362526720","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_560116163460743168"]}},{"text":"RT @US_FDA: Getting the right drug to target the right mutation would be a big break for treating patients w/ pancreatic cancer. http://t.c…","id":"560110741257469952","created_at":"2015-01-27T16:23:01.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":28,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560110741257469952","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560079791660212224"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #Vacancy – Call for Head of Scientific Evaluation of Regulated Products Department. Apply by 2 March http://t.co/DCs4Y7MyO7","id":"560110557060427776","created_at":"2015-01-27T16:22:17.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/DCs4Y7MyO7","expanded_url":"http://bit.ly/1yL9ph5","display_url":"bit.ly/1yL9ph5"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":21,"tag":"Vacancy"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560110557060427776","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560087189930139648"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDACBER: #DrugFacts Week: Did you know biological products can be made of sugars, proteins, nucleic acids or cells &amp; tissues. http://t.…","id":"560110380891258880","created_at":"2015-01-27T16:21:35.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"FDACBER","id":"303777686"}],"hashtags":[{"start":13,"end":23,"tag":"DrugFacts"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560110380891258880","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560097486904107009"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: Are you a scientist in the field of #RiskAssessment or #FoodSafety?Submit your abstract for #EFSAExpo2015 conference http://t.…","id":"560110283025547264","created_at":"2015-01-27T16:21:12.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":49,"end":64,"tag":"RiskAssessment"},{"start":68,"end":79,"tag":"FoodSafety"},{"start":105,"end":118,"tag":"EFSAExpo2015"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560110283025547264","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"560101183936012288"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Increasing the availability of #veterinary #medicines - we recommended 20 new medicines for animals in 2014 : http://t.co/tvkYzcIVtI","id":"560081926242172928","created_at":"2015-01-27T14:28:31.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/tvkYzcIVtI","expanded_url":"http://bit.ly/1wz29j7","display_url":"bit.ly/1wz29j7"}],"mentions":{},"hashtags":[{"start":31,"end":42,"tag":"veterinary"},{"start":43,"end":53,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"560081926242172928","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Over the past 20 years we recommended authorisation of 975 human #medicines and 188 #veterinary medicines: http://t.co/ezDRLrf946 #EMA20","id":"560044392267149312","created_at":"2015-01-27T11:59:22.000Z","entities":{"urls":[{"start":107,"end":129,"url":"http://t.co/ezDRLrf946","expanded_url":"http://bit.ly/1zoJn5u","display_url":"bit.ly/1zoJn5u"}],"mentions":{},"hashtags":[{"start":65,"end":75,"tag":"medicines"},{"start":84,"end":95,"tag":"veterinary"},{"start":130,"end":136,"tag":"EMA20"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":1,"like_count":4,"quote_count":0},"conversation_id":"560044392267149312","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to apply for our tender for #effectiveness and #pharmacoepidemiology studies: http://t.co/cFDK7GRFAk #procurement","id":"560043620141907968","created_at":"2015-01-27T11:56:18.000Z","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"mentions":{},"hashtags":[{"start":43,"end":57,"tag":"effectiveness"},{"start":62,"end":83,"tag":"pharmacoepidemiology"},{"start":116,"end":128,"tag":"procurement"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"560043620141907968","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've launched a central repository to facilitate assessment of #medicines safety reports: http://t.co/ojhBII2fgo #pharmacovigilance","id":"560043198060691456","created_at":"2015-01-27T11:54:38.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/ojhBII2fgo","expanded_url":"http://bit.ly/15CMxoz","display_url":"bit.ly/15CMxoz"}],"mentions":{},"hashtags":[{"start":64,"end":74,"tag":"medicines"},{"start":114,"end":132,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"560043198060691456","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the EPAR for #Duloxetine Lilly, a #medicine for depression, neuropathic pain &amp; anxiety: http://t.co/tADtazCGXf","id":"560042921811259392","created_at":"2015-01-27T11:53:32.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/tADtazCGXf","expanded_url":"http://bit.ly/1uQTEpx","display_url":"bit.ly/1uQTEpx"}],"mentions":{},"hashtags":[{"start":29,"end":40,"tag":"Duloxetine"},{"start":50,"end":59,"tag":"medicine"}],"annotations":[{"start":41,"end":45,"probability":0.5412,"type":"Person","normalized_text":"Lilly"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"560042921811259392","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've launched a central repository to facilitate assessment of #medicine safety reports: http://t.co/ojhBII2fgo #pharmacovigilance","id":"559775792344096769","created_at":"2015-01-26T18:12:03.000Z","entities":{"urls":[{"start":90,"end":112,"url":"http://t.co/ojhBII2fgo","expanded_url":"http://bit.ly/15CMxoz","display_url":"bit.ly/15CMxoz"}],"mentions":{},"hashtags":[{"start":64,"end":73,"tag":"medicine"},{"start":113,"end":131,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":6,"quote_count":0},"conversation_id":"559775792344096769","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"20 years of EMA at a glance. Check it out! #EMA20 http://t.co/lq92ltngAp","id":"559773810858422272","created_at":"2015-01-26T18:04:11.000Z","entities":{"urls":[{"start":50,"end":72,"url":"http://t.co/lq92ltngAp","expanded_url":"https://twitter.com/EMA_News/status/559773810858422272/photo/1","display_url":"pic.twitter.com/lq92ltngAp"}],"mentions":{},"hashtags":[{"start":43,"end":49,"tag":"EMA20"}],"annotations":{}},"public_metrics":{"retweet_count":23,"reply_count":1,"like_count":7,"quote_count":0},"conversation_id":"559773810858422272","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_559773809587150848"]}},{"text":"RT @eupatientsforum: We would need 15 min of your time for a survey on patients’ information related to personalised medicines https://t.co…","id":"559771329768222721","created_at":"2015-01-26T17:54:19.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559771329768222721","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559760668749230080"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICESciAdvice: Survey on adaptive designs in EMA scientific advice letters has been accessed &gt;1400x from http://t.co/KM19LzhVi3 #Trials…","id":"559771220875681792","created_at":"2015-01-26T17:53:53.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/KM19LzhVi3","expanded_url":"http://www.trialsjournal.com/content/15/1/383","display_url":"trialsjournal.com/content/15/1/3…"}],"mentions":[{"start":3,"end":17,"username":"NICESciAdvice","id":"2834291205"}],"hashtags":[{"start":135,"end":142,"tag":"Trials"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559771220875681792","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559760342440771585"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Today marks the 20th anniversary of the establishment of @EMA_News. Check their new page http://t.co/bGwxdqTbPb #EMA20 #Happ…","id":"559770612634501120","created_at":"2015-01-26T17:51:28.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/bGwxdqTbPb","expanded_url":"http://bit.ly/1zONA28","display_url":"bit.ly/1zONA28"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":72,"end":81,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":127,"end":133,"tag":"EMA20"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559770612634501120","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559750131491569665"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: Dr Chan: Medics managing some cases of #TB &amp; gonorrhoea are already empty-handed as even “last resort” medicines no longer work #A…","id":"559770536507891712","created_at":"2015-01-26T17:51:10.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":48,"end":51,"tag":"TB"}],"annotations":[{"start":9,"end":15,"probability":0.8848,"type":"Person","normalized_text":"Dr Chan"}]},"public_metrics":{"retweet_count":50,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559770536507891712","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559747014553247744"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: During the 150th session of the #European #Pharmacopoeia Commission, 13 new texts were adopted http://t.co/gmVwVJqk8X","id":"559770472553127937","created_at":"2015-01-26T17:50:55.000Z","entities":{"urls":[{"start":110,"end":132,"url":"http://t.co/gmVwVJqk8X","expanded_url":"http://bit.ly/1BAkNyB","display_url":"bit.ly/1BAkNyB"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":47,"end":56,"tag":"European"},{"start":57,"end":71,"tag":"Pharmacopoeia"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559770472553127937","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559745258326880256"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: Dr Chan: The consequences [of antimicrobial resistance] can be succinctly expressed: the end of modern medicine as we know it #AMR…","id":"559770444019302400","created_at":"2015-01-26T17:50:48.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":135,"end":139,"tag":"AMR"}],"annotations":[{"start":9,"end":15,"probability":0.9262,"type":"Person","normalized_text":"Dr Chan"}]},"public_metrics":{"retweet_count":117,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559770444019302400","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559745053875515392"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: Dr Chan: The world is moving towards a post-antibiotic era in which many common infectious diseases may once again kill #AMR #EB136","id":"559770373697572864","created_at":"2015-01-26T17:50:31.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":129,"end":133,"tag":"AMR"},{"start":134,"end":140,"tag":"EB136"}],"annotations":[{"start":9,"end":15,"probability":0.8763,"type":"Person","normalized_text":"Dr Chan"}]},"public_metrics":{"retweet_count":107,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559770373697572864","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559743059051950081"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: Check out this #Storify about the 14th EGA Regulatory and Scientific Affairs Conference! http://t.co/4H87ZMLyzX #EGAreg15","id":"559770332924747776","created_at":"2015-01-26T17:50:22.000Z","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/4H87ZMLyzX","expanded_url":"http://bit.ly/1CYgH0k","display_url":"bit.ly/1CYgH0k"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"hashtags":[{"start":32,"end":40,"tag":"Storify"},{"start":129,"end":138,"tag":"EGAreg15"}],"annotations":[{"start":56,"end":103,"probability":0.3803,"type":"Other","normalized_text":"EGA Regulatory and Scientific Affairs Conference"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559770332924747776","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559742589734092804"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: Dr Chan: The #AMR consequences for human health are severe, especially with so few replacement products in the pipeline #EB136","id":"559770119636000769","created_at":"2015-01-26T17:49:31.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":22,"end":26,"tag":"AMR"},{"start":129,"end":135,"tag":"EB136"}],"annotations":[{"start":9,"end":15,"probability":0.9005,"type":"Person","normalized_text":"Dr Chan"}]},"public_metrics":{"retweet_count":41,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559770119636000769","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559740365079855104"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: Dr Chan: Resistance to antimicrobial medicines is happening in all the world for an increasingly broad range of pathogens #AMR #EB…","id":"559769742119292928","created_at":"2015-01-26T17:48:01.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":131,"end":135,"tag":"AMR"}],"annotations":[{"start":9,"end":15,"probability":0.7943,"type":"Person","normalized_text":"Dr Chan"}]},"public_metrics":{"retweet_count":183,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559769742119292928","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559737443243790336"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @HAIEurope: Faulty clinical studies by GVK Biosciences in India leads @EMA_News to recommend removal of 700 #generics from market http:/…","id":"559767797488963584","created_at":"2015-01-26T17:40:17.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"HAIEurope","id":"3314634701"},{"start":73,"end":82,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":111,"end":120,"tag":"generics"}],"annotations":[{"start":42,"end":56,"probability":0.8815,"type":"Organization","normalized_text":"GVK Biosciences"},{"start":61,"end":65,"probability":0.9967,"type":"Place","normalized_text":"India"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559767797488963584","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559724016173584384"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Today marks the 20th anniversary of the establishment of EMA. Check our new web page: http://t.co/nADL5I5UC9 #EMA20","id":"559749656440483840","created_at":"2015-01-26T16:28:12.000Z","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/nADL5I5UC9","expanded_url":"http://bit.ly/1zONA28","display_url":"bit.ly/1zONA28"}],"mentions":{},"hashtags":[{"start":109,"end":115,"tag":"EMA20"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"559749656440483840","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Duloxetine Lilly,  a #medicine for depression, neuropathic pain &amp;\nanxiety: http://t.co/tADtazCGXf","id":"559696799070699520","created_at":"2015-01-26T12:58:10.000Z","entities":{"urls":[{"start":122,"end":144,"url":"http://t.co/tADtazCGXf","expanded_url":"http://bit.ly/1uQTEpx","display_url":"bit.ly/1uQTEpx"}],"mentions":{},"hashtags":[{"start":42,"end":53,"tag":"Duloxetine"},{"start":64,"end":73,"tag":"medicine"}],"annotations":[{"start":54,"end":58,"probability":0.6842,"type":"Person","normalized_text":"Lilly"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"559696799070699520","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've organised several #EudraVigilance #training courses on electronic reporting of Individual Case Safety Reports: http://t.co/SDEWnyAqf8","id":"559690957281828864","created_at":"2015-01-26T12:34:57.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/SDEWnyAqf8","expanded_url":"http://bit.ly/1wrU5k3","display_url":"bit.ly/1wrU5k3"}],"mentions":{},"hashtags":[{"start":24,"end":39,"tag":"EudraVigilance"},{"start":40,"end":49,"tag":"training"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559690957281828864","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've organised a series of #training courses on the eXtended #EudraVigilance Medicinal Product Dictionary: http://t.co/v2ow2YhdJa","id":"559690890156204033","created_at":"2015-01-26T12:34:41.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/v2ow2YhdJa","expanded_url":"http://bit.ly/1BkiP2Y","display_url":"bit.ly/1BkiP2Y"}],"mentions":{},"hashtags":[{"start":28,"end":37,"tag":"training"},{"start":62,"end":77,"tag":"EudraVigilance"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559690890156204033","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Last week we recommended #Saxenda (#liraglutide) for approval in weight management in adults: http://t.co/V3DSbOk5ny","id":"559690727912112128","created_at":"2015-01-26T12:34:02.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/V3DSbOk5ny","expanded_url":"http://bit.ly/1xIKarR","display_url":"bit.ly/1xIKarR"}],"mentions":{},"hashtags":[{"start":25,"end":33,"tag":"Saxenda"},{"start":35,"end":47,"tag":"liraglutide"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559690727912112128","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Last week we recommended suspending a number of #medicines due to flawed studies conducted at GVK Biosciences: http://t.co/VL4kuw0ujo","id":"559690617518034944","created_at":"2015-01-26T12:33:36.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/VL4kuw0ujo","expanded_url":"http://bit.ly/1yMeQg4","display_url":"bit.ly/1yMeQg4"}],"mentions":{},"hashtags":[{"start":48,"end":58,"tag":"medicines"}],"annotations":[{"start":94,"end":108,"probability":0.7225,"type":"Organization","normalized_text":"GVK Biosciences"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"559690617518034944","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The highlights of last week's meeting of our committee for human #medicines (CHMP) are available on our website: http://t.co/KdVytFaFze","id":"559690513927139328","created_at":"2015-01-26T12:33:11.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/KdVytFaFze","expanded_url":"http://bit.ly/1xIJuTf","display_url":"bit.ly/1xIJuTf"}],"mentions":{},"hashtags":[{"start":65,"end":75,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"559690513927139328","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to apply for our tender for #effectiveness and #pharmacoepidemiology studies: http://t.co/cFDK7GRFAk #procurement","id":"559690142567653376","created_at":"2015-01-26T12:31:43.000Z","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"mentions":{},"hashtags":[{"start":43,"end":57,"tag":"effectiveness"},{"start":62,"end":83,"tag":"pharmacoepidemiology"},{"start":116,"end":128,"tag":"procurement"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559690142567653376","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week left to comment on draft #guideline on submission requirements for #influenza #vaccines: http://t.co/iP8ORy66BO  #consultation","id":"559689203702054912","created_at":"2015-01-26T12:27:59.000Z","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/iP8ORy66BO","expanded_url":"http://bit.ly/1B9ZpA4","display_url":"bit.ly/1B9ZpA4"}],"mentions":{},"hashtags":[{"start":34,"end":44,"tag":"guideline"},{"start":76,"end":86,"tag":"influenza"},{"start":87,"end":96,"tag":"vaccines"},{"start":122,"end":135,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559689203702054912","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: #european #pharmacopoeia  2 months left to comments on draft pharmacopoeial texts. Deadline: 31 March 2015 http://t.co/0qwtT…","id":"559686257740374017","created_at":"2015-01-26T12:16:16.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":15,"end":24,"tag":"european"},{"start":25,"end":39,"tag":"pharmacopoeia"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559686257740374017","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559663277308133376"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @INFARMED_IP: Inspection at GVK Biosciences  http://t.co/xek24bHjlb","id":"559685929104056321","created_at":"2015-01-26T12:14:58.000Z","entities":{"urls":[{"start":48,"end":70,"url":"http://t.co/xek24bHjlb","expanded_url":"http://bit.ly/1CrEp7b","display_url":"bit.ly/1CrEp7b"}],"mentions":[{"start":3,"end":15,"username":"INFARMED_IP","id":"1392501529"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559685929104056321","source":"TweetDeck","lang":"fr","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eupatientsforum: Join 50 other top #patient advocates to learn more about medicines R&amp;D - apply now for #eupati Fall 2015 course! http:…","id":"559685100582236160","created_at":"2015-01-26T12:11:41.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"hashtags":[{"start":39,"end":47,"tag":"patient"},{"start":112,"end":119,"tag":"eupati"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559685100582236160","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559636304661868544"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @luca__pani: The European Union promotes international coordination on generic medicines http://t.co/nZNcPCd53q","id":"559684639926013952","created_at":"2015-01-26T12:09:51.000Z","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/nZNcPCd53q","expanded_url":"http://bit.ly/1uuSY3b","display_url":"bit.ly/1uuSY3b"}],"mentions":[{"start":3,"end":14,"username":"luca__pani","id":"2176193576"}],"hashtags":{},"annotations":[{"start":20,"end":33,"probability":0.5744,"type":"Organization","normalized_text":"European Union"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559684639926013952","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_EU: @EFSA_EU experts developed toolbox to rank #risks http://t.co/LDTYXX0GEq #biologicalhazards","id":"559684339613847552","created_at":"2015-01-26T12:08:39.000Z","entities":{"urls":[{"start":63,"end":85,"url":"http://t.co/LDTYXX0GEq","expanded_url":"http://bit.ly/1yk42AB","display_url":"bit.ly/1yk42AB"}],"mentions":[{"start":3,"end":11,"username":"ECDC_EU","id":"204752573"},{"start":13,"end":21,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":56,"end":62,"tag":"risks"},{"start":86,"end":104,"tag":"biologicalhazards"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"559684339613847552","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"559630595664642048"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@Chouchi_O Apologies for the intermittent service. We're looking into it.","id":"559040334651748353","created_at":"2015-01-24T17:29:36.000Z","entities":{"urls":{},"mentions":[{"start":0,"end":10,"username":"Chouchi_O","id":"229928793"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558997096943349760","source":"Twitter for iPhone","lang":"en","referenced_tweets":[{"type":"replied_to","id":"558997096943349760"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"229928793"},{"text":"@SIN_NL_ORG The website is working again now. The list of medicines recommended for suspension is here: http://t.co/Up4C4YM4Zm","id":"558929239509323777","created_at":"2015-01-24T10:08:09.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/Up4C4YM4Zm","expanded_url":"http://bit.ly/1uG40Za","display_url":"bit.ly/1uG40Za"}],"mentions":[{"start":0,"end":11,"username":"SIN_NL_ORG","id":"1222841256"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"558596275067957248","source":"Twitter for iPhone","lang":"en","referenced_tweets":[{"type":"replied_to","id":"558908814561665024"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"1222841256"},{"text":"@SIN_NL_ORG We apologise for this outage. We're working on fixing the problem as quickly as possible.","id":"558921952539463681","created_at":"2015-01-24T09:39:12.000Z","entities":{"urls":{},"mentions":[{"start":0,"end":11,"username":"SIN_NL_ORG","id":"1222841256"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"558596275067957248","source":"Twitter for iPhone","lang":"en","referenced_tweets":[{"type":"replied_to","id":"558908814561665024"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"1222841256"},{"text":"RT @eurordis: 24 January is #MoebiusSyndrome Awareness Day http://t.co/EBw9yZbxW6 @MoebiusSyndrome","id":"558697009222524929","created_at":"2015-01-23T18:45:21.000Z","entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/EBw9yZbxW6","expanded_url":"http://ow.ly/HClY2","display_url":"ow.ly/HClY2"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":82,"end":98,"username":"MoebiusSyndrome","id":"40899292"}],"hashtags":[{"start":28,"end":44,"tag":"MoebiusSyndrome"}],"annotations":[{"start":45,"end":57,"probability":0.7749,"type":"Other","normalized_text":"Awareness Day"}]},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558697009222524929","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558625543051309056"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: Check out our new report on substances which have carcinogenic, mutagenic or reprotoxic properties #CMR http://t.co/xx9sqMc3Nb","id":"558696932764577793","created_at":"2015-01-23T18:45:03.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/xx9sqMc3Nb","expanded_url":"http://bit.ly/1J0Rgxh","display_url":"bit.ly/1J0Rgxh"}],"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"hashtags":[{"start":112,"end":116,"tag":"CMR"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558696932764577793","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558639225881776128"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Doing #science for policy. Discover more: http://t.co/ikjuvHIL2u  #EUscience @EU_ScienceHub #FF","id":"558696811565953024","created_at":"2015-01-23T18:44:34.000Z","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/ikjuvHIL2u","expanded_url":"http://youtu.be/mG08Yjuy5f4","display_url":"youtu.be/mG08Yjuy5f4"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":92,"end":106,"username":"EU_ScienceHub","id":"2754681001"}],"hashtags":[{"start":21,"end":29,"tag":"science"},{"start":81,"end":91,"tag":"EUscience"},{"start":107,"end":110,"tag":"FF"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558696811565953024","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558652928035397632"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Keep informed! Download all of the #EDQM press releases from 2014 http://t.co/4VYpkjr1m5","id":"558696702086225920","created_at":"2015-01-23T18:44:08.000Z","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/4VYpkjr1m5","expanded_url":"http://bit.ly/1GIclAI","display_url":"bit.ly/1GIclAI"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":50,"end":55,"tag":"EDQM"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558696702086225920","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558670897390051328"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myESMO: Interested in an ESMO Fellowship? Applications opened today #oncologyfellowships http://t.co/C2K2bSRAOA","id":"558696648776613889","created_at":"2015-01-23T18:43:55.000Z","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/C2K2bSRAOA","expanded_url":"http://ow.ly/HQ1nU","display_url":"ow.ly/HQ1nU"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"hashtags":[{"start":72,"end":92,"tag":"oncologyfellowships"}],"annotations":[{"start":29,"end":43,"probability":0.4936,"type":"Organization","normalized_text":"ESMO Fellowship"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558696648776613889","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558681838881751040"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: Learn more about IMI2 Call 3 topic on quality control in #vaccine manufacture at our webinar on Mon 26/1, 14:30 CET http://t.co…","id":"558696626983014400","created_at":"2015-01-23T18:43:50.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":[{"start":69,"end":77,"tag":"vaccine"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558696626983014400","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558688532047613952"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Book your place at our regulatory info day with @IFAHEurope on 12-13 March: http://t.co/8qsvp0iFHh #veterinary #medicine","id":"558695662653833216","created_at":"2015-01-23T18:40:00.000Z","entities":{"urls":[{"start":76,"end":98,"url":"http://t.co/8qsvp0iFHh","expanded_url":"http://bit.ly/1CYdL45","display_url":"bit.ly/1CYdL45"}],"mentions":{},"hashtags":[{"start":99,"end":110,"tag":"veterinary"},{"start":111,"end":120,"tag":"medicine"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"558695662653833216","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the EPAR for #Cyramza (#ramucirumab), a #medicine to treat gastric #cancer: http://t.co/N7PzOGXgnc","id":"558693510032138241","created_at":"2015-01-23T18:31:27.000Z","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/N7PzOGXgnc","expanded_url":"http://bit.ly/1up99PF","display_url":"bit.ly/1up99PF"}],"mentions":{},"hashtags":[{"start":29,"end":37,"tag":"Cyramza"},{"start":39,"end":51,"tag":"ramucirumab"},{"start":56,"end":65,"tag":"medicine"},{"start":83,"end":90,"tag":"cancer"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"558693510032138241","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week to comment on draft #guideline on submission requirements for #influenza #vaccines: http://t.co/iP8ORy66BO #consultation","id":"558674137833824256","created_at":"2015-01-23T17:14:28.000Z","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/iP8ORy66BO","expanded_url":"http://bit.ly/1B9ZpA4","display_url":"bit.ly/1B9ZpA4"}],"mentions":{},"hashtags":[{"start":29,"end":39,"tag":"guideline"},{"start":71,"end":81,"tag":"influenza"},{"start":82,"end":91,"tag":"vaccines"},{"start":116,"end":129,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"558674137833824256","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We're organising several #EudraVigilance #training courses on electronic reporting of Individual Case Safety Reports: http://t.co/SDEWnyAqf8","id":"558622618073702400","created_at":"2015-01-23T13:49:45.000Z","entities":{"urls":[{"start":118,"end":140,"url":"http://t.co/SDEWnyAqf8","expanded_url":"http://bit.ly/1wrU5k3","display_url":"bit.ly/1wrU5k3"}],"mentions":{},"hashtags":[{"start":25,"end":40,"tag":"EudraVigilance"},{"start":41,"end":50,"tag":"training"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"558622618073702400","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We're organising a series of #training courses on the eXtended #EudraVigilance Medicinal Product Dictionary: http://t.co/v2ow2YhdJa","id":"558621701035266048","created_at":"2015-01-23T13:46:06.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/v2ow2YhdJa","expanded_url":"http://bit.ly/1BkiP2Y","display_url":"bit.ly/1BkiP2Y"}],"mentions":{},"hashtags":[{"start":29,"end":38,"tag":"training"},{"start":63,"end":78,"tag":"EudraVigilance"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"558621701035266048","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: Landmark reached - the #EU has now authorised 100 orphan medicinal products! #raredisease @EMA_News http://t.co/uqo96KJlUK","id":"558618777030766592","created_at":"2015-01-23T13:34:29.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/uqo96KJlUK","expanded_url":"http://ow.ly/HODcD","display_url":"ow.ly/HODcD"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":104,"end":113,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":37,"end":40,"tag":"EU"},{"start":91,"end":103,"tag":"raredisease"}],"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558618777030766592","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558602705669992449"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've recommended #Saxenda (#liraglutide) for approval in weight management in adults: http://t.co/V3DSbOk5ny","id":"558596707001597952","created_at":"2015-01-23T12:06:47.000Z","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/V3DSbOk5ny","expanded_url":"http://bit.ly/1xIKarR","display_url":"bit.ly/1xIKarR"}],"mentions":{},"hashtags":[{"start":18,"end":26,"tag":"Saxenda"},{"start":28,"end":40,"tag":"liraglutide"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558596707001597952","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've recommended suspending a number of #medicines due to flawed studies conducted at GVK Biosciences: http://t.co/VL4kuw0ujo","id":"558596275067957248","created_at":"2015-01-23T12:05:04.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/VL4kuw0ujo","expanded_url":"http://bit.ly/1yMeQg4","display_url":"bit.ly/1yMeQg4"}],"mentions":{},"hashtags":[{"start":41,"end":51,"tag":"medicines"}],"annotations":[{"start":87,"end":101,"probability":0.6813,"type":"Organization","normalized_text":"GVK Biosciences"}]},"public_metrics":{"retweet_count":16,"reply_count":2,"like_count":2,"quote_count":0},"conversation_id":"558596275067957248","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the highlights of this week's meeting of our committee for human #medicines (CHMP): http://t.co/KdVytFaFze","id":"558595633633067008","created_at":"2015-01-23T12:02:31.000Z","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/KdVytFaFze","expanded_url":"http://bit.ly/1xIJuTf","display_url":"bit.ly/1xIJuTf"}],"mentions":{},"hashtags":[{"start":81,"end":91,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":1,"like_count":2,"quote_count":0},"conversation_id":"558595633633067008","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Register for our regulatory info day with @IFAHEurope on 12-13 March: http://t.co/8qsvp0iFHh #veterinary #medicine","id":"558594638299553792","created_at":"2015-01-23T11:58:34.000Z","entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/8qsvp0iFHh","expanded_url":"http://bit.ly/1CYdL45","display_url":"bit.ly/1CYdL45"}],"mentions":{},"hashtags":[{"start":93,"end":104,"tag":"veterinary"},{"start":105,"end":114,"tag":"medicine"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"558594638299553792","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for #Cyramza (#ramucirumab), a #medicine to treat gastric #cancer: http://t.co/N7PzOGXgnc","id":"558590687785279488","created_at":"2015-01-23T11:42:52.000Z","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/N7PzOGXgnc","expanded_url":"http://bit.ly/1up99PF","display_url":"bit.ly/1up99PF"}],"mentions":{},"hashtags":[{"start":42,"end":50,"tag":"Cyramza"},{"start":52,"end":64,"tag":"ramucirumab"},{"start":69,"end":78,"tag":"medicine"},{"start":96,"end":103,"tag":"cancer"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"558590687785279488","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: Less than 40 days until our @rarediseaseday event in #Brussels. Track the event with #RareEU2015 or register here: http://t.c…","id":"558385954189496320","created_at":"2015-01-22T22:09:20.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":42,"end":57,"username":"rarediseaseday","id":"19982434"}],"hashtags":[{"start":67,"end":76,"tag":"Brussels"},{"start":99,"end":110,"tag":"RareEU2015"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558385954189496320","source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558311943698919424"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm The French medicines agency publishes its new #thesaurus of #medicineinteractions http://t.co/BkP9fhiObn","id":"558385859251412992","created_at":"2015-01-22T22:08:57.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/BkP9fhiObn","expanded_url":"http://ow.ly/HLOYd","display_url":"ow.ly/HLOYd"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"hashtags":[{"start":55,"end":65,"tag":"thesaurus"},{"start":69,"end":90,"tag":"medicineinteractions"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"558385859251412992","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Sign up to receive #EDQM's first newsletter of the year! Subscribe for free today: http://t.co/dKDLcZ8z1r  #EDQM","id":"558384540948107264","created_at":"2015-01-22T22:03:43.000Z","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/dKDLcZ8z1r","expanded_url":"http://bit.ly/1BcFP6b","display_url":"bit.ly/1BcFP6b"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":34,"end":39,"tag":"EDQM"},{"start":122,"end":127,"tag":"EDQM"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558384540948107264","source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558299046876827648"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: New international standard to improve #safety of #medicines. Guide by @EMA_News http://t.co/k87svh5eue http://t.co/lig1GBxt…","id":"558384239776124928","created_at":"2015-01-22T22:02:31.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/k87svh5eue","expanded_url":"http://europa.eu/!pq99XD","display_url":"europa.eu/!pq99XD"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"},{"start":86,"end":95,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":54,"end":61,"tag":"safety"},{"start":65,"end":75,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558384239776124928","source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558284007713308672"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IFAHEurope: IFAH-Europe/@EMA_News Infoday 12-13/March: to attend, contact us @JHJournalist @Official_VT @vetsonline @Vet_Record - http:…","id":"558383971319709696","created_at":"2015-01-22T22:01:27.000Z","entities":{"urls":{},"mentions":[{"start":28,"end":37,"username":"EMA_News","id":"116716199"},{"start":81,"end":94,"username":"JHJournalist","id":"2382044864"},{"start":95,"end":107,"username":"official_vt","id":"877238970115121152"},{"start":108,"end":119,"username":"vetsonline","id":"4860726625"},{"start":120,"end":131,"username":"Vet_Record","id":"168454907"}],"hashtags":{},"annotations":[{"start":21,"end":26,"probability":0.7672,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558383971319709696","source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558281626674003969"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: New international standard to improve #safety of #medicines - @EMA_News publishes guide http://t.co/D1Qx0ya65Z http://t.co/b…","id":"558383682554458113","created_at":"2015-01-22T22:00:18.000Z","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/D1Qx0ya65Z","expanded_url":"http://europa.eu/!pq99XD","display_url":"europa.eu/!pq99XD"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":77,"end":86,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":53,"end":60,"tag":"safety"},{"start":64,"end":74,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":17,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558383682554458113","source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558281236486307840"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: EDQM will participate in “International Drug Regulators' Meet” organised by @Pharmexcil + AIDCOC #HYDERABAD 23-24 Jan http:/…","id":"558383216839901184","created_at":"2015-01-22T21:58:27.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"},{"start":91,"end":102,"username":"Pharmexcil","id":"600041205"}],"hashtags":[{"start":112,"end":122,"tag":"HYDERABAD"}],"annotations":[{"start":41,"end":69,"probability":0.2992,"type":"Other","normalized_text":"International Drug Regulators"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558383216839901184","source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558269652842065921"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: Public consultation on application of transparency rules of EU Clinical Trial Regulation http://t.co/3JJIVYu5TC","id":"558382969178832898","created_at":"2015-01-22T21:57:28.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/3JJIVYu5TC","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/01/news_detail_002253.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"annotations":[{"start":73,"end":100,"probability":0.3376,"type":"Other","normalized_text":"EU Clinical Trial Regulation"}]},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558382969178832898","source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558266046961172481"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: New EMA guide will help industry and regulatory authorities to implement changes http://t.co/it1lATXvrE","id":"558382906155225088","created_at":"2015-01-22T21:57:13.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/it1lATXvrE","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/01/news_detail_002252.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558382906155225088","source":"Twitter Web Client","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558265879621038081"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Type 2 diabetes: Italian medicines agency launches an #algorithm to define individual therapy http://t.co/dVnaAhDxuI","id":"558359701587779584","created_at":"2015-01-22T20:25:01.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/dVnaAhDxuI","expanded_url":"http://www.agenziafarmaco.gov.it/it/content/diabete-di-tipo-2-aifa-lancia-algoritmo-definizione-terapia-individuale","display_url":"agenziafarmaco.gov.it/it/content/dia…"}],"mentions":{},"hashtags":[{"start":54,"end":64,"tag":"algorithm"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":7,"quote_count":0},"conversation_id":"558359701587779584","source":"Twitter for iPhone","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: Register to attend our @rarediseaseday #RareEU2015 event in #Brussels: http://t.co/E2lhu2FrXG or take part online http://t.co…","id":"558327909510029312","created_at":"2015-01-22T18:18:41.000Z","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/E2lhu2FrXG","expanded_url":"http://ow.ly/HKHUM","display_url":"ow.ly/HKHUM","status":410,"unwound_url":"https://docs.google.com/a/eurordis.org/forms/d/1CSzrsvUIPIZNR-xcoCGj6TtAkbMRcYk1LE0DEtgr6RE/viewform?c=0&w=1"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":37,"end":52,"username":"rarediseaseday","id":"19982434"}],"hashtags":[{"start":53,"end":64,"tag":"RareEU2015"},{"start":74,"end":83,"tag":"Brussels"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558327909510029312","source":"Twitter for iPhone","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558240766024511488"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myESMO: SPECTAcolor demonstrates its viability to facilitate next generation cancer #clinicaltrials #colorectalcancer http://t.co/p3LGD…","id":"558326623993610240","created_at":"2015-01-22T18:13:35.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"hashtags":[{"start":88,"end":103,"tag":"clinicaltrials"},{"start":104,"end":121,"tag":"colorectalcancer"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558326623993610240","source":"Twitter for iPhone","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558201729851064320"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: Improving the efficiency of the current #regulatory system at #EGAreg15 with @EMA_News and FAMHP (BE) today in London #pha…","id":"558228445130670080","created_at":"2015-01-22T11:43:27.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":94,"end":103,"username":"EMA_News","id":"116716199"}],"hashtags":[{"start":57,"end":68,"tag":"regulatory"},{"start":79,"end":88,"tag":"EGAreg15"}],"annotations":[{"start":128,"end":133,"probability":0.9919,"type":"Place","normalized_text":"London"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558228445130670080","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558228252410777600"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: Scientists open their DNA databases online and create a network that could pave the way for gene analysis http://t.co/GqFx…","id":"558223312258883585","created_at":"2015-01-22T11:23:03.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558223312258883585","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558217533606477825"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Yesterday we published a guide to reflect changes under new international standard to improve #safety of #medicines: http://t.co/n56aynhOuG","id":"558213904367898624","created_at":"2015-01-22T10:45:40.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/n56aynhOuG","expanded_url":"http://bit.ly/159EbnZ","display_url":"bit.ly/159EbnZ"}],"mentions":{},"hashtags":[{"start":94,"end":101,"tag":"safety"},{"start":105,"end":115,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":4,"quote_count":0},"conversation_id":"558213904367898624","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've revised our #paediatric #guidance to reflect changes to the @EU_Commission #guideline: http://t.co/34Lr6JGzbm","id":"558213501869912064","created_at":"2015-01-22T10:44:04.000Z","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/34Lr6JGzbm","expanded_url":"http://bit.ly/1woOZ88","display_url":"bit.ly/1woOZ88"}],"mentions":[{"start":66,"end":80,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":18,"end":29,"tag":"paediatric"},{"start":30,"end":39,"tag":"guidance"},{"start":81,"end":91,"tag":"guideline"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"558213501869912064","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The assessment report for #Paliperidone Janssen, a #medicine to treat #schizophrenia, is now available: http://t.co/j329ZzuBPE","id":"558212818181558272","created_at":"2015-01-22T10:41:21.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/j329ZzuBPE","expanded_url":"http://bit.ly/1Gvp7lX","display_url":"bit.ly/1Gvp7lX"}],"mentions":{},"hashtags":[{"start":26,"end":39,"tag":"Paliperidone"},{"start":51,"end":60,"tag":"medicine"},{"start":70,"end":84,"tag":"schizophrenia"}],"annotations":[{"start":40,"end":46,"probability":0.8632,"type":"Person","normalized_text":"Janssen"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"558212818181558272","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Europarl_EN: 2015 @EU_Commission work programme: reducing #RedTape – or scrapping important measures? Discuss it on @LinkedIn! http://t…","id":"558211985616420864","created_at":"2015-01-22T10:38:03.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"Europarl_EN","id":"36329597"},{"start":22,"end":36,"username":"EU_Commission","id":"157981564"},{"start":120,"end":129,"username":"LinkedIn","id":"13058772"}],"hashtags":[{"start":62,"end":70,"tag":"RedTape"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558211985616420864","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558208711513354240"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: 1 week left to discover the EDQM’s exhibition displayed at the Faculty of Pharmacy in Strasbourg! http://t.co/qzdHhUyFxH","id":"558211936534663168","created_at":"2015-01-22T10:37:51.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/qzdHhUyFxH","expanded_url":"http://bit.ly/1BZ5JY7","display_url":"bit.ly/1BZ5JY7"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":{},"annotations":[{"start":101,"end":110,"probability":0.9465,"type":"Place","normalized_text":"Strasbourg"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558211936534663168","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558208359833559040"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: WHO Executive Board documents: Antimicrobial resistance: Draft global action plan http://t.co/Z54odf3N90 #EB136","id":"558211924404744192","created_at":"2015-01-22T10:37:48.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/Z54odf3N90","expanded_url":"http://goo.gl/ZXNbzN","display_url":"goo.gl/ZXNbzN"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":114,"end":120,"tag":"EB136"}],"annotations":{}},"public_metrics":{"retweet_count":61,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558211924404744192","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558208352917139456"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: WHO Exec Board documents: Antimicrobial resistance: summary report on progress implementing res. WHA67.25 http://t.co/uBFKaIwnbm #…","id":"558211851063156736","created_at":"2015-01-22T10:37:31.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/uBFKaIwnbm","expanded_url":"http://goo.gl/wcRbOl","display_url":"goo.gl/wcRbOl"}],"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":32,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558211851063156736","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558206187641245696"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: New EU political landscape: how will it impact pharmaceutical policy? Follow us today at #EGAreg15 in London #pharma #gene…","id":"558211016023351296","created_at":"2015-01-22T10:34:11.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"hashtags":[{"start":106,"end":115,"tag":"EGAreg15"},{"start":126,"end":133,"tag":"pharma"}],"annotations":[{"start":119,"end":124,"probability":0.99,"type":"Place","normalized_text":"London"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558211016023351296","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558193518741827587"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: #Flu #vaccination rate lagging across Europe; uptake from 1-77% in older age groups in 2012/13 http://t.co/gbA97SVJmt http://…","id":"558210939900952576","created_at":"2015-01-22T10:33:53.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/gbA97SVJmt","expanded_url":"http://bit.ly/1y1hJV1","display_url":"bit.ly/1y1hJV1"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"}],"hashtags":[{"start":14,"end":18,"tag":"Flu"},{"start":19,"end":31,"tag":"vaccination"}],"annotations":[{"start":52,"end":57,"probability":0.9721,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":31,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558210939900952576","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558191397300604928"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egabiosimilars: #DidYouKnow that the @EU_Commission Consensus Information Document on #biosimilars exists in French? http://t.co/u04TrC…","id":"558210602473369600","created_at":"2015-01-22T10:32:33.000Z","entities":{"urls":{},"mentions":[{"start":41,"end":55,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":20,"end":31,"tag":"DidYouKnow"},{"start":90,"end":102,"tag":"biosimilars"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558210602473369600","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558187320025698305"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: IMI to introduce DupCheck, a new tool for avoiding duplicate enrolment of patients in CTs http://t.co/GmvAJ41PbD @IMI_JU","id":"558210304321282048","created_at":"2015-01-22T10:31:22.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/GmvAJ41PbD","expanded_url":"http://goo.gl/1bi9TP","display_url":"goo.gl/1bi9TP"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":124,"end":131,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"558210304321282048","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"558179474488197120"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've launched a #consultation on application of #transparency rules of EU Clinical Trial Regulation: http://t.co/wphje1LVNV #clinicaltrials","id":"557970665479753728","created_at":"2015-01-21T18:39:07.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/wphje1LVNV","expanded_url":"http://bit.ly/1BEmtax","display_url":"bit.ly/1BEmtax"}],"mentions":{},"hashtags":[{"start":17,"end":30,"tag":"consultation"},{"start":49,"end":62,"tag":"transparency"},{"start":125,"end":140,"tag":"clinicaltrials"}],"annotations":[{"start":72,"end":99,"probability":0.5549,"type":"Other","normalized_text":"EU Clinical Trial Regulation"}]},"public_metrics":{"retweet_count":16,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"557970665479753728","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: Risk to #Europe posed by #MERS-CoV remains low, the latest @ECDC_EU risk assessment update concludes: http://t.co/V1aofok0Vv","id":"557945741793320960","created_at":"2015-01-21T17:00:05.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/V1aofok0Vv","expanded_url":"http://bit.ly/1ALM6Rk","display_url":"bit.ly/1ALM6Rk"}],"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":73,"end":81,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":22,"end":29,"tag":"Europe"},{"start":39,"end":44,"tag":"MERS"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557945741793320960","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557944944447737856"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the assessment report for Paliperidone Janssen (#paliperidone), a #medicine to treat #schizophrenia: http://t.co/j329ZzuBPE","id":"557931224787062784","created_at":"2015-01-21T16:02:24.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/j329ZzuBPE","expanded_url":"http://bit.ly/1Gvp7lX","display_url":"bit.ly/1Gvp7lX"}],"mentions":{},"hashtags":[{"start":64,"end":77,"tag":"paliperidone"},{"start":82,"end":91,"tag":"medicine"},{"start":101,"end":115,"tag":"schizophrenia"}],"annotations":[{"start":42,"end":61,"probability":0.9587,"type":"Person","normalized_text":"Paliperidone Janssen"}]},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557931224787062784","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @my_ueg: Can't wait to the February issue of UEG Journal? Why not read latest original articles ahead of print: http://t.co/97Fx3D3irO","id":"557922355386023938","created_at":"2015-01-21T15:27:09.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/97Fx3D3irO","expanded_url":"http://ueg.sagepub.com/content/early/recent","display_url":"ueg.sagepub.com/content/early/…"}],"mentions":[{"start":3,"end":10,"username":"my_ueg","id":"487344065"}],"hashtags":{},"annotations":[{"start":48,"end":58,"probability":0.4875,"type":"Organization","normalized_text":"UEG Journal"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557922355386023938","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557921491397144578"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: EDQM to present 18th Edition Guide to the Preparation, Use and Quality Assurance of Blood Components at #IBST London http://…","id":"557922336528408576","created_at":"2015-01-21T15:27:05.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":119,"end":124,"tag":"IBST"}],"annotations":[{"start":125,"end":130,"probability":0.7111,"type":"Place","normalized_text":"London"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557922336528408576","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557921275990278144"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Regulatory information - #paediatric #guidance revised to reflect changes to European Commission #guideline: http://t.co/34Lr6JGzbm","id":"557922153522528256","created_at":"2015-01-21T15:26:21.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/34Lr6JGzbm","expanded_url":"http://bit.ly/1woOZ88","display_url":"bit.ly/1woOZ88"}],"mentions":{},"hashtags":[{"start":25,"end":36,"tag":"paediatric"},{"start":37,"end":46,"tag":"guidance"},{"start":97,"end":107,"tag":"guideline"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557922153522528256","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published a guide to help implement changes under new international standard to improve #safety of #medicines: http://t.co/n56aynhOuG","id":"557916271506100225","created_at":"2015-01-21T15:02:59.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/n56aynhOuG","expanded_url":"http://bit.ly/159EbnZ","display_url":"bit.ly/159EbnZ"}],"mentions":{},"hashtags":[{"start":94,"end":101,"tag":"safety"},{"start":105,"end":115,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"557916271506100225","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Did you see the latest #certification monthly report? http://t.co/ceSI0HPUjK","id":"557914534657413120","created_at":"2015-01-21T14:56:05.000Z","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/ceSI0HPUjK","expanded_url":"http://bit.ly/1EtO2jF","display_url":"bit.ly/1EtO2jF"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":38,"end":52,"tag":"certification"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557914534657413120","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557897264367431681"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Uroweb: #prostatecancer not only affects the patient but also the people around him. Read more in #EAUPatientInfo: http://t.co/c80POuFV…","id":"557914028505579520","created_at":"2015-01-21T14:54:04.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"Uroweb","id":"114455333"}],"hashtags":[{"start":12,"end":27,"tag":"prostatecancer"},{"start":102,"end":117,"tag":"EAUPatientInfo"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557914028505579520","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557913016218288128"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: Looking for information about an #animal #drug - check out our database - http://t.co/2Zc186ZmGY","id":"557914007072690176","created_at":"2015-01-21T14:53:59.000Z","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/2Zc186ZmGY","expanded_url":"http://bit.ly/9m6Tpb","display_url":"bit.ly/9m6Tpb"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"hashtags":[{"start":54,"end":61,"tag":"animal"},{"start":62,"end":67,"tag":"drug"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557914007072690176","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557913664855224320"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Public #consultation on application of #transparency rules of EU Clinical Trial Regulation: http://t.co/VBaBHDz0PS #clinicaltrials","id":"557874398418731009","created_at":"2015-01-21T12:16:36.000Z","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/VBaBHDz0PS","expanded_url":"http://bit.ly/1BEmtax","display_url":"bit.ly/1BEmtax"}],"mentions":{},"hashtags":[{"start":7,"end":20,"tag":"consultation"},{"start":39,"end":52,"tag":"transparency"},{"start":115,"end":130,"tag":"clinicaltrials"}],"annotations":[{"start":62,"end":89,"probability":0.45,"type":"Other","normalized_text":"EU Clinical Trial Regulation"}]},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"557874398418731009","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: 3 monographs will cease to form part of #European #Pharmacopoeia on 1 January 2016 http://t.co/Z1d1kZhpxR","id":"557848000954126337","created_at":"2015-01-21T10:31:42.000Z","entities":{"urls":[{"start":98,"end":120,"url":"http://t.co/Z1d1kZhpxR","expanded_url":"http://bit.ly/1B1tVw9","display_url":"bit.ly/1B1tVw9"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":55,"end":64,"tag":"European"},{"start":65,"end":79,"tag":"Pharmacopoeia"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557848000954126337","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557817017450131456"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myESMO: Early reg deadline for Signalling Pathways symposium is today! #personalisedmedicine #MAPKpathway  http://t.co/JcVxWBp0bP","id":"557847919144214529","created_at":"2015-01-21T10:31:22.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/JcVxWBp0bP","expanded_url":"http://ow.ly/HG6WX","display_url":"ow.ly/HG6WX"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"hashtags":[{"start":75,"end":96,"tag":"personalisedmedicine"},{"start":97,"end":109,"tag":"MAPKpathway"}],"annotations":[{"start":35,"end":53,"probability":0.601,"type":"Organization","normalized_text":"Signalling Pathways"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557847919144214529","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557822113873428480"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Did you know the new version of the Standard Terms database, with access available free of charge upon registration? http://…","id":"557847831420370945","created_at":"2015-01-21T10:31:01.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557847831420370945","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557828286567706624"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: Webinar on the CNS RADAR topic of IMI2 Call 3 will kick off today at 14:30 CET. Still on time to register at  http://t.co/M8fNP…","id":"557847789502484480","created_at":"2015-01-21T10:30:51.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557847789502484480","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557830552750133248"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: The 3rd Call of IMI2 also features a topic on #Pertussis #vaccination research. Join our webinar tomorrow  @14:00 CET http://t.…","id":"557847753053974529","created_at":"2015-01-21T10:30:43.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"},{"start":119,"end":122,"username":"14","id":"823428165582356480"}],"hashtags":[{"start":58,"end":68,"tag":"Pertussis"},{"start":69,"end":81,"tag":"vaccination"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557847753053974529","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557831832721686529"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: EU research project will develop #app to improve #dementia sufferers' quality of life http://t.co/Ysj6JMP4PO #mhealth #H202…","id":"557847677644595200","created_at":"2015-01-21T10:30:25.000Z","entities":{"urls":[{"start":102,"end":124,"url":"http://t.co/Ysj6JMP4PO","expanded_url":"http://ow.ly/HGf27","display_url":"ow.ly/HGf27"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"hashtags":[{"start":49,"end":53,"tag":"app"},{"start":65,"end":74,"tag":"dementia"},{"start":125,"end":133,"tag":"mhealth"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557847677644595200","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557834804797112320"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: .@EFSA_EU: #BPA poses no #health risk to consumers at current exposure levels.http://t.co/PvCSPgVfBq HT @YasminaBourouis","id":"557847493510459393","created_at":"2015-01-21T10:29:41.000Z","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/PvCSPgVfBq","expanded_url":"http://europa.eu/!Pn48wM","display_url":"europa.eu/!Pn48wM"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":16,"end":24,"username":"EFSA_EU","id":"84582815"},{"start":119,"end":135,"username":"YasminaBourouis","id":"551809536"}],"hashtags":[{"start":26,"end":30,"tag":"BPA"},{"start":40,"end":47,"tag":"health"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557847493510459393","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557841036761104385"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EUEnvironment: We are #recruiting a #press officer, experienced in communicating the #environment. Apply by 23 February. http://t.co/Qa…","id":"557847445041082369","created_at":"2015-01-21T10:29:29.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"EUEnvironment","id":"22362552"}],"hashtags":[{"start":26,"end":37,"tag":"recruiting"},{"start":40,"end":46,"tag":"press"},{"start":89,"end":101,"tag":"environment"}],"annotations":{}},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557847445041082369","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557843603624820736"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAMedia: See this week’s media tip sheet from the FDA press office: http://t.co/HR86qNNDXd","id":"557585631946502145","created_at":"2015-01-20T17:09:08.000Z","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/HR86qNNDXd","expanded_url":"http://go.usa.gov/ubVw","display_url":"go.usa.gov/ubVw"}],"mentions":[{"start":3,"end":12,"username":"FDAMedia","id":"2528303509"}],"hashtags":{},"annotations":[{"start":55,"end":57,"probability":0.8631,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557585631946502145","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557574194041741312"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @BushbyKate: Testing my social media skills- @TargetMD: Join us at 6.30pm for Facebook Q+A on #Translarna #Duchenne community: https://t…","id":"557585434579337216","created_at":"2015-01-20T17:08:21.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"BushbyKate","id":"1216228962"}],"hashtags":{},"annotations":[{"start":81,"end":88,"probability":0.4004,"type":"Organization","normalized_text":"Facebook"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557585434579337216","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557569506797965312"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Eurovaccine: Comment from @ECDC_EU on Dec’s @EUCouncil conclusions on #vaccination as an effective public health tool: http://t.co/aSTu…","id":"557585373279559680","created_at":"2015-01-20T17:08:07.000Z","entities":{"urls":{},"mentions":[{"start":30,"end":38,"username":"ECDC_EU","id":"204752573"},{"start":48,"end":58,"username":"EUCouncil","id":"206717989"}],"hashtags":[{"start":74,"end":86,"tag":"vaccination"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557585373279559680","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557569323276193793"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDA_MCMi: Comments on new Drug Trials Snapshot due Jan. 23. About snapshots: http://t.co/VW8cDsCvM8 How to comment: http://t.co/sABENyC…","id":"557558859339157504","created_at":"2015-01-20T15:22:45.000Z","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/VW8cDsCvM8","expanded_url":"http://ht.ly/HD7ne","display_url":"ht.ly/HD7ne"}],"mentions":[{"start":3,"end":12,"username":"FDA_MCMi","id":"1606025952"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557558859339157504","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557558256378605568"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICESciAdvice: February's Regulatory Rapporteur online now - focus #orphandrugs http://t.co/RrpQ4mKsqJ #regaffairs http://t.co/dkgz5TeL…","id":"557552276798459905","created_at":"2015-01-20T14:56:36.000Z","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/RrpQ4mKsqJ","expanded_url":"http://bit.ly/15qiEZa","display_url":"bit.ly/15qiEZa"}],"mentions":[{"start":3,"end":17,"username":"NICESciAdvice","id":"2834291205"}],"hashtags":[{"start":71,"end":83,"tag":"orphandrugs"},{"start":107,"end":118,"tag":"regaffairs"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557552276798459905","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557543814026768384"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICESciAdvice: New Regulatory Rapporteur looking at orphan drugs. Free access to focus article: http://t.co/RrpQ4mKsqJ  via @TOPRANEWS","id":"557552258838450176","created_at":"2015-01-20T14:56:31.000Z","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/RrpQ4mKsqJ","expanded_url":"http://bit.ly/15qiEZa","display_url":"bit.ly/15qiEZa"}],"mentions":[{"start":3,"end":17,"username":"NICESciAdvice","id":"2834291205"},{"start":128,"end":138,"username":"TOPRANEWS","id":"26739900"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557552258838450176","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557543709093662720"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Latest #Pheur supplement includes 6 new and 47 revised texts. Download the Contents of supplement 8.5 http://t.co/B0SXdPIpIY","id":"557551835628969984","created_at":"2015-01-20T14:54:51.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/B0SXdPIpIY","expanded_url":"http://bit.ly/1CerUvG","display_url":"bit.ly/1CerUvG"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":22,"end":28,"tag":"Pheur"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557551835628969984","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557540103263096833"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: The @WEBRADR website is LIVE! Read how using social media &amp; new technologies lead to reporting of #drugsafety issues http://t…","id":"557551717139873792","created_at":"2015-01-20T14:54:22.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"},{"start":18,"end":26,"username":"WEBRADR","id":"2797520425"}],"hashtags":[{"start":116,"end":127,"tag":"drugsafety"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557551717139873792","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557539427812376576"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSAJournal: #Coxiril® (diclazuril) for #rabbits for fattening and #breeding http://t.co/qYzknqrsDb  #coccidiostat","id":"557551626400321536","created_at":"2015-01-20T14:54:01.000Z","entities":{"urls":[{"start":81,"end":103,"url":"http://t.co/qYzknqrsDb","expanded_url":"http://bit.ly/15sbweb","display_url":"bit.ly/15sbweb"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"hashtags":[{"start":17,"end":25,"tag":"Coxiril"},{"start":44,"end":52,"tag":"rabbits"},{"start":71,"end":80,"tag":"breeding"},{"start":105,"end":118,"tag":"coccidiostat"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557551626400321536","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557538983434268672"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @FDAanimalhealth: New #FDA Guidance Document Search Now Available http://t.co/Tp4lvc1hPo","id":"557538735764807680","created_at":"2015-01-20T14:02:47.000Z","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/Tp4lvc1hPo","expanded_url":"http://1.usa.gov/1CKKB8F","display_url":"1.usa.gov/1CKKB8F"}],"mentions":[{"start":3,"end":19,"username":"FDAanimalhealth","id":"109290405"}],"hashtags":[{"start":25,"end":29,"tag":"FDA"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557538735764807680","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557537837604945920"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #minutes from our December #veterinary medicine committee (CVMP) meeting are available: http://t.co/8WrSPDzfAl","id":"557530994400833536","created_at":"2015-01-20T13:32:02.000Z","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/8WrSPDzfAl","expanded_url":"http://bit.ly/151Msu1","display_url":"bit.ly/151Msu1"}],"mentions":{},"hashtags":[{"start":4,"end":12,"tag":"minutes"},{"start":31,"end":42,"tag":"veterinary"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557530994400833536","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"A week left to review guidance on persistent bioaccumulative toxic substances in #veterinary #medicine: http://t.co/U4BLpM1icJ #consultation","id":"557530733087297536","created_at":"2015-01-20T13:30:59.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/U4BLpM1icJ","expanded_url":"http://bit.ly/1wanHXb","display_url":"bit.ly/1wanHXb"}],"mentions":{},"hashtags":[{"start":81,"end":92,"tag":"veterinary"},{"start":93,"end":102,"tag":"medicine"},{"start":127,"end":140,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557530733087297536","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: Joint Principles for Communication of info on Quality&amp;Manufacturing Potential Supply Disruption http://t.co/BshgfO48tP @EGA @aes…","id":"557530447702654976","created_at":"2015-01-20T13:29:51.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/BshgfO48tP","expanded_url":"http://goo.gl/h7lDoo","display_url":"goo.gl/h7lDoo"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":134,"end":138,"username":"EGA","id":"76840245"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557530447702654976","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557527655634190336"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: \"What you need to know about biosimilar medicines\" @EuropeanCommiss Consensus Information Doc now available in Polish http…","id":"557529527438827520","created_at":"2015-01-20T13:26:12.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"},{"start":68,"end":84,"username":"EuropeanCommiss","id":"1328964018"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557529527438827520","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557496819794837504"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egagenerics: #Genericmedicines are subject to Good Manufacturing Practice (GMP) inspections http://t.co/Icpze22k5X #EGAgenerics","id":"557529444248985600","created_at":"2015-01-20T13:25:52.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/Icpze22k5X","expanded_url":"http://bit.ly/1yM6AcQ","display_url":"bit.ly/1yM6AcQ"}],"mentions":[{"start":3,"end":15,"username":"egagenerics","id":"1229029034"}],"hashtags":[{"start":17,"end":34,"tag":"Genericmedicines"},{"start":119,"end":131,"tag":"EGAgenerics"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557529444248985600","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557492779773730817"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @TOPRANEWS: Read February's Regulatory Rapporteur online now - focus #orphandrugs http://t.co/DvspGtnsLR #regaffairs http://t.co/FzXEaNn…","id":"557529366427889664","created_at":"2015-01-20T13:25:34.000Z","entities":{"urls":[{"start":85,"end":107,"url":"http://t.co/DvspGtnsLR","expanded_url":"http://bit.ly/15qiEZa","display_url":"bit.ly/15qiEZa"}],"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"hashtags":[{"start":72,"end":84,"tag":"orphandrugs"},{"start":108,"end":119,"tag":"regaffairs"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557529366427889664","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557492238452662273"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @TOPRANEWS: New Regulatory Rapporteur looking at orphan drugs. Free access to focus article: http://t.co/g806MC4rlD  #orphandrugs #RareD…","id":"557529237855698944","created_at":"2015-01-20T13:25:03.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/g806MC4rlD","expanded_url":"http://bit.ly/15qiEZa","display_url":"bit.ly/15qiEZa"}],"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"}],"hashtags":[{"start":120,"end":132,"tag":"orphandrugs"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557529237855698944","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557491651888041984"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: EMA to share assessments reports for generic medicines with regulators outside the EU http://t.co/DZphi1RVMk","id":"557481141159358464","created_at":"2015-01-20T10:13:56.000Z","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/DZphi1RVMk","expanded_url":"http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2015/01/news_detail_002251.jsp&mid=WC0b01ac058004d5c1","display_url":"ema.europa.eu/ema/index.jsp?…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"annotations":[{"start":13,"end":15,"probability":0.4788,"type":"Organization","normalized_text":"EMA"}]},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557481141159358464","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557480197227044864"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: #EDQM #ReferenceStandards: Did  you know about the list of newly adopted batches and new products, available daily? http://t…","id":"557479553736933376","created_at":"2015-01-20T10:07:37.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":15,"end":20,"tag":"EDQM"},{"start":21,"end":40,"tag":"ReferenceStandards"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557479553736933376","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557479502738391040"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #minutes from our December #veterinary medicine committee (CVMP) meeting: http://t.co/8WrSPDzfAl","id":"557477236795015168","created_at":"2015-01-20T09:58:25.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/8WrSPDzfAl","expanded_url":"http://bit.ly/151Msu1","display_url":"bit.ly/151Msu1"}],"mentions":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":47,"end":58,"tag":"veterinary"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557477236795015168","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We're going to share assessments reports for #generic #medicines with regulators outside the EU: http://t.co/V2QSJ3R5aP","id":"557468991497965568","created_at":"2015-01-20T09:25:39.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/V2QSJ3R5aP","expanded_url":"http://bit.ly/1uieSqv","display_url":"bit.ly/1uieSqv"}],"mentions":{},"hashtags":[{"start":45,"end":53,"tag":"generic"},{"start":54,"end":64,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":3,"quote_count":0},"conversation_id":"557468991497965568","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #agenda for this week's committee for human #medicines (CHMP) meeting is available: http://t.co/BRgPabKypy","id":"557468233675329537","created_at":"2015-01-20T09:22:38.000Z","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/BRgPabKypy","expanded_url":"http://bit.ly/14Wtjd7","display_url":"bit.ly/14Wtjd7"}],"mentions":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":48,"end":58,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557468233675329537","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week to review guidance on persistent, bioaccumulative, toxic substances in #veterinary #medicine: http://t.co/U4BLpM1icJ  #consultation","id":"557464123811057664","created_at":"2015-01-20T09:06:18.000Z","entities":{"urls":[{"start":103,"end":125,"url":"http://t.co/U4BLpM1icJ","expanded_url":"http://bit.ly/1wanHXb","display_url":"bit.ly/1wanHXb"}],"mentions":{},"hashtags":[{"start":80,"end":91,"tag":"veterinary"},{"start":92,"end":101,"tag":"medicine"},{"start":127,"end":140,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"557464123811057664","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSA &amp; @ECDC_EU 1st annual meeting on vector-borne diseases takes place next week in Parma #VectorNet http://t.co/xi1W5q3zPq","id":"557462803268009984","created_at":"2015-01-20T09:01:04.000Z","entities":{"urls":[{"start":120,"end":142,"url":"http://t.co/xi1W5q3zPq","expanded_url":"http://bit.ly/1yGIJhT","display_url":"bit.ly/1yGIJhT"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"},{"start":25,"end":33,"username":"ECDC_EU","id":"204752573"}],"hashtags":[{"start":13,"end":18,"tag":"EFSA"},{"start":109,"end":119,"tag":"VectorNet"}],"annotations":[{"start":99,"end":103,"probability":0.9048,"type":"Place","normalized_text":"Parma"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557462803268009984","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557461179006996481"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @DrugInfoAssn: I added a video to a @YouTube playlist http://t.co/uK7KWquDh8 Theme 7 - Special Development Pathways in Paediatrics, the …","id":"557462434882285568","created_at":"2015-01-20T08:59:36.000Z","entities":{"urls":[{"start":57,"end":79,"url":"http://t.co/uK7KWquDh8","expanded_url":"http://youtu.be/Moq4TvL03ZU?a","display_url":"youtu.be/Moq4TvL03ZU?a"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":39,"end":47,"username":"YouTube","id":"10228272"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557462434882285568","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557458810462167040"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: What investments make people healthier &amp; more productive? Report by @wef http://t.co/YLX0sDpOIz http://t.co/vi0KHI1HhJ HT @I…","id":"557222204996608000","created_at":"2015-01-19T17:05:01.000Z","entities":{"urls":[{"start":92,"end":114,"url":"http://t.co/YLX0sDpOIz","expanded_url":"http://ow.ly/HxRxq","display_url":"ow.ly/HxRxq"},{"start":115,"end":137,"url":"http://t.co/vi0KHI1HhJ","expanded_url":"http://ow.ly/i/8j4cU","display_url":"ow.ly/i/8j4cU"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":87,"end":91,"username":"wef","id":"5120691"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":14,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557222204996608000","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557133571211939840"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eumsplatform: Supporting #research in MS, top priority in @MSIntFederation New Year Resolution poll. #MultipleSclerosis","id":"557222059999498240","created_at":"2015-01-19T17:04:26.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"eumsplatform","id":"600110872"},{"start":62,"end":78,"username":"MSIntFederation","id":"390672087"}],"hashtags":[{"start":29,"end":38,"tag":"research"},{"start":105,"end":123,"tag":"MultipleSclerosis"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557222059999498240","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557172943177146368"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IAPOtweets: It's a year since we established the Consensus Framework for Ethical Collaboration: http://t.co/npmOT1mmrK http://t.co/vvMS…","id":"557222034313584640","created_at":"2015-01-19T17:04:20.000Z","entities":{"urls":[{"start":100,"end":122,"url":"http://t.co/npmOT1mmrK","expanded_url":"http://bit.ly/17PQ5oV","display_url":"bit.ly/17PQ5oV"}],"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557222034313584640","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557171551385419777"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: Call for applications for #research funding from DEBRA International is open, deadline 1 March http://t.co/3S5CvEC8KN #Epider…","id":"557221938691846145","created_at":"2015-01-19T17:03:57.000Z","entities":{"urls":[{"start":109,"end":131,"url":"http://t.co/3S5CvEC8KN","expanded_url":"http://ow.ly/HfObE","display_url":"ow.ly/HfObE"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":[{"start":40,"end":49,"tag":"research"}],"annotations":[{"start":63,"end":81,"probability":0.7194,"type":"Organization","normalized_text":"DEBRA International"}]},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557221938691846145","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557178274380787713"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: The EU #eHealth in Focus newsletter came out: http://t.co/4cZJTWt6fX #mHealth #policy #healthcare #funding http://t.co/vz6n…","id":"557221895972872192","created_at":"2015-01-19T17:03:47.000Z","entities":{"urls":[{"start":62,"end":84,"url":"http://t.co/4cZJTWt6fX","expanded_url":"http://ow.ly/HyX4Y","display_url":"ow.ly/HyX4Y"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"hashtags":[{"start":23,"end":31,"tag":"eHealth"},{"start":85,"end":93,"tag":"mHealth"},{"start":94,"end":101,"tag":"policy"},{"start":102,"end":113,"tag":"healthcare"},{"start":114,"end":122,"tag":"funding"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557221895972872192","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557184410232295424"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: #EFSAExpo2015 scientific conference ‘Shaping the future of #FoodSafety, together’. Registrations are now open! http://t.co/SNS…","id":"557221776745586688","created_at":"2015-01-19T17:03:18.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":13,"end":26,"tag":"EFSAExpo2015"},{"start":72,"end":83,"tag":"FoodSafety"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557221776745586688","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557193204748255232"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_ECHA: We are prioritising substances which have carcinogenic, mutagenic or reprotoxic properties (CMRs) for risk management http://t…","id":"557221747519664129","created_at":"2015-01-19T17:03:11.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":11,"username":"EU_ECHA","id":"331604970"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557221747519664129","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557193707976667136"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Did you know it? 8th Edition 2015 #Pheur covers 2267 monographs and 349 other texts. All about the 8th Edition: http://t.co/…","id":"557221654972362752","created_at":"2015-01-19T17:02:49.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":49,"end":55,"tag":"Pheur"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557221654972362752","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557198948222644224"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eupatientsforum: Do you want to become a #patient #expert in medicines R&amp;D? Apply now until 31 March for #eupati Training Course:http:/…","id":"557221465079422979","created_at":"2015-01-19T17:02:04.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"eupatientsforum","id":"545343465"}],"hashtags":[{"start":45,"end":53,"tag":"patient"},{"start":54,"end":61,"tag":"expert"},{"start":113,"end":120,"tag":"eupati"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557221465079422979","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557219713651335168"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Food_EU: #AnimalHealth: #EU commits close to €180 million to combat animal diseases in 2015 http://t.co/8JhJ80han1 http://t.co/boGjkihs…","id":"557214134518185984","created_at":"2015-01-19T16:32:56.000Z","entities":{"urls":[{"start":96,"end":118,"url":"http://t.co/8JhJ80han1","expanded_url":"http://europa.eu/!Nv39cv","display_url":"europa.eu/!Nv39cv"}],"mentions":[{"start":3,"end":11,"username":"Food_EU","id":"2874880006"}],"hashtags":[{"start":13,"end":26,"tag":"AnimalHealth"},{"start":28,"end":31,"tag":"EU"}],"annotations":{}},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557214134518185984","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"557210435041370112"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Europe to boost international cooperation on #generics: http://t.co/V2QSJ3R5aP","id":"557197308803448832","created_at":"2015-01-19T15:26:05.000Z","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/V2QSJ3R5aP","expanded_url":"http://bit.ly/1uieSqv","display_url":"bit.ly/1uieSqv"}],"mentions":{},"hashtags":[{"start":45,"end":54,"tag":"generics"}],"annotations":[{"start":0,"end":5,"probability":0.9744,"type":"Place","normalized_text":"Europe"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557197308803448832","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda of this week's committee for human #medicines (CHMP): http://t.co/BRgPabKypy","id":"557120560262836224","created_at":"2015-01-19T10:21:07.000Z","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/BRgPabKypy","expanded_url":"http://bit.ly/14Wtjd7","display_url":"bit.ly/14Wtjd7"}],"mentions":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":63,"end":73,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"557120560262836224","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One more week to answer our tender for provision of internal #audit services: http://t.co/cFDK7GRFAk  #procurement","id":"557111210618146816","created_at":"2015-01-19T09:43:57.000Z","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"mentions":{},"hashtags":[{"start":61,"end":67,"tag":"audit"},{"start":102,"end":114,"tag":"procurement"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557111210618146816","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our human #medicine committee (CHMP) meets this week. Highlights out on Friday: http://t.co/7QdDRdhU61","id":"557111110395232257","created_at":"2015-01-19T09:43:33.000Z","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/7QdDRdhU61","expanded_url":"http://bit.ly/1u8WHsQ","display_url":"bit.ly/1u8WHsQ"}],"mentions":{},"hashtags":[{"start":10,"end":19,"tag":"medicine"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"557111110395232257","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the highlights from last week's #veterinary #medicines committee (CVMP) meeting: http://t.co/TlAsFGzcb7","id":"557110973019209728","created_at":"2015-01-19T09:43:01.000Z","entities":{"urls":[{"start":97,"end":119,"url":"http://t.co/TlAsFGzcb7","expanded_url":"http://bit.ly/1ykzvcB","display_url":"bit.ly/1ykzvcB"}],"mentions":{},"hashtags":[{"start":48,"end":59,"tag":"veterinary"},{"start":60,"end":70,"tag":"medicines"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"557110973019209728","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @rarediseaseday: The official #RareDisease Day 2015 poster is out! Download it and share it with the world! http://t.co/RMgcj2yZ6C http:…","id":"556137300707799042","created_at":"2015-01-16T17:13:59.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/RMgcj2yZ6C","expanded_url":"http://ow.ly/HrGjL","display_url":"ow.ly/HrGjL"}],"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"hashtags":[{"start":33,"end":45,"tag":"RareDisease"}],"annotations":{}},"public_metrics":{"retweet_count":138,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556137300707799042","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556137187545481216"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: 1st topic of IMI2 Remote assessment of disease and relapse (RADAR) programme to be explained at webinar on 21/01 http://t.co/M8…","id":"556135654753828866","created_at":"2015-01-16T17:07:27.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556135654753828866","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556134429656354816"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @V_Andriukaitis: #EU research efforts at front line of fight against #Ebola  http://t.co/jYjJHoCQyF  @Moedas @StylianidesEU","id":"556135487224954880","created_at":"2015-01-16T17:06:47.000Z","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/jYjJHoCQyF","expanded_url":"http://europa.eu/!My83XK","display_url":"europa.eu/!My83XK"}],"mentions":[{"start":3,"end":18,"username":"V_Andriukaitis","id":"575269517"},{"start":104,"end":111,"username":"Moedas","id":"20058825"},{"start":112,"end":126,"username":"StylianidesEU","id":"2413938919"}],"hashtags":[{"start":20,"end":23,"tag":"EU"},{"start":72,"end":78,"tag":"Ebola"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556135487224954880","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556131492766973952"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @DrugInfoAssn: Why is there a high turnover rate among principal #clinical #investigators?http://t.co/c6TbXbBwM4 via @pharmalot #clinica…","id":"556135379288735744","created_at":"2015-01-16T17:06:21.000Z","entities":{"urls":[{"start":93,"end":115,"url":"http://t.co/c6TbXbBwM4","expanded_url":"http://ow.ly/HrwpI","display_url":"ow.ly/HrwpI"}],"mentions":[{"start":3,"end":16,"username":"DrugInfoAssn","id":"28870127"},{"start":120,"end":130,"username":"pharmalot","id":"13171622"}],"hashtags":[{"start":68,"end":77,"tag":"clinical"},{"start":78,"end":92,"tag":"investigators"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556135379288735744","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556128811704913920"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_H2020: The fight against #Ebola is heating up: 8 projects will be funded under the #IMI Ebola+programme http://t.co/XQeZavnvvu #Hori…","id":"556115363298312192","created_at":"2015-01-16T15:46:49.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/XQeZavnvvu","expanded_url":"http://bit.ly/1AYwVGX","display_url":"bit.ly/1AYwVGX"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"}],"hashtags":[{"start":32,"end":38,"tag":"Ebola"},{"start":90,"end":94,"tag":"IMI"}],"annotations":{}},"public_metrics":{"retweet_count":9,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556115363298312192","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556115088156139520"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @innovationunion: The fight against #Ebola is heating up: 8 projects will be funded under the #IMI Ebola+programme http://t.co/kdrDNIF5t…","id":"556115352615403520","created_at":"2015-01-16T15:46:46.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":19,"username":"innovationunion","id":"786508396245639172"}],"hashtags":[{"start":39,"end":45,"tag":"Ebola"},{"start":97,"end":101,"tag":"IMI"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556115352615403520","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556115088143560704"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EUlondonrep: UK researchers lead EU funded projects on Ebola vaccine candidate http://t.co/z0tCAqIUX7","id":"556115329370558464","created_at":"2015-01-16T15:46:41.000Z","entities":{"urls":[{"start":83,"end":105,"url":"http://t.co/z0tCAqIUX7","expanded_url":"http://bit.ly/1E7iWQi","display_url":"bit.ly/1E7iWQi"}],"mentions":{},"hashtags":{},"annotations":[{"start":17,"end":18,"probability":0.965,"type":"Place","normalized_text":"UK"},{"start":37,"end":38,"probability":0.6858,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556115329370558464","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556114760572219392"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: IMI announced the launch of 8 #Ebola projects today! Learn more at http://t.co/R5FkaIvEO7 #vaccines #diagnostics","id":"556109003722592257","created_at":"2015-01-16T15:21:33.000Z","entities":{"urls":[{"start":79,"end":101,"url":"http://t.co/R5FkaIvEO7","expanded_url":"http://bit.ly/IMIEbola","display_url":"bit.ly/IMIEbola"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":[{"start":42,"end":48,"tag":"Ebola"},{"start":102,"end":111,"tag":"vaccines"},{"start":112,"end":124,"tag":"diagnostics"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556109003722592257","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556108734913847296"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: EU research efforts at front line of fight against Ebola http://t.co/a4egmpD3uX","id":"556108769764343808","created_at":"2015-01-16T15:20:37.000Z","entities":{"urls":[{"start":70,"end":92,"url":"http://t.co/a4egmpD3uX","expanded_url":"http://europa.eu/rapid/press-release_IP-15-3343_en.htm","display_url":"europa.eu/rapid/press-re…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"annotations":[{"start":13,"end":14,"probability":0.5692,"type":"Organization","normalized_text":"EU"},{"start":64,"end":68,"probability":0.4528,"type":"Other","normalized_text":"Ebola"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556108769764343808","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556108578273394689"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurireland: 8 research projects into #Ebola to receive €216 million in funding to develop vaccines and rapid diagnostics tests: http://…","id":"556106597962100737","created_at":"2015-01-16T15:11:59.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"eurireland","id":"44890795"}],"hashtags":[{"start":41,"end":47,"tag":"Ebola"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556106597962100737","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556106318508216321"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the highlights from this week's #veterinary medicine committee (CVMP) meeting: http://t.co/TlAsFGzcb7","id":"556106300443361280","created_at":"2015-01-16T15:10:48.000Z","entities":{"urls":[{"start":95,"end":117,"url":"http://t.co/TlAsFGzcb7","expanded_url":"http://bit.ly/1ykzvcB","display_url":"bit.ly/1ykzvcB"}],"mentions":{},"hashtags":[{"start":48,"end":59,"tag":"veterinary"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556106300443361280","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EURLex: .@EU_Commission announces 8 new research projects in particular #Ebola vaccines &amp; rapid diagnostics http://t.co/K8cRPAu6qV","id":"556105107730100224","created_at":"2015-01-16T15:06:04.000Z","entities":{"urls":[{"start":116,"end":138,"url":"http://t.co/K8cRPAu6qV","expanded_url":"http://ow.ly/Hr3z8","display_url":"ow.ly/Hr3z8"}],"mentions":[{"start":3,"end":10,"username":"EURLex","id":"294028805"},{"start":13,"end":27,"username":"EU_Commission","id":"157981564"}],"hashtags":[{"start":76,"end":82,"tag":"Ebola"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556105107730100224","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556103752550457344"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EUintheUS: EU announces 8 research projects into #Ebola that will be funded w/ a total of €215M. http://t.co/2QW2b0BeVx","id":"556097785196732416","created_at":"2015-01-16T14:36:58.000Z","entities":{"urls":[{"start":101,"end":123,"url":"http://t.co/2QW2b0BeVx","expanded_url":"http://www.euintheus.org/press-media/eu-research-efforts-at-front-line-of-fight-against-ebola/","display_url":"euintheus.org/press-media/eu…"}],"mentions":[{"start":3,"end":13,"username":"EUintheUS","id":"217616314"}],"hashtags":[{"start":53,"end":59,"tag":"Ebola"}],"annotations":[{"start":15,"end":16,"probability":0.8448,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556097785196732416","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556097454203219969"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Moedas: Fighting #Ebola: 8 new projects worth 216M€ http://t.co/OrPXZRgihl","id":"556097435463086081","created_at":"2015-01-16T14:35:35.000Z","entities":{"urls":[{"start":56,"end":78,"url":"http://t.co/OrPXZRgihl","expanded_url":"http://europa.eu/rapid/press-release_IP-15-3343_en.htm","display_url":"europa.eu/rapid/press-re…"}],"mentions":[{"start":3,"end":10,"username":"Moedas","id":"20058825"}],"hashtags":[{"start":21,"end":27,"tag":"Ebola"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556097435463086081","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556097270933118976"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSA_EU: AHAW Chair talks about the challenge of assessing transboundary #diseases http://t.co/N8sR8bzqaw","id":"556095730289750018","created_at":"2015-01-16T14:28:48.000Z","entities":{"urls":[{"start":87,"end":109,"url":"http://t.co/N8sR8bzqaw","expanded_url":"http://bit.ly/154L76H","display_url":"bit.ly/154L76H"}],"mentions":[{"start":3,"end":11,"username":"EFSA_EU","id":"84582815"}],"hashtags":[{"start":77,"end":86,"tag":"diseases"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556095730289750018","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556092367875604480"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @AEMPSGOB: Publication of the Monthly Bulletin from the Spanish medicines agency for the month of December 2014 http://t.co/mUVozKgKcS","id":"556084291512569857","created_at":"2015-01-16T13:43:21.000Z","entities":{"urls":[{"start":115,"end":137,"url":"http://t.co/mUVozKgKcS","expanded_url":"http://bit.ly/1E74W98","display_url":"bit.ly/1E74W98"}],"mentions":[{"start":3,"end":12,"username":"AEMPSGOB","id":"326845755"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"556084291512569857","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"One week left to answer our tender for provision of internal #audit services: http://t.co/cFDK7GRFAk  #procurement","id":"556081069876064256","created_at":"2015-01-16T13:30:33.000Z","entities":{"urls":[{"start":78,"end":100,"url":"http://t.co/cFDK7GRFAk","expanded_url":"http://bit.ly/18SjN71","display_url":"bit.ly/18SjN71"}],"mentions":{},"hashtags":[{"start":61,"end":67,"tag":"audit"},{"start":102,"end":114,"tag":"procurement"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556081069876064256","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two more weeks to comment on our draft guideline on #influenza #vaccine requirements: http://t.co/iP8ORy66BO  #consultation","id":"556080100471750656","created_at":"2015-01-16T13:26:42.000Z","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/iP8ORy66BO","expanded_url":"http://bit.ly/1B9ZpA4","display_url":"bit.ly/1B9ZpA4"}],"mentions":{},"hashtags":[{"start":52,"end":62,"tag":"influenza"},{"start":63,"end":71,"tag":"vaccine"},{"start":110,"end":123,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"556080100471750656","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Our human #medicine committee (CHMP) meets next week. Highlights will be out on Friday: http://t.co/7QdDRdhU61","id":"556079725849092096","created_at":"2015-01-16T13:25:12.000Z","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/7QdDRdhU61","expanded_url":"http://bit.ly/1u8WHsQ","display_url":"bit.ly/1u8WHsQ"}],"mentions":{},"hashtags":[{"start":10,"end":19,"tag":"medicine"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"556079725849092096","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @GCessak: EMA: Human medicines highlights - December 2014 http://t.co/VD8fA9Tuuk","id":"556078989929099266","created_at":"2015-01-16T13:22:17.000Z","entities":{"urls":[{"start":61,"end":83,"url":"http://t.co/VD8fA9Tuuk","expanded_url":"http://www.ema.europa.eu/docs/en_GB/document_library/Newsletter/2015/01/WC500180411.pdf","display_url":"ema.europa.eu/docs/en_GB/doc…"}],"mentions":[{"start":3,"end":11,"username":"GCessak","id":"556859372"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556078989929099266","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556065121718775808"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EuropaBio: #GMO cultivation law, @EMA_News approvals &amp; other EU #biotech news @EuropaBio newsletter - subscribe 2 receive it we…https:/…","id":"556078432938119169","created_at":"2015-01-16T13:20:04.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"},{"start":37,"end":46,"username":"EMA_News","id":"116716199"},{"start":86,"end":96,"username":"EuropaBio","id":"19642657"}],"hashtags":[{"start":15,"end":19,"tag":"GMO"},{"start":72,"end":80,"tag":"biotech"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556078432938119169","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556058582739718144"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Berlaymont: EU research efforts at front line of fight against Ebola http://t.co/qKERsi0fxe","id":"556077962051977217","created_at":"2015-01-16T13:18:12.000Z","entities":{"urls":[{"start":73,"end":95,"url":"http://t.co/qKERsi0fxe","expanded_url":"http://bit.ly/1yqjvnP","display_url":"bit.ly/1yqjvnP"}],"mentions":[{"start":3,"end":14,"username":"Berlaymont","id":"19003991"}],"hashtags":{},"annotations":[{"start":16,"end":17,"probability":0.5692,"type":"Organization","normalized_text":"EU"},{"start":67,"end":71,"probability":0.4528,"type":"Other","normalized_text":"Ebola"}]},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556077962051977217","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556052859599323137"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EuropaBio: #science-based regulation not only on paper but also in practice - read more in our weekly @EuropaBio newsletter http://t.co…","id":"556077797874364416","created_at":"2015-01-16T13:17:33.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"},{"start":106,"end":116,"username":"EuropaBio","id":"19642657"}],"hashtags":[{"start":15,"end":23,"tag":"science"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556077797874364416","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556049149360361472"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFPIA: EFPIA and @IMI_JU Announce New Ebola+ Projects to Further Collaborative Efforts Against Ebola http://t.co/OW5fCmTLfF #H2020","id":"556077242565292032","created_at":"2015-01-16T13:15:20.000Z","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/OW5fCmTLfF","expanded_url":"http://goo.gl/iTRrca","display_url":"goo.gl/iTRrca"}],"mentions":[{"start":3,"end":9,"username":"EFPIA","id":"52084584"},{"start":21,"end":28,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":[{"start":128,"end":134,"tag":"H2020"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556077242565292032","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556048843109060608"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_H2020: @EU_Commission announces 8 new #research projects worth €216 million to fight #Ebola http://t.co/6tgtdC5qdc @Moedas #EbolaRes…","id":"556077173707399168","created_at":"2015-01-16T13:15:04.000Z","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/6tgtdC5qdc","expanded_url":"http://europa.eu/!My83XK","display_url":"europa.eu/!My83XK"}],"mentions":[{"start":3,"end":12,"username":"EU_H2020","id":"920249612329504768"},{"start":14,"end":28,"username":"EU_Commission","id":"157981564"},{"start":122,"end":129,"username":"Moedas","id":"20058825"}],"hashtags":[{"start":45,"end":54,"tag":"research"},{"start":92,"end":98,"tag":"Ebola"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556077173707399168","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556048563508379649"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: Press release: First IMI #Ebola projects get underway http://t.co/sMVcN3IytA #vaccines #diagnostics","id":"556077002944704512","created_at":"2015-01-16T13:14:23.000Z","entities":{"urls":[{"start":66,"end":88,"url":"http://t.co/sMVcN3IytA","expanded_url":"http://bit.ly/15bNmV6","display_url":"bit.ly/15bNmV6"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":[{"start":37,"end":43,"tag":"Ebola"},{"start":89,"end":98,"tag":"vaccines"},{"start":99,"end":111,"tag":"diagnostics"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556077002944704512","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"556045615453712384"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ansm: French medicines agency has published a summary of the topics discussed at the #PRAC meeting, January 2015 http://t.co/azHSxL6Xgw","id":"556069035910381568","created_at":"2015-01-16T12:42:44.000Z","entities":{"urls":[{"start":117,"end":139,"url":"http://t.co/azHSxL6Xgw","expanded_url":"http://bit.ly/1Ans0g2","display_url":"bit.ly/1Ans0g2"}],"mentions":[{"start":3,"end":8,"username":"ansm","id":"2443530930"}],"hashtags":[{"start":89,"end":94,"tag":"PRAC"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":2,"quote_count":0},"conversation_id":"556069035910381568","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks left to comment on our draft guideline on #influenza #vaccine requirements: http://t.co/iP8ORy66BO #consultation","id":"556020830686429184","created_at":"2015-01-16T09:31:11.000Z","entities":{"urls":[{"start":86,"end":108,"url":"http://t.co/iP8ORy66BO","expanded_url":"http://bit.ly/1B9ZpA4","display_url":"bit.ly/1B9ZpA4"}],"mentions":{},"hashtags":[{"start":52,"end":62,"tag":"influenza"},{"start":63,"end":71,"tag":"vaccine"},{"start":109,"end":122,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556020830686429184","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Aifa_ufficiale: #Pharmacotherapy for #neuropathic #pain: a systematic review and meta-analysis http://t.co/WjvExwH6sR","id":"556019824921694208","created_at":"2015-01-16T09:27:11.000Z","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/WjvExwH6sR","expanded_url":"http://bit.ly/1IQ6KEm","display_url":"bit.ly/1IQ6KEm"}],"mentions":[{"start":3,"end":18,"username":"Aifa_ufficiale","id":"441940097"}],"hashtags":[{"start":20,"end":36,"tag":"Pharmacotherapy"},{"start":41,"end":53,"tag":"neuropathic"},{"start":54,"end":59,"tag":"pain"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"556019824921694208","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: #EDQM successfully continues its ISO 9001 certification http://t.co/pVmfgIrgK5","id":"555785206142361601","created_at":"2015-01-15T17:54:53.000Z","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/pVmfgIrgK5","expanded_url":"http://bit.ly/1yiedZQ","display_url":"bit.ly/1yiedZQ"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":15,"end":20,"tag":"EDQM"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555785206142361601","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555763727526813696"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ECDC_Flu: #flu vaccine effectiveness in 2012/13 in Europe &amp; more on ethics&amp;strategy in HCWs' #vaccination @Eurosurveillanc: http://t.co…","id":"555782046959042560","created_at":"2015-01-15T17:42:20.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":12,"username":"ECDC_Flu","id":"1371668696"},{"start":118,"end":134,"username":"Eurosurveillanc","id":"455839750"}],"hashtags":[{"start":14,"end":18,"tag":"flu"},{"start":105,"end":117,"tag":"vaccination"}],"annotations":[{"start":55,"end":60,"probability":0.9931,"type":"Place","normalized_text":"Europe"},{"start":91,"end":94,"probability":0.4142,"type":"Place","normalized_text":"HCWs"}]},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555782046959042560","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555773874240225280"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Special edition of our #EU #Health newsletter on Scientific Committees. Focus on Synthetic Biology #synbio http://t.co/WoK85…","id":"555782017078800384","created_at":"2015-01-15T17:42:13.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":38,"end":41,"tag":"EU"},{"start":42,"end":49,"tag":"Health"},{"start":114,"end":121,"tag":"synbio"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555782017078800384","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555774822433968130"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO: Countries in equatorial Africa have seen #Ebola for nearly four decades.\nThat's not the case with West Africa http://t.co/oK62Fuvr…","id":"555781982551277568","created_at":"2015-01-15T17:42:05.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":50,"end":56,"tag":"Ebola"}],"annotations":[{"start":22,"end":38,"probability":0.9247,"type":"Place","normalized_text":"equatorial Africa"},{"start":107,"end":117,"probability":0.827,"type":"Place","normalized_text":"West Africa"}]},"public_metrics":{"retweet_count":44,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555781982551277568","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555778903391100928"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Our #synthetic biology #publicconsultation http://t.co/4Mq0tLbyuP covered by @sciencemagazine http://t.co/Z8ie55HoAF http://…","id":"555728328167264256","created_at":"2015-01-15T14:08:53.000Z","entities":{"urls":[{"start":58,"end":80,"url":"http://t.co/4Mq0tLbyuP","expanded_url":"http://europa.eu/!kv96Wq","display_url":"europa.eu/!kv96Wq"},{"start":109,"end":131,"url":"http://t.co/Z8ie55HoAF","expanded_url":"http://www.sciencemag.org/content/347/6218/107.full","display_url":"sciencemag.org/content/347/62…"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"},{"start":92,"end":108,"username":"ScienceMagazine","id":"32372834"}],"hashtags":[{"start":19,"end":29,"tag":"synthetic"},{"start":38,"end":57,"tag":"publicconsultation"}],"annotations":{}},"public_metrics":{"retweet_count":8,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555728328167264256","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555657854225768448"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Monograph on Clostridium novyi alpha antitoxin for veterinary use will cease to form part of #European #Pharmacopoeia http:/…","id":"555728284332593152","created_at":"2015-01-15T14:08:42.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":108,"end":117,"tag":"European"},{"start":118,"end":132,"tag":"Pharmacopoeia"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555728284332593152","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555660996703166464"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @WHO_Europe: World Health Day this year (7 April) is on #foodsafety along the food chain: from farm to plate http://t.co/Qy2u0JJNjH #WHD…","id":"555727829074452481","created_at":"2015-01-15T14:06:54.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/Qy2u0JJNjH","expanded_url":"http://bit.ly/1sBYupi","display_url":"bit.ly/1sBYupi"}],"mentions":[{"start":3,"end":14,"username":"WHO_Europe","id":"125403342"}],"hashtags":[{"start":59,"end":70,"tag":"foodsafety"}],"annotations":[{"start":16,"end":31,"probability":0.6609,"type":"Other","normalized_text":"World Health Day"}]},"public_metrics":{"retweet_count":13,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555727829074452481","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555704249234243584"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Meeting of #PatientSafety &amp; Quality of Care Working Group, 18/12/14 - presentations available http://t.co/Zhs6GE9KZQ http://…","id":"555727783100710912","created_at":"2015-01-15T14:06:43.000Z","entities":{"urls":[{"start":113,"end":135,"url":"http://t.co/Zhs6GE9KZQ","expanded_url":"http://europa.eu/!RP44cv","display_url":"europa.eu/!RP44cv"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":26,"end":40,"tag":"PatientSafety"}],"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555727783100710912","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555704936076697600"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IMI_JU: Still on time to register for webinar on #prediabetes &amp; #type2diabetes topic. Sign up at http://t.co/AvOtRiQ3CW, webinar starts…","id":"555727676796076032","created_at":"2015-01-15T14:06:17.000Z","entities":{"urls":[{"start":105,"end":127,"url":"http://t.co/AvOtRiQ3CW","expanded_url":"http://ow.ly/HmHV2","display_url":"ow.ly/HmHV2"}],"mentions":[{"start":3,"end":10,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":[{"start":53,"end":65,"tag":"prediabetes"},{"start":72,"end":86,"tag":"type2diabetes"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555727676796076032","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555714405871386624"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @eurordis: A short film on how new online technologies can allow us to build relationships with other patients http://t.co/j5zTEHhRUF #R…","id":"555727455554912256","created_at":"2015-01-15T14:05:24.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/j5zTEHhRUF","expanded_url":"http://ow.ly/HfNAj","display_url":"ow.ly/HfNAj"}],"mentions":[{"start":3,"end":12,"username":"eurordis","id":"26993786"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555727455554912256","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555723647785385984"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @US_FDA: #FDAVoice: FDA’s Center for Drug Evaluation and Research Approved Many Innovative Drugs in 2014 http://t.co/PCQTxEzSfB","id":"555727428027678721","created_at":"2015-01-15T14:05:18.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/PCQTxEzSfB","expanded_url":"http://go.usa.gov/zve9","display_url":"go.usa.gov/zve9"}],"mentions":[{"start":3,"end":10,"username":"US_FDA","id":"208120290"}],"hashtags":[{"start":12,"end":21,"tag":"FDAVoice"}],"annotations":[{"start":23,"end":25,"probability":0.9032,"type":"Organization","normalized_text":"FDA"}]},"public_metrics":{"retweet_count":16,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555727428027678721","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555723932062736385"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EUTenders: Get an overview here on how the new EU directives on call for tenders will affect #PublicProcurement in #EU and #EEA http://…","id":"555726930499366913","created_at":"2015-01-15T14:03:19.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EUTenders","id":"294046348"}],"hashtags":[{"start":97,"end":115,"tag":"PublicProcurement"},{"start":119,"end":122,"tag":"EU"},{"start":127,"end":131,"tag":"EEA"}],"annotations":[{"start":51,"end":52,"probability":0.5351,"type":"Organization","normalized_text":"EU"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555726930499366913","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555724720319250432"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @TOPRANEWS: Health Technology Assessment (HTA), 27-28 January, London - joint workshop with @NICESciAdvice: http://t.co/zg26XM7EPO #rega…","id":"555690922818940928","created_at":"2015-01-15T11:40:14.000Z","entities":{"urls":[{"start":111,"end":133,"url":"http://t.co/zg26XM7EPO","expanded_url":"http://bit.ly/1wYsh6K","display_url":"bit.ly/1wYsh6K"}],"mentions":[{"start":3,"end":13,"username":"TOPRANEWS","id":"26739900"},{"start":95,"end":109,"username":"NICESciAdvice","id":"2834291205"}],"hashtags":{},"annotations":[{"start":66,"end":71,"probability":0.5752,"type":"Place","normalized_text":"London"}]},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555690922818940928","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555686032315015168"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #minutes from the December meeting of our #pharmacovigilance committee (PRAC): http://t.co/RZiRXMgPCs","id":"555656995517501441","created_at":"2015-01-15T09:25:25.000Z","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/RZiRXMgPCs","expanded_url":"http://bit.ly/1xZrPKR","display_url":"bit.ly/1xZrPKR"}],"mentions":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":62,"end":80,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555656995517501441","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda for this week's #Paediatric Committee (PDCO) meeting: http://t.co/Hiv8073FWf","id":"555656912621277185","created_at":"2015-01-15T09:25:06.000Z","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/Hiv8073FWf","expanded_url":"http://bit.ly/1xpvAEe","display_url":"bit.ly/1xpvAEe"}],"mentions":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":44,"end":55,"tag":"Paediatric"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555656912621277185","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICEcomms: For expert commentary on important new evidence read Eyes on Evidence. January issue out now http://t.co/kLevay3mA7","id":"555434764799606784","created_at":"2015-01-14T18:42:22.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/kLevay3mA7","expanded_url":"http://evidence.nhs.uk/about-evidence-services/bulletins-and-alerts/eyes-on-evidence/eyes-on-evidence-2015","display_url":"evidence.nhs.uk/about-evidence…"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":12,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555434764799606784","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555414042790338560"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #minutes from the December meeting of our #pharmacovigilance committee (PRAC): http://t.co/RZiRXMgPCs","id":"555406956878635008","created_at":"2015-01-14T16:51:52.000Z","entities":{"urls":[{"start":99,"end":121,"url":"http://t.co/RZiRXMgPCs","expanded_url":"http://bit.ly/1xZrPKR","display_url":"bit.ly/1xZrPKR"}],"mentions":{},"hashtags":[{"start":20,"end":28,"tag":"minutes"},{"start":62,"end":80,"tag":"pharmacovigilance"}],"annotations":{}},"public_metrics":{"retweet_count":6,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"555406956878635008","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda for this week's #Paediatric Committee (PDCO) meeting: http://t.co/Hiv8073FWf","id":"555405977479303168","created_at":"2015-01-14T16:47:58.000Z","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/Hiv8073FWf","expanded_url":"http://bit.ly/1xpvAEe","display_url":"bit.ly/1xpvAEe"}],"mentions":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":44,"end":55,"tag":"Paediatric"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"555405977479303168","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"The #agenda for this week's #veterinary committee (CVMP) meeting is available on our website: http://t.co/WuGVDhpmSj","id":"555405680371568640","created_at":"2015-01-14T16:46:47.000Z","entities":{"urls":[{"start":94,"end":116,"url":"http://t.co/WuGVDhpmSj","expanded_url":"http://bit.ly/1u5G77y","display_url":"bit.ly/1u5G77y"}],"mentions":{},"hashtags":[{"start":4,"end":11,"tag":"agenda"},{"start":28,"end":39,"tag":"veterinary"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"555405680371568640","source":"Twitter Web Client","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@PaulineCastres Apologies for the misunderstanding. Please forward your question to http://t.co/kcV5QnSch2 so that we can reply in full.","id":"555405377547026432","created_at":"2015-01-14T16:45:35.000Z","entities":{"urls":[{"start":84,"end":106,"url":"http://t.co/kcV5QnSch2","expanded_url":"http://bit.ly/X4lXwT","display_url":"bit.ly/X4lXwT"}],"mentions":[{"start":0,"end":15,"username":"PaulineCastres","id":"2828136269"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555297228404056064","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"555403578270289920"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"2828136269"},{"text":"RT @edqm_news: PhEur 8th Edition: 3 monographs will be suppressed on 1 January 2016. Find out which ones: http://t.co/Z1d1kZhpxR #european …","id":"555399952982355969","created_at":"2015-01-14T16:24:02.000Z","entities":{"urls":[{"start":106,"end":128,"url":"http://t.co/Z1d1kZhpxR","expanded_url":"http://bit.ly/1B1tVw9","display_url":"bit.ly/1B1tVw9"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":129,"end":138,"tag":"european"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555399952982355969","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555397531811999744"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EFSAJournal: #Suilectin (Phaseolus vulgaris lectins) for #piglets (growth enhancer) http://t.co/UF8ziXjFoB #zootechnical additives, #le…","id":"555399831024566272","created_at":"2015-01-14T16:23:33.000Z","entities":{"urls":[{"start":88,"end":110,"url":"http://t.co/UF8ziXjFoB","expanded_url":"http://bit.ly/1KJKMX9","display_url":"bit.ly/1KJKMX9"}],"mentions":[{"start":3,"end":15,"username":"EFSAJournal","id":"1479912948"}],"hashtags":[{"start":17,"end":27,"tag":"Suilectin"},{"start":61,"end":69,"tag":"piglets"},{"start":111,"end":124,"tag":"zootechnical"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555399831024566272","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555396546326691843"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: “Reducing blood cholesterol” What #health claims are authorized in #EU &amp; for which substances? http://t.co/9G0TKTpCiv http:/…","id":"555393325399048194","created_at":"2015-01-14T15:57:42.000Z","entities":{"urls":[{"start":114,"end":136,"url":"http://t.co/9G0TKTpCiv","expanded_url":"http://europa.eu/!MW69qC","display_url":"europa.eu/!MW69qC"}],"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":49,"end":56,"tag":"health"},{"start":82,"end":85,"tag":"EU"}],"annotations":{}},"public_metrics":{"retweet_count":19,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555393325399048194","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555375545744359424"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @NICEcomms: Valuing treatments: the regenerative medicine challenge - blog https://t.co/Gl7EhuvawU #regenmed #healtheconomics http://t.c…","id":"555392679484604416","created_at":"2015-01-14T15:55:08.000Z","entities":{"urls":[{"start":78,"end":101,"url":"https://t.co/Gl7EhuvawU","expanded_url":"https://www.nice.org.uk/news/blog/valuing-treatments-the-regenerative-medicine-challenge","display_url":"nice.org.uk/news/blog/valu…"}],"mentions":[{"start":3,"end":13,"username":"NICEComms","id":"85555796"}],"hashtags":[{"start":102,"end":111,"tag":"regenmed"},{"start":112,"end":128,"tag":"healtheconomics"}],"annotations":{}},"public_metrics":{"retweet_count":11,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555392679484604416","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555357591715713024"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EuropaBio: @EU_Commission @Moedas launches  new  €200m #FastTrack to #Innovation to promote #innovation #Horizon2020 #biotech4l…http://…","id":"555392410327740416","created_at":"2015-01-14T15:54:03.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EuropaBio","id":"19642657"},{"start":15,"end":29,"username":"EU_Commission","id":"157981564"},{"start":30,"end":37,"username":"Moedas","id":"20058825"}],"hashtags":[{"start":59,"end":69,"tag":"FastTrack"},{"start":73,"end":84,"tag":"Innovation"},{"start":96,"end":107,"tag":"innovation"},{"start":108,"end":120,"tag":"Horizon2020"},{"start":121,"end":131,"tag":"biotech4l"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555392410327740416","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555349967754129408"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @JeanGeorgesAE: Two day meeting in Paris for launch of ambitious @IMI_JU funded project on prevention of Alzheimer's dementia http://t.c…","id":"555391998421897218","created_at":"2015-01-14T15:52:25.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":17,"username":"JeanGeorgesAE","id":"1502220312"},{"start":68,"end":75,"username":"imi_ju","id":"1473203261469790214"}],"hashtags":{},"annotations":[{"start":38,"end":42,"probability":0.9974,"type":"Place","normalized_text":"Paris"}]},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555391998421897218","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555334675947061249"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @edqm_news: Download the new #OCABR Guideline (Human vaccines) - to come into force on 1st February 2015 http://t.co/l64YByG6MN","id":"555391877030363136","created_at":"2015-01-14T15:51:56.000Z","entities":{"urls":[{"start":108,"end":130,"url":"http://t.co/l64YByG6MN","expanded_url":"http://bit.ly/1DMENjv","display_url":"bit.ly/1DMENjv"}],"mentions":[{"start":3,"end":13,"username":"edqm_news","id":"2242197968"}],"hashtags":[{"start":32,"end":38,"tag":"OCABR"}],"annotations":{}},"public_metrics":{"retweet_count":4,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555391877030363136","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555334424100085760"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @MHRApress: From 15 Jan Diclofenac tablets - used to treat pain and inflammation - will be prescription only http://t.co/h1BLG0WdKr","id":"555391519130386433","created_at":"2015-01-14T15:50:31.000Z","entities":{"urls":[{"start":112,"end":134,"url":"http://t.co/h1BLG0WdKr","expanded_url":"http://ow.ly/Hinx7","display_url":"ow.ly/Hinx7"}],"mentions":[{"start":3,"end":13,"username":"MHRApress","id":"330990243"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555391519130386433","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555321216526209024"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: #HepC cure rates getting better &amp; better w/ new developments in treatment. Heres the latest on new #hepatitis C drugs\nhtt…","id":"555391056632872960","created_at":"2015-01-14T15:48:41.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":[{"start":18,"end":23,"tag":"HepC"},{"start":121,"end":131,"tag":"hepatitis"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555391056632872960","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555307234750889985"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"@PaulineCastres We published the latest report in October: http://t.co/QRuI7XiGzj","id":"555390675848818688","created_at":"2015-01-14T15:47:10.000Z","entities":{"urls":[{"start":59,"end":81,"url":"http://t.co/QRuI7XiGzj","expanded_url":"http://bit.ly/1ttm6fS","display_url":"bit.ly/1ttm6fS"}],"mentions":[{"start":0,"end":15,"username":"PaulineCastres","id":"2828136269"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":1,"like_count":0,"quote_count":0},"conversation_id":"555297228404056064","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"replied_to","id":"555349494062415872"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}},"in_reply_to_user_id":"2828136269"},{"text":"RT @rarediseaseday: Here are 7 ways to participate in #RareDisease Day http://t.co/sI4jcXyX5M How will you be recognizing Feb. 28?","id":"555310302787796993","created_at":"2015-01-14T10:27:48.000Z","entities":{"urls":[{"start":71,"end":93,"url":"http://t.co/sI4jcXyX5M","expanded_url":"http://www.rarediseaseday.org/article/get-involved","display_url":"rarediseaseday.org/article/get-in…"}],"mentions":[{"start":3,"end":18,"username":"rarediseaseday","id":"19982434"}],"hashtags":[{"start":54,"end":66,"tag":"RareDisease"}],"annotations":{}},"public_metrics":{"retweet_count":27,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555310302787796993","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555304619266801664"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @ZVALatvija: 46% of our survey respondents use antibiotics as recommended by their doctor, and always read the package leaflet.","id":"555300855608803328","created_at":"2015-01-14T09:50:15.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":14,"username":"ZVALatvija","id":"1576993495"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"555300855608803328","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"We've published the #agenda for this week's #veterinary committee (CVMP) meeting: http://t.co/WuGVDhpmSj","id":"555297228404056064","created_at":"2015-01-14T09:35:50.000Z","entities":{"urls":[{"start":82,"end":104,"url":"http://t.co/WuGVDhpmSj","expanded_url":"http://bit.ly/1u5G77y","display_url":"bit.ly/1u5G77y"}],"mentions":{},"hashtags":[{"start":20,"end":27,"tag":"agenda"},{"start":44,"end":55,"tag":"veterinary"}],"annotations":{}},"public_metrics":{"retweet_count":3,"reply_count":1,"like_count":1,"quote_count":0},"conversation_id":"555297228404056064","source":"Bitly","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"Two weeks to review guidance on persistent, bioaccumulative, toxic substances in #veterinary #medicine: http://t.co/U4BLpM1icJ #consultation","id":"555064898984878080","created_at":"2015-01-13T18:12:39.000Z","entities":{"urls":[{"start":104,"end":126,"url":"http://t.co/U4BLpM1icJ","expanded_url":"http://bit.ly/1wanHXb","display_url":"bit.ly/1wanHXb"}],"mentions":{},"hashtags":[{"start":81,"end":92,"tag":"veterinary"},{"start":93,"end":102,"tag":"medicine"},{"start":127,"end":140,"tag":"consultation"}],"annotations":{}},"public_metrics":{"retweet_count":0,"reply_count":0,"like_count":1,"quote_count":0},"conversation_id":"555064898984878080","source":"TweetDeck","lang":"en","referenced_tweets":{},"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_eHealth: Results #mHealth Green Paper consultation published: http://t.co/UsPzdyN3oG","id":"555063708507189248","created_at":"2015-01-13T18:07:55.000Z","entities":{"urls":[{"start":69,"end":91,"url":"http://t.co/UsPzdyN3oG","expanded_url":"http://ow.ly/HfdYE","display_url":"ow.ly/HfdYE"}],"mentions":[{"start":3,"end":14,"username":"EU_eHealth","id":"931560712484343810"}],"hashtags":[{"start":24,"end":32,"tag":"mHealth"}],"annotations":{}},"public_metrics":{"retweet_count":10,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555063708507189248","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555011403577573377"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @egabiosimilars: Sharing your #health data can help #doctors and researchers http://t.co/ub3Dm4YR31 #mhealth #wearables","id":"555063642795032577","created_at":"2015-01-13T18:07:39.000Z","entities":{"urls":[{"start":80,"end":102,"url":"http://t.co/ub3Dm4YR31","expanded_url":"http://bit.ly/1APZqbd","display_url":"bit.ly/1APZqbd"}],"mentions":{},"hashtags":[{"start":33,"end":40,"tag":"health"},{"start":55,"end":63,"tag":"doctors"},{"start":103,"end":111,"tag":"mhealth"},{"start":112,"end":122,"tag":"wearables"}],"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555063642795032577","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555016446523105281"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @myESMO: Don't forget, #IMPAKT15 abstract deadine is tomorrow: Wed 14 Jan #breastcancer http://t.co/6C1BodAMyp","id":"555063135452037120","created_at":"2015-01-13T18:05:38.000Z","entities":{"urls":[{"start":91,"end":113,"url":"http://t.co/6C1BodAMyp","expanded_url":"http://ow.ly/HfFVg","display_url":"ow.ly/HfFVg"}],"mentions":[{"start":3,"end":10,"username":"myESMO","id":"69232855"}],"hashtags":[{"start":26,"end":35,"tag":"IMPAKT15"},{"start":77,"end":90,"tag":"breastcancer"}],"annotations":{}},"public_metrics":{"retweet_count":1,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555063135452037120","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555034864597348354"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @Hep_Alliance: Poll reveals 82% agreed prisoners should be offered a #HCV test as part of their induction into prison http://t.co/tnEUaA…","id":"555063050374774787","created_at":"2015-01-13T18:05:18.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":16,"username":"Hep_Alliance","id":"20170584"}],"hashtags":[{"start":72,"end":76,"tag":"HCV"}],"annotations":{}},"public_metrics":{"retweet_count":5,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555063050374774787","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555039694204203009"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @EU_Health: Final opinion: Guidance on Determination of Potential Health Effects of #Nanomaterials Used in Medical Devices http://t.co/5…","id":"555062965989543937","created_at":"2015-01-13T18:04:58.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":13,"username":"EU_Health","id":"606325697"}],"hashtags":[{"start":87,"end":101,"tag":"Nanomaterials"}],"annotations":{}},"public_metrics":{"retweet_count":7,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555062965989543937","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555042753181388802"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}},{"text":"RT @IAPOtweets: 2015: An exciting year ahead! Our January news is out now! http://t.co/fQDZ1ADGc1 http://t.co/Vfwj1OJ6Te","id":"555062935882854401","created_at":"2015-01-13T18:04:51.000Z","entities":{"urls":[{"start":75,"end":97,"url":"http://t.co/fQDZ1ADGc1","expanded_url":"http://bit.ly/1xkMwf0","display_url":"bit.ly/1xkMwf0"},{"start":98,"end":120,"url":"http://t.co/Vfwj1OJ6Te","expanded_url":"https://twitter.com/IAPOtweets/status/555044102996496384/photo/1","display_url":"pic.twitter.com/Vfwj1OJ6Te"}],"mentions":[{"start":3,"end":14,"username":"IAPOtweets","id":"14682411"}],"hashtags":{},"annotations":{}},"public_metrics":{"retweet_count":2,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555062935882854401","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555044102996496384"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":["3_555044101930766338"]}},{"text":"RT @WHO: #Ebola survivors are helping to train health workers in #Liberia. Austin, a WHO “expert patient trainer” shares how http://t.co/CG…","id":"555062875732336640","created_at":"2015-01-13T18:04:36.000Z","entities":{"urls":{},"mentions":[{"start":3,"end":7,"username":"WHO","id":"14499829"}],"hashtags":[{"start":9,"end":15,"tag":"Ebola"},{"start":65,"end":73,"tag":"Liberia"}],"annotations":[{"start":75,"end":80,"probability":0.9071,"type":"Place","normalized_text":"Austin"}]},"public_metrics":{"retweet_count":92,"reply_count":0,"like_count":0,"quote_count":0},"conversation_id":"555062875732336640","source":"TweetDeck","lang":"en","referenced_tweets":[{"type":"retweeted","id":"555046690617827328"}],"possibly_sensitive":false,"author_id":"116716199","attachments":{"media_keys":{}}}]
